<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Pharmaceutics</journal-id><journal-id journal-id-type="iso-abbrev">Pharmaceutics</journal-id><journal-id journal-id-type="publisher-id">pharmaceutics</journal-id><journal-title-group><journal-title>Pharmaceutics</journal-title></journal-title-group><issn pub-type="epub">1999-4923</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6781314</article-id><article-id pub-id-type="doi">10.3390/pharmaceutics11090432</article-id><article-id pub-id-type="publisher-id">pharmaceutics-11-00432</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Hydrogels Based Drug Delivery Synthesis, Characterization and Administration</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Onaciu</surname><given-names>Anca</given-names></name><xref ref-type="aff" rid="af1-pharmaceutics-11-00432">1</xref></contrib><contrib contrib-type="author"><name><surname>Munteanu</surname><given-names>Raluca Andrada</given-names></name><xref ref-type="aff" rid="af1-pharmaceutics-11-00432">1</xref></contrib><contrib contrib-type="author"><name><surname>Moldovan</surname><given-names>Alin Iulian</given-names></name><xref ref-type="aff" rid="af1-pharmaceutics-11-00432">1</xref><xref ref-type="aff" rid="af2-pharmaceutics-11-00432">2</xref></contrib><contrib contrib-type="author"><name><surname>Moldovan</surname><given-names>Cristian Silviu</given-names></name><xref ref-type="aff" rid="af1-pharmaceutics-11-00432">1</xref><xref ref-type="aff" rid="af2-pharmaceutics-11-00432">2</xref><xref ref-type="aff" rid="af3-pharmaceutics-11-00432">3</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-3856-3784</contrib-id><name><surname>Berindan-Neagoe</surname><given-names>Ioana</given-names></name><xref ref-type="aff" rid="af1-pharmaceutics-11-00432">1</xref><xref ref-type="aff" rid="af3-pharmaceutics-11-00432">3</xref><xref ref-type="aff" rid="af4-pharmaceutics-11-00432">4</xref><xref rid="c1-pharmaceutics-11-00432" ref-type="corresp">*</xref></contrib></contrib-group><aff id="af1-pharmaceutics-11-00432"><label>1</label>Medfuture&#x02014;Research Center for Advanced Medicine, &#x0201c;Iuliu Ha&#x0021b;ieganu&#x0201d; University of Medicine and Pharmacy, Marinescu 23/Pasteur 4-6 Street, 400337 Cluj-Napoca, Romania</aff><aff id="af2-pharmaceutics-11-00432"><label>2</label>Department of Pharmaceutical Physics-Biophysics, Faculty of Pharmacy, &#x0201c;Iuliu Ha&#x0021b;ieganu&#x0201d; University of Medicine and Pharmacy, Pasteur 6 Street, 400349 Cluj-Napoca, Romania</aff><aff id="af3-pharmaceutics-11-00432"><label>3</label>Research Center for Functional Genomics, Biomedicine and Translational Medicine, &#x0201c;Iuliu Ha&#x0021b;ieganu&#x0201d; University of Medicine and Pharmacy, Marinescu 23 Street, 400337 Cluj-Napoca, Romania</aff><aff id="af4-pharmaceutics-11-00432"><label>4</label>The Oncology Institute &#x0201c;Prof Dr Ion Chiricu&#x0021b;a&#x0201d;, Republicii 34-36 Street, 400015 Cluj-Napoca, Romania</aff><author-notes><corresp id="c1-pharmaceutics-11-00432"><label>*</label>Correspondence: <email>ioananeagoe29@gmail.com</email>; Tel.: +4-0758102794</corresp></author-notes><pub-date pub-type="epub"><day>23</day><month>8</month><year>2019</year></pub-date><pub-date pub-type="collection"><month>9</month><year>2019</year></pub-date><volume>11</volume><issue>9</issue><elocation-id>432</elocation-id><history><date date-type="received"><day>14</day><month>6</month><year>2019</year></date><date date-type="accepted"><day>12</day><month>8</month><year>2019</year></date></history><permissions><copyright-statement>&#x000a9; 2019 by the authors.</copyright-statement><copyright-year>2019</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Hydrogels represent 3D polymeric networks specially designed for various medical applications. Due to their porous structure, they are able to swollen and to entrap large amounts of therapeutic agents and other molecules. In addition, their biocompatibility and biodegradability properties, together with a controlled release profile, make hydrogels a potential drug delivery system. In vivo studies have demonstrated their effectiveness as curing platforms for various diseases and affections. In addition, the results of the clinical trials are very encouraging and promising for the use of hydrogels as future target therapy strategies.</p></abstract><kwd-group><kwd>hydrogels</kwd><kwd>drug delivery</kwd><kwd>target therapy</kwd><kwd>polymers</kwd><kwd>biocompatibility</kwd><kwd>in vivo administration</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-pharmaceutics-11-00432"><title>1. Introduction</title><p>Hydrogels are three-dimensional (3D) polymeric networks, whose hydrophilic structure allows the absorption of large amounts of water (thousands of times their dry weight) [<xref rid="B1-pharmaceutics-11-00432" ref-type="bibr">1</xref>]. Hydrogels consisting of synthetic polymers are currently gaining more interest than natural-derived polymers due to their enhanced life-time, higher capacity to absorb water [<xref rid="B2-pharmaceutics-11-00432" ref-type="bibr">2</xref>], improved mechanical properties [<xref rid="B3-pharmaceutics-11-00432" ref-type="bibr">3</xref>] and finely-tuned degradation [<xref rid="B4-pharmaceutics-11-00432" ref-type="bibr">4</xref>]. Depending on their structure, hydrogels can be chemically stable or easily degradable [<xref rid="B5-pharmaceutics-11-00432" ref-type="bibr">5</xref>]. According to the type of cross-linking between the polymers, hydrogels can be classified in physical, held together by non-covalent, reversible interactions and chemical hydrogels, linked by non-reversible covalent bonds [<xref rid="B4-pharmaceutics-11-00432" ref-type="bibr">4</xref>].</p><p>Their unique properties, including reliable biocompatibility, tunable mechanical and degradation features, sensitivity to various stimuli and the ability to be easily conjugated with hydrophilic and hydrophobic therapeutic compounds [<xref rid="B4-pharmaceutics-11-00432" ref-type="bibr">4</xref>] has made them important candidates in biomedical applications including drug delivery [<xref rid="B6-pharmaceutics-11-00432" ref-type="bibr">6</xref>], tissue engineering [<xref rid="B7-pharmaceutics-11-00432" ref-type="bibr">7</xref>,<xref rid="B8-pharmaceutics-11-00432" ref-type="bibr">8</xref>,<xref rid="B9-pharmaceutics-11-00432" ref-type="bibr">9</xref>], 3D cell cultures [<xref rid="B10-pharmaceutics-11-00432" ref-type="bibr">10</xref>], in vitro diagnostics and stem cell research [<xref rid="B1-pharmaceutics-11-00432" ref-type="bibr">1</xref>] (<xref ref-type="fig" rid="pharmaceutics-11-00432-f001">Figure 1</xref>).</p><p>In the therapeutic area, drug delivery approaches require outstanding improvements in obtaining safe transport systems in order to achieve the desired therapeutic effect and to avoid the side effects. Biomimetic strategies involving polymers describe innovative industrial products orientated to target therapy and controlled release. Hydrogels inspired design offer favorable conditions for therapeutic compounds encapsulation and protection. Furthermore, they are becoming biological responsive structures which ensure adequate biocompatibility and biodegradability.</p></sec><sec id="sec2-pharmaceutics-11-00432"><title>2. Hydrogel Synthesis Methods</title><p>Hydrogel synthesis is an essential step in developing new structures with beneficial properties for drug delivery action. The hydrogel structure is defined by the hydration of hydrophilic groups and domains of the polymers involved. Therefore, these groups and their interconnected chains create three-dimensional networks via crosslinking, avoiding their dissolution in the aqueous phase [<xref rid="B2-pharmaceutics-11-00432" ref-type="bibr">2</xref>,<xref rid="B11-pharmaceutics-11-00432" ref-type="bibr">11</xref>]. </p><p>The standard synthesis procedures imply polymerization and crosslinking. These techniques can happen in parallel in one step, or one after the other in multiple steps [<xref rid="B2-pharmaceutics-11-00432" ref-type="bibr">2</xref>]. </p><p>Polymerization process is part of the gelation process. The structure and the conformation of the starting material influence the formation of soluble branched polymer networks [<xref rid="B12-pharmaceutics-11-00432" ref-type="bibr">12</xref>]. The starting material refers to polymer monomers, prepolymers, or hydrophilic polymers [<xref rid="B13-pharmaceutics-11-00432" ref-type="bibr">13</xref>]. The monomers and polyfunctional comonomers act as crosslinkers in network development. Sometimes polymerization is generated by radical initiators [<xref rid="B14-pharmaceutics-11-00432" ref-type="bibr">14</xref>,<xref rid="B15-pharmaceutics-11-00432" ref-type="bibr">15</xref>] or photoinitiators [<xref rid="B16-pharmaceutics-11-00432" ref-type="bibr">16</xref>,<xref rid="B17-pharmaceutics-11-00432" ref-type="bibr">17</xref>] like irradiation [<xref rid="B18-pharmaceutics-11-00432" ref-type="bibr">18</xref>,<xref rid="B19-pharmaceutics-11-00432" ref-type="bibr">19</xref>,<xref rid="B20-pharmaceutics-11-00432" ref-type="bibr">20</xref>]. </p><p>Hydrophilic polymers are often used for hydrogel synthesis due to their biocompatibility [<xref rid="B21-pharmaceutics-11-00432" ref-type="bibr">21</xref>,<xref rid="B22-pharmaceutics-11-00432" ref-type="bibr">22</xref>] in aqueous environments [<xref rid="B23-pharmaceutics-11-00432" ref-type="bibr">23</xref>] and mostly due to their loading drug potential [<xref rid="B24-pharmaceutics-11-00432" ref-type="bibr">24</xref>]. </p><p>The swelling property of a hydrogel is significant for further use in medical applications because most of the body tissues are composed of large amounts of water [<xref rid="B25-pharmaceutics-11-00432" ref-type="bibr">25</xref>]. Swelling features of various polymers are advantageous for functionalization with therapeutic agents. On the other side, the effectiveness of such systems could consist of their capacity to deliver these agents without side outcomes. </p><p>The crosslinker agent plays a significant role in hydrogel swelling [<xref rid="B26-pharmaceutics-11-00432" ref-type="bibr">26</xref>] and degradation [<xref rid="B27-pharmaceutics-11-00432" ref-type="bibr">27</xref>]. It influences the physical properties of the final hydrogel product [<xref rid="B28-pharmaceutics-11-00432" ref-type="bibr">28</xref>]. Crosslinking methods imply covalent or non-covalent interactions between polymer monomers providing elastic characteristics [<xref rid="B2-pharmaceutics-11-00432" ref-type="bibr">2</xref>,<xref rid="B11-pharmaceutics-11-00432" ref-type="bibr">11</xref>,<xref rid="B29-pharmaceutics-11-00432" ref-type="bibr">29</xref>,<xref rid="B30-pharmaceutics-11-00432" ref-type="bibr">30</xref>]. For this reason, two different types of hydrogels were identified: chemical gels based on covalent interactions (<xref ref-type="fig" rid="pharmaceutics-11-00432-f002">Figure 2</xref>C) and physical gels based on non-covalent interactions [<xref rid="B11-pharmaceutics-11-00432" ref-type="bibr">11</xref>] (<xref ref-type="fig" rid="pharmaceutics-11-00432-f002">Figure 2</xref>B).</p><p>On the other hand, there are factors involved in altering hydrogels assembly [<xref rid="B31-pharmaceutics-11-00432" ref-type="bibr">31</xref>]. Chemical stimuli (pH [<xref rid="B32-pharmaceutics-11-00432" ref-type="bibr">32</xref>,<xref rid="B33-pharmaceutics-11-00432" ref-type="bibr">33</xref>], ionic strength [<xref rid="B34-pharmaceutics-11-00432" ref-type="bibr">34</xref>,<xref rid="B35-pharmaceutics-11-00432" ref-type="bibr">35</xref>], solvent composition [<xref rid="B36-pharmaceutics-11-00432" ref-type="bibr">36</xref>], and molecules [<xref rid="B37-pharmaceutics-11-00432" ref-type="bibr">37</xref>]) (<xref ref-type="fig" rid="pharmaceutics-11-00432-f002">Figure 2</xref>A) lead to permanent gels. Physical stimuli (temperature [<xref rid="B38-pharmaceutics-11-00432" ref-type="bibr">38</xref>], electric field [<xref rid="B39-pharmaceutics-11-00432" ref-type="bibr">39</xref>], magnetic field [<xref rid="B40-pharmaceutics-11-00432" ref-type="bibr">40</xref>], light [<xref rid="B16-pharmaceutics-11-00432" ref-type="bibr">16</xref>,<xref rid="B41-pharmaceutics-11-00432" ref-type="bibr">41</xref>], pressure [<xref rid="B42-pharmaceutics-11-00432" ref-type="bibr">42</xref>]) (<xref ref-type="fig" rid="pharmaceutics-11-00432-f002">Figure 2</xref>A) determine the reversible conversion between un-swollen and swollen state called phase transition. Biological stimuli (enzymes [<xref rid="B43-pharmaceutics-11-00432" ref-type="bibr">43</xref>], antigens [<xref rid="B44-pharmaceutics-11-00432" ref-type="bibr">44</xref>], and nucleic acids [<xref rid="B45-pharmaceutics-11-00432" ref-type="bibr">45</xref>]) (<xref ref-type="fig" rid="pharmaceutics-11-00432-f002">Figure 2</xref>A) affect the physical properties of the hydrogels like solubility [<xref rid="B46-pharmaceutics-11-00432" ref-type="bibr">46</xref>]. These stimuli-responsive polymers belong to the group of intelligent or smart materials [<xref rid="B47-pharmaceutics-11-00432" ref-type="bibr">47</xref>,<xref rid="B48-pharmaceutics-11-00432" ref-type="bibr">48</xref>].</p><p>Smart polymers can form self-assembly structures through two significant procedures: using peptide/protein materials or using hybrid systems containing minimum a synthetic macromolecule and a peptide/protein motif [<xref rid="B49-pharmaceutics-11-00432" ref-type="bibr">49</xref>]. Their synthesis includes supramolecular chemistry and the control of the dynamic of supramolecular interactions and bonds for future media conditions [<xref rid="B50-pharmaceutics-11-00432" ref-type="bibr">50</xref>]. Proteins and peptides extend the system properties to degradability, stimuli-responsive phase transition, and also biological molecules targeting [<xref rid="B51-pharmaceutics-11-00432" ref-type="bibr">51</xref>]. Such smart hydrogels own convenient characteristics for drug delivery systems through their structural, morphological, and functional modifications occurred due to stimuli detection [<xref rid="B52-pharmaceutics-11-00432" ref-type="bibr">52</xref>]. These modifications ensure a time-dependent controlled release of the therapeutic agent with long circulation time converging to minimal side effects [<xref rid="B53-pharmaceutics-11-00432" ref-type="bibr">53</xref>].</p></sec><sec id="sec3-pharmaceutics-11-00432"><title>3. Classification </title><p>Hydrogels can be classified considering different parameters like: polymer origin, ionic charge and biodegradability [<xref rid="B54-pharmaceutics-11-00432" ref-type="bibr">54</xref>].</p><p>According to the polymer origin, the hydrogel composition can be synthetic, natural or it can contain both synthetic and natural polymers and is called hybrid [<xref rid="B55-pharmaceutics-11-00432" ref-type="bibr">55</xref>]. Lately, the synthetic hydrogels are preferred due to their high water absorption properties, long life, and also a variety of chemistry which confers better strengthens and resistance in different conditions [<xref rid="B2-pharmaceutics-11-00432" ref-type="bibr">2</xref>]. </p><p>Ionic charge influences the uptake of the charged drug molecules. A positively charged hydrogel will embed and release negatively charged low molecular weight molecules [<xref rid="B56-pharmaceutics-11-00432" ref-type="bibr">56</xref>]. Furthermore, the ionic charged hydrogels have implications on cellular interactions and behavior [<xref rid="B57-pharmaceutics-11-00432" ref-type="bibr">57</xref>].</p><p>Biodegradable hydrogels need to meet some specific features as biocompatibility and adaptability to various media conditions and preparation procedures. Such hydrogels are potential candidates for drug delivery applications because of their flexibility. Biodegradation process describes a chemical decomposition of a complex hydrogel into a simple structure through solubilizing or hydrolysis dictated by various external stimuli like pH, ionic strength, temperature or enzymes [<xref rid="B27-pharmaceutics-11-00432" ref-type="bibr">27</xref>]. Therefore, these hydrogels can be divided into chemical, physical and biological stimuli responsive categories.</p><p>Otherwise, non-biodegradable hydrogels offer multiple possibilities for tissue engineering applications by encapsulating growth factors, proteins [<xref rid="B58-pharmaceutics-11-00432" ref-type="bibr">58</xref>]. Other medical fields that are exploiting these type of hydrogels are plastic and reconstruction surgery, orthopedic implants, ocular lens, and microfluidic devices [<xref rid="B59-pharmaceutics-11-00432" ref-type="bibr">59</xref>]. </p><p><xref rid="pharmaceutics-11-00432-t001" ref-type="table">Table 1</xref> summarizes important classes of hydrogels and their properties and applications.</p></sec><sec id="sec4-pharmaceutics-11-00432"><title>4. Hydrogel Functionalization with Therapeutic Agents</title><p>Crosslinking synthesis methods make possible the functionalization with drugs and other therapeutic agents in order to develop new delivery systems [<xref rid="B121-pharmaceutics-11-00432" ref-type="bibr">121</xref>]. The hydrogel design describes cross-linked polymers and meshes that allow compound solution loading and diffusion. When functionalizing, the size of the meshes is to be taken into consideration [<xref rid="B122-pharmaceutics-11-00432" ref-type="bibr">122</xref>]. This procedure can be performed at two different times of hydrogel synthesis: at the beginning by mixing the drug with the other reagents or at the end after hydrogel is done [<xref rid="B29-pharmaceutics-11-00432" ref-type="bibr">29</xref>]. In situ loading method suits for hydrophilic drugs and is based on dissolving the drug into the water together with the polymer powder. The other technique is called post-loading and refers to dry hydrogel films immersion into drug solution for a certain period of time. In both of these cases, after drug incorporation, the hydrogel has a dried state and confers protection. In addition, cross-linkers are essential factors in controlled release of high or low molecular weight therapeutic agents, and in most cases the degradable cross-linkers are preferred [<xref rid="B56-pharmaceutics-11-00432" ref-type="bibr">56</xref>]. </p><p>Wong and Dodou, 2017, synthesized poly(ethylene oxide) hydrogels cross-linked with pentaerythritol tetra-acrylate using ultraviolet light for cross-linking reaction. These hydrogel films were loaded with various drugs (lidocaine hydrochloride, diclofenac sodium and ibuprofen) using post-loading and in situ loading methods. The study results revealed that in situ loading procedure was more successful regarding drug encapsulation [<xref rid="B123-pharmaceutics-11-00432" ref-type="bibr">123</xref>].</p><p>Prince et al., 2019, used in situ loading technique for thermoresponsive poly(&#x003f5;-caprolactone-co-lactide)-block-poly(ethylene glycol)-block-poly(&#x003f5;-caprolactone-<italic>co</italic>-lactide) hydrogels functionalization with celecoxib. PEG&#x02019;s length affects hydrogel loading capacity and 2000 g/mol was found to be the optimal length for drug delivery applications [<xref rid="B124-pharmaceutics-11-00432" ref-type="bibr">124</xref>].</p><p>Many drugs and small molecules, especially the hydrophobic ones, can be encapsulated in order to enter the gel for further medical applications. For instance, many nanosystems (metallic [<xref rid="B125-pharmaceutics-11-00432" ref-type="bibr">125</xref>], lipid [<xref rid="B126-pharmaceutics-11-00432" ref-type="bibr">126</xref>], polymeric [<xref rid="B127-pharmaceutics-11-00432" ref-type="bibr">127</xref>], peptides [<xref rid="B128-pharmaceutics-11-00432" ref-type="bibr">128</xref>]) are used for targeted delivery [<xref rid="B129-pharmaceutics-11-00432" ref-type="bibr">129</xref>]. Nanoparticles are fashioned to ensure drug pharmacokinetics and pharmacodynamics [<xref rid="B130-pharmaceutics-11-00432" ref-type="bibr">130</xref>].</p><p>The use of nanoparticles can help the crosslinking reaction by adsorbing or attaching to polymer chains [<xref rid="B131-pharmaceutics-11-00432" ref-type="bibr">131</xref>], but also they can modify the hydrogel assembly properties [<xref rid="B132-pharmaceutics-11-00432" ref-type="bibr">132</xref>]. Due to the porous hydrogel structure, nanoparticles are easily embedded within a polymeric 3D network. This aspect is mandatory for achieving controlled release profile and can impede in choosing the right nanoparticles for drug molecules delivery, respectively those for hydrogel functionalization [<xref rid="B133-pharmaceutics-11-00432" ref-type="bibr">133</xref>]. Other nanoparticle physico-chemical properties like size, polydispersity index, and spatial orientation inside the gel need to be carefully adjusted [<xref rid="B134-pharmaceutics-11-00432" ref-type="bibr">134</xref>]. </p><p>High loading capacity combined with controlled drug release and prolonged stability, will represent advantages for the newly designed system [<xref rid="B135-pharmaceutics-11-00432" ref-type="bibr">135</xref>]. </p><p>Nanoparticle functionalized gels can perform targeted drug delivery in different ways: passive [<xref rid="B136-pharmaceutics-11-00432" ref-type="bibr">136</xref>], stimuli-responsive [<xref rid="B137-pharmaceutics-11-00432" ref-type="bibr">137</xref>], site-specific [<xref rid="B138-pharmaceutics-11-00432" ref-type="bibr">138</xref>] or detoxification manner [<xref rid="B139-pharmaceutics-11-00432" ref-type="bibr">139</xref>]. </p></sec><sec id="sec5-pharmaceutics-11-00432"><title>5. Characterization Methods</title><p>When considering hydrogel characteristics usually investigated, the typical protocol will most probably compose of two kinds of tests: structural and functional. For structural analysis, an assortment of microscopy techniques have become, to a degree, the golden standard. As hydrogels are three dimensional, commonly optically clear, materials, conventional bright field microscopy is sparsely used. By far, the most common technique is Scanning Electron Microscopy (SEM). An extensive review of morphological characterization of hydrogels has been recently published [<xref rid="B140-pharmaceutics-11-00432" ref-type="bibr">140</xref>], and it implies that an SEM is a go-to instrument for hydrogel characterization regardless of composition. SEM imaging does require specialized sample preparation instrumentation, but the methodology was standardized to most gel types. Briefly, formalin fixed samples are dehydrated and freeze-dried, followed by either Au or Au/Pd sputtering under vacuum before imaging [<xref rid="B141-pharmaceutics-11-00432" ref-type="bibr">141</xref>]. Newer protocols forgo the fixation and dehydration steps [<xref rid="B142-pharmaceutics-11-00432" ref-type="bibr">142</xref>] even though there is evidence that liquid nitrogen snap freezing followed by freeze-drying induces gel shrinkage and incorrect evaluation of pore size [<xref rid="B143-pharmaceutics-11-00432" ref-type="bibr">143</xref>,<xref rid="B144-pharmaceutics-11-00432" ref-type="bibr">144</xref>]. SEM is generally used to asses pore formation and pore size [<xref rid="B145-pharmaceutics-11-00432" ref-type="bibr">145</xref>], crosslinking status [<xref rid="B146-pharmaceutics-11-00432" ref-type="bibr">146</xref>] and the effect certain loading compounds have on general gel structure [<xref rid="B147-pharmaceutics-11-00432" ref-type="bibr">147</xref>].</p><p>While SEM does provide valuable qualitative information, alternatives do exist and can potentially provide complementary information to the limited capacity of regular SEM of generating two-dimensional projections. Laser scanning confocal microscopy (LSCM), used in combination with fluorescent dyes is capable of generating Z-stacks to evaluate similar aspects (i.e., pore dimensions and shape) to SEM [<xref rid="B140-pharmaceutics-11-00432" ref-type="bibr">140</xref>,<xref rid="B148-pharmaceutics-11-00432" ref-type="bibr">148</xref>]. Where LSCM shines is the complementary characterization capacity it has. Hydrogel loading and unloading of solutes [<xref rid="B149-pharmaceutics-11-00432" ref-type="bibr">149</xref>], dispersion and mobility of the solute [<xref rid="B150-pharmaceutics-11-00432" ref-type="bibr">150</xref>] or distribution of solid loading materials [<xref rid="B151-pharmaceutics-11-00432" ref-type="bibr">151</xref>] are tested with the condition that the solute (or other compounds of interest) is fluorescent or can be spiked/bound to a fluorescent marker. Structural characteristics, along with mechanical proprieties, can also be observed by different variations of Scanning Probe Microscopy. It was proved that the elastic modulus of the gel correlates is correlated with cell differentiation [<xref rid="B152-pharmaceutics-11-00432" ref-type="bibr">152</xref>] and migration [<xref rid="B153-pharmaceutics-11-00432" ref-type="bibr">153</xref>]. As the modulus of the hydrogel correlates with the degree of polymer cross-linkage [<xref rid="B154-pharmaceutics-11-00432" ref-type="bibr">154</xref>] and cross-linkage to solute mobility through the gel [<xref rid="B155-pharmaceutics-11-00432" ref-type="bibr">155</xref>], Atomic Force Microscopy is a powerful multimodal analysis tool in the characterization of hydrogels, allowing not only topological and roughness investigations but also functional ones. Of course, all the techniques presented can be used in parallel or correlatively to offer complementary information or potentially highly specific characteristics such as individual pore mechanics [<xref rid="B156-pharmaceutics-11-00432" ref-type="bibr">156</xref>]. </p><p>Functional analysis is paramount to understanding the effects that solute/external stimuli have on the hydrogel. The most important ones seem to be: absorption capacity and rate, absorbency under load, lowest solute, and extra monomer level, pH, and photostability [<xref rid="B2-pharmaceutics-11-00432" ref-type="bibr">2</xref>]. Drug release from the hydrogel is usually a function of the diffusion capacity of the drug and the retention capacity of the gel. This is most commonly measured by dynamically probing the concentration of the drug in the medium of interest and plotting the concentration against a certain time interval or as a percentage. The actual analysis is highly dependent of the nature of the tested compound and can range from HPLC for peptides [<xref rid="B157-pharmaceutics-11-00432" ref-type="bibr">157</xref>], electrochemical probing for gases such as H<sub>2</sub>S [<xref rid="B158-pharmaceutics-11-00432" ref-type="bibr">158</xref>] or various fluorescence/colorimetric/absorbancy tests. </p><p>The controlled release can be achieved through various strategies based on hydrogel composition and properties. For instance, there are some molecules that can initiate and enhance the degradation rate [<xref rid="B159-pharmaceutics-11-00432" ref-type="bibr">159</xref>,<xref rid="B160-pharmaceutics-11-00432" ref-type="bibr">160</xref>]. Matrix-metalloproteinases family members can cleave the oligo-peptide bonds [<xref rid="B161-pharmaceutics-11-00432" ref-type="bibr">161</xref>]. Other examples are represented by glucose [<xref rid="B162-pharmaceutics-11-00432" ref-type="bibr">162</xref>] and thrombin [<xref rid="B163-pharmaceutics-11-00432" ref-type="bibr">163</xref>], which are playing important roles in physiological processes. On the other hand, external stimuli [<xref rid="B164-pharmaceutics-11-00432" ref-type="bibr">164</xref>,<xref rid="B165-pharmaceutics-11-00432" ref-type="bibr">165</xref>] can determine hydrogel networks disruption. Hydrogels swelling capacity is an important target for the sustained release mechanism [<xref rid="B166-pharmaceutics-11-00432" ref-type="bibr">166</xref>] and is also influenced by stimuli sensitivity [<xref rid="B167-pharmaceutics-11-00432" ref-type="bibr">167</xref>]. </p><p>In addition, hydrogel mechanical deformation using magnetic field or ultrasounds is a very common procedure. In this regard, Liu et al., 2006, proposed an intelligent magnetic hydrogel loaded with drug molecules capable of tunable controlled release profile time dependent [<xref rid="B168-pharmaceutics-11-00432" ref-type="bibr">168</xref>]. Ultrasound guided drug release approach was digitally integrated into ionically crosslinked hydrogels [<xref rid="B169-pharmaceutics-11-00432" ref-type="bibr">169</xref>].</p><p>Many mathematical models are used for predicting the drug delivery efficiency of polymeric hydrogels. These determinations are based on mesh size, mechanical, mass-transport and diffusion behavior using hydrodynamics, obstruction, free volume and combined theories [<xref rid="B166-pharmaceutics-11-00432" ref-type="bibr">166</xref>,<xref rid="B170-pharmaceutics-11-00432" ref-type="bibr">170</xref>].</p></sec><sec id="sec6-pharmaceutics-11-00432"><title>6. In Vivo Biocompatibility and Biodegradability</title><p>In order to compare and investigate the effects of hydrogels in vivo, it is necessary to evaluate its biocompatibility, since living organisms are prone to develop inflammatory reactions which are facilitated by the degradation of the synthetic polymers [<xref rid="B171-pharmaceutics-11-00432" ref-type="bibr">171</xref>]. As stated in a review by Naahidi et al., hydrogel toxicity and biocompatibility is dependent on the breakdown of the polymer into monomers or oligomers, the crosslinking agents or trace polymerization agents [<xref rid="B172-pharmaceutics-11-00432" ref-type="bibr">172</xref>]. Besides achieving favorable hydrogel formulations for drug delivery, the main challenges are performing toxicity screening [<xref rid="B173-pharmaceutics-11-00432" ref-type="bibr">173</xref>], maintaining long-term stability, and controlling the release properties of the therapeutic agents. One favorable aspect of hydrogel research has been its longevity. The over 100 years of research have produced gel-like biopolymers with low toxicity and high biocompatibility, especially those derived from natural molecules such as collagen, chitosan, fibrin, and hyaluronic acid [<xref rid="B174-pharmaceutics-11-00432" ref-type="bibr">174</xref>]. However, while previous in vitro studies have shown promising results regarding the biodegradability and biocompatibility of these compounds, further in vivo studies are necessary at this point [<xref rid="B175-pharmaceutics-11-00432" ref-type="bibr">175</xref>]. </p></sec><sec id="sec7-pharmaceutics-11-00432"><title>7. Hydrogel Administration</title><p>As mentioned above, a complex problem regarding the administration of various biomaterials in vivo reflects the ability of the material to conserve and promote a biologically safe environment for the subjected animals. In vivo testing is challenging because there still is a need for an established and reliable animal model in order to achieve biomechanical restoration. Following these standards, different injectable hydrogels protocols were developed and optimized, which because the body very well tolerated them, are ideal candidates for performing in vivo testing on rodents [<xref rid="B176-pharmaceutics-11-00432" ref-type="bibr">176</xref>]. Given the fact that these delivery systems are suitable for clinical use, the most accessible routes of administration are subcutaneous [<xref rid="B177-pharmaceutics-11-00432" ref-type="bibr">177</xref>], oral [<xref rid="B178-pharmaceutics-11-00432" ref-type="bibr">178</xref>], rectal [<xref rid="B179-pharmaceutics-11-00432" ref-type="bibr">179</xref>], topical and transdermal [<xref rid="B180-pharmaceutics-11-00432" ref-type="bibr">180</xref>], orthotopic [<xref rid="B181-pharmaceutics-11-00432" ref-type="bibr">181</xref>], intraperitoneal [<xref rid="B182-pharmaceutics-11-00432" ref-type="bibr">182</xref>] and ocular [<xref rid="B183-pharmaceutics-11-00432" ref-type="bibr">183</xref>]. <xref ref-type="fig" rid="pharmaceutics-11-00432-f003">Figure 3</xref> represents all these administration routes.</p><sec id="sec7dot1-pharmaceutics-11-00432"><title>7.1. Subcutaneous Hydrogel Delivery System</title><p>One of the most efficient methods to evaluate the response to the therapy and assessing the toxic response in vivo in mice is performing a subcutaneous injection. Since the subcutaneous area is vascularized, the implanted hydrogels or other biomaterials are immune privileged, so a mild reaction to foreign moieties is to be expected [<xref rid="B176-pharmaceutics-11-00432" ref-type="bibr">176</xref>]. Bare polyethylene hydrogels have been proven to not exhibit cytotoxicity in murine models even after 60 days when injected subcutaneously [<xref rid="B184-pharmaceutics-11-00432" ref-type="bibr">184</xref>]. Similar results regarding biocompatibility were obtained with ellagic acid hydrogels [<xref rid="B185-pharmaceutics-11-00432" ref-type="bibr">185</xref>], nano-patterned poly-acrylamide hydrogels [<xref rid="B186-pharmaceutics-11-00432" ref-type="bibr">186</xref>] chitosan and gelatin hydrogels [<xref rid="B187-pharmaceutics-11-00432" ref-type="bibr">187</xref>,<xref rid="B188-pharmaceutics-11-00432" ref-type="bibr">188</xref>], alginate [<xref rid="B189-pharmaceutics-11-00432" ref-type="bibr">189</xref>] and pectin [<xref rid="B190-pharmaceutics-11-00432" ref-type="bibr">190</xref>]. It is worth mentioning that the majority of the studies do report mild inflammatory responses.</p></sec><sec id="sec7dot2-pharmaceutics-11-00432"><title>7.2. Oral Delivery</title><p>The oral delivery route represents by far the most convenient solution under adjustable parameters and patient compliance [<xref rid="B191-pharmaceutics-11-00432" ref-type="bibr">191</xref>]. Orally administered hydrogels should provide bioavailability depending on medium particularities, such as pH variations along the intestinal tract [<xref rid="B192-pharmaceutics-11-00432" ref-type="bibr">192</xref>]. MPEG, caprolactone and, itaconic acid pH-sensitive hydrogels were tested for acute oral toxicity in BALB/c mice and showed no signs of toxicity [<xref rid="B193-pharmaceutics-11-00432" ref-type="bibr">193</xref>]. When considering oral ingestion, the metabolic effect that monomers have on the organism is very significant. Poly-glycolic and poly-lactic-<italic>co</italic>-glycolic acid hydrogel degradation have been shown to affect healthy metabolism [<xref rid="B172-pharmaceutics-11-00432" ref-type="bibr">172</xref>], leading to some limitations in terms of hydrogel therapy such as:<list list-type="order"><list-item><p>Presence of digestive enzymes could lead to denaturation;</p></list-item><list-item><p>Low permeability through the epithelial membrane into the bloodstream;</p></list-item><list-item><p>Superior and inferior digestive systems can represent potential therapeutic targets [<xref rid="B194-pharmaceutics-11-00432" ref-type="bibr">194</xref>].</p></list-item></list></p></sec><sec id="sec7dot3-pharmaceutics-11-00432"><title>7.3. Rectal Delivery</title><p>Rectal administration offers plenty of advantages such as rapid absorption of the compound, avoidance of the gastrointestinal tract, limited adverse reactions of the therapeutics, and provides controlled release of the compound in the context of the stable environmental conditions encountered in the rectum. Based on an earlier study that showed excellent biocompatibility on the digestive tract [<xref rid="B195-pharmaceutics-11-00432" ref-type="bibr">195</xref>], rectally administrated catechol-chitosan- based hydrogels with mucoadhesive properties have been tested in murine models and show no toxic effects after 10 days [<xref rid="B196-pharmaceutics-11-00432" ref-type="bibr">196</xref>]. Regarding this issue, Afaf A. et al., developed a hydrogel-based product and made a correlation between in vitro and in vivo profile with promising results [<xref rid="B179-pharmaceutics-11-00432" ref-type="bibr">179</xref>].</p></sec><sec id="sec7dot4-pharmaceutics-11-00432"><title>7.4. Topical and Transdermal Delivery</title><p>Hydrogel therapy is suitable for the topical and transdermal approach. Nowadays, the general concept about nanosystems in the context of skin penetration is that the skin barrier restricts the delivery via epidermis and dermis. In truth, hydrogel penetration through the skin seems unlikely as the macroscale mesh-like structure would prohibit penetration and has been shown, in the case of collagen hydrogels, to not even affect burn models [<xref rid="B197-pharmaceutics-11-00432" ref-type="bibr">197</xref>]. Various alternative hydrogel formulations are commonly tested on graft donors with no discernable side effects compared to other gel-based formulations commonly used in hospital environments [<xref rid="B198-pharmaceutics-11-00432" ref-type="bibr">198</xref>]. Recent studies demonstrated that this method of delivery is reliable as a delivery system for nanoparticles with various roles, and it only depends on nanoparticles diameter, charge, and structure. The coating influences the penetration rate. Peptide layered nanocarriers are more efficient than pegylated ones. Ex vivo studies were carried out, using skin samples collected from mouse and human through surgical resection [<xref rid="B199-pharmaceutics-11-00432" ref-type="bibr">199</xref>]. </p></sec><sec id="sec7dot5-pharmaceutics-11-00432"><title>7.5. Orthotopic Injections</title><p>Administration of hydrogels via intratumoral injection is a practical approach, which requires the release of the nanostructure system loaded in a hydrogel matrix. These hydrogel structures are so-called &#x0201c;macroscopic gels&#x0201d; that are coming with the imperative need to decrease potential damages of associated tissues during an injection [<xref rid="B200-pharmaceutics-11-00432" ref-type="bibr">200</xref>]. Qinjie Wu et al., 2015 synthesized a smart hydrogel responsive to temperature, which prevented the formation of peritoneal adhesion on a damaged abdominal wall [<xref rid="B181-pharmaceutics-11-00432" ref-type="bibr">181</xref>]. Where orthotopic treatment using hydrogels seems to show promise is in the post-resection cavity where it can act as a slow release to improve long term survival [<xref rid="B201-pharmaceutics-11-00432" ref-type="bibr">201</xref>,<xref rid="B202-pharmaceutics-11-00432" ref-type="bibr">202</xref>].</p></sec><sec id="sec7dot6-pharmaceutics-11-00432"><title>7.6. Intraperitoneal Delivery</title><p>Intraperitoneal administration of hydrogel systems shows promising results and is considered to be a noninvasive option, as well as an optimal formulation for various pharmaceutical agents. One of these structures was prepared by Chih-Hao Chen et al., in 2018 and was successfully incorporated in the mouse peritoneum achieving dual action: drug delivery and postoperative anti-adhesiveness [<xref rid="B203-pharmaceutics-11-00432" ref-type="bibr">203</xref>]. Similarly to orthotopic injected hydrogels, intraperitoneal hydrogels (mostly gelatin based gels) by themselves show no cytotoxicity and high degrees of biocompatibility [<xref rid="B204-pharmaceutics-11-00432" ref-type="bibr">204</xref>]. It is worth mentioning that the capacity of the gels to absorb high amounts of water could be detrimental in the case of any injectable formulations [<xref rid="B182-pharmaceutics-11-00432" ref-type="bibr">182</xref>]. </p></sec><sec id="sec7dot7-pharmaceutics-11-00432"><title>7.7. Ocular Delivery</title><p>Formulations for ocular delivery are complicated to develop; several implications are creating limitations like inferior bioavailability and absorption [<xref rid="B183-pharmaceutics-11-00432" ref-type="bibr">183</xref>]. Eye topical applications can be performed but with minimal disease addressability. Delivering therapeutic agents in maximum concentrations needed in the posterior segment encounters failure in most of the cases [<xref rid="B205-pharmaceutics-11-00432" ref-type="bibr">205</xref>]. However, for a better approach of the posterior segment, intraocular injections are more operative, but in this case, ocular complications are the primary concern. There are still other approaches like intravitreal, intracameral or peri-ocular injections, but with a significant risk of side effects [<xref rid="B206-pharmaceutics-11-00432" ref-type="bibr">206</xref>]. Improvements in protocols alongside adaptations of in vivo performance for sustainable results are needed. The standard hydrogels used for contact lenses (silicone and polymethylemethacrylate) are, however, generally highly biocompatible with almost 50 years of results proving it [<xref rid="B207-pharmaceutics-11-00432" ref-type="bibr">207</xref>]. Some issues with silicone hydrogels causing eye inflammation have been reported [<xref rid="B208-pharmaceutics-11-00432" ref-type="bibr">208</xref>] but, the only specific limitation to capable hydrogel based therapeutics seem to be those mentioned above. </p></sec><sec id="sec7dot8-pharmaceutics-11-00432"><title>7.8. Tissue Engineering and Bone Repair</title><p>Innovative biocompatible and biodegradable injectable hydrogels have been synthesized for cartilage and bone tissue [<xref rid="B209-pharmaceutics-11-00432" ref-type="bibr">209</xref>], vascular tissue, skin, and other soft tissues engineering [<xref rid="B210-pharmaceutics-11-00432" ref-type="bibr">210</xref>]. In this regard, the viscosity of the hydrogel plays a significant role together with sol-gel transition in specific physiological environment [<xref rid="B210-pharmaceutics-11-00432" ref-type="bibr">210</xref>]. </p><p>The injectable systems have the flexibility to fill irregular-shaped defects and offer the possibility to reduce surgical invasion [<xref rid="B211-pharmaceutics-11-00432" ref-type="bibr">211</xref>]. Significant current research strategies have been reported regarding the use of autografts in bone implantation therapy, due to the advantage of minimized rejection rates [<xref rid="B212-pharmaceutics-11-00432" ref-type="bibr">212</xref>]. Recent attempts have been made in injectable bio hydrogels (collagen [<xref rid="B213-pharmaceutics-11-00432" ref-type="bibr">213</xref>], chitosan [<xref rid="B214-pharmaceutics-11-00432" ref-type="bibr">214</xref>], gelatin [<xref rid="B215-pharmaceutics-11-00432" ref-type="bibr">215</xref>], cellulose [<xref rid="B97-pharmaceutics-11-00432" ref-type="bibr">97</xref>]) in cell-based therapies to increase biomimetic capacity. For instance, Park and Lee developed an oxidized alginate/hyaluronic acid hydrogel construct and tested it together with chondrocytes in vivo on mice, and obtained positive results on cartilage regeneration [<xref rid="B216-pharmaceutics-11-00432" ref-type="bibr">216</xref>]. </p><p>Among these, stem cell delivery systems are focusing on microfluidics to avoid microenvironment interactions. Various hydrogel constructs like microspheres were fromulated for stem cells encapsulation. For example, Zhao et al., 2016, synthesized light responsive hydrogel microspheres made by gelatin and methacryloyl chloride. Bone marrow-derived mesenchymal stem cells were encapsulated using post-loading procedures and then tested in vivo on rabbit femoral condyle animal model following orthotopic implantation protocol. This microfluidic approach demonstrates the feasibility of this method in osteogenesis [<xref rid="B217-pharmaceutics-11-00432" ref-type="bibr">217</xref>]. </p><p>In situ gel forming tissue implants are suitable for transplantation during invasive surgeries directly into defects. The difficult regeneration of articular cartilage represents a very challenging problem. Due to the fact that this tissue is not presenting vascularization, the immune response is absent and it allows the use of allogenic constructs in the context of tissue engineering matter. Perrier-Groult et al., 2019, implemented a protocol for subcutaneous administration of agarose hydrogels embedded with human chondrocytes in order to promote their differentiation to cartilage matrix. In this regard, humanized mouse models are preferred for the evaluation of such implants acceptance [<xref rid="B218-pharmaceutics-11-00432" ref-type="bibr">218</xref>]. </p><p>Considering the aspects mentioned above, when choosing the experimental design for in vivo studies using murine models, the age of the animal should be considered because it can influence the outcomes through various metabolic pathways involved in hydrogels degradation and clearance [<xref rid="B175-pharmaceutics-11-00432" ref-type="bibr">175</xref>]. </p><p>Regarding hazard assessment, many different hydrogel systems aim to deliver the therapeutic agent in a controlled manner for better effects at the target site [<xref rid="B219-pharmaceutics-11-00432" ref-type="bibr">219</xref>]. In a general approach to a pathology, orthotopic murine models simulate clinical conditions with better accuracy than cell line-based models, due to proper exposure to a microenvironment that is more similar to the pathological status in human [<xref rid="B220-pharmaceutics-11-00432" ref-type="bibr">220</xref>]. Therefore, orthotropic animal models should be implemented in order to improve the response to therapy significantly.</p></sec></sec><sec id="sec8-pharmaceutics-11-00432"><title>8. Clinical Trials </title><p>Bringing together the advantages of a biocompatible hydrogel with the therapeutic effect of various molecules provides new efficient configurations adapted for medical devices development. Polymer science is holding up the attention of scientists because of the promising properties of biomedical clinical applications. </p><p>In the last decade, an increasing number of clinical trials investigated the use of hydrogel structures for drug delivery systems. According to <uri>ClinicalTrials.gov</uri>, over 300 completed studies are presenting encouraging results for hydrogel use with significant applicability in visual disorders and dermatological affections. <xref rid="pharmaceutics-11-00432-t002" ref-type="table">Table 2</xref> emphasizes prominent examples of such products.</p></sec><sec id="sec9-pharmaceutics-11-00432"><title>9. Future Perspectives</title><p>In the frame of current work, hydrogels aim to become feasible tools for microfluidics, biosensing and tissue regeneration engineering (potential scaffold for new tissues and organs). Future proposed designs highlight the control over structural and morphological properties in order to improve their biomimetic capabilities. </p><p>Furthermore, hydrogel usage in generating complex 3D multi-cell models offers promise in reducing the number of animals used for testing and while at the same time provides medium that more closely resembles aspects of the human body. All of these considerations will inevitably lead to accelerating pharmaceutical formulation development and deployment on the market. It is truly difficult to exemplify the role and applications that hydrogels have in biomedical research mainly due to their usage not being restricted to the topics described in this review. It is, however, easy to observe the capacity that this technology has to transcend a certain niche and in a very timely manner be implemented in a completely new field of work. The most difficult hurdles for medical and biological research seem to have been overcome and hydrogels have become a common day item in not only researchers&#x02019; lives but the general public&#x02019;s lives too. </p><p>Recently, electronics progress relieves the use of hydrogel technology for healthcare oriented applications. Lab-on-a-chip microfluidic devices are considered practical and compelling for diagnostic and drug screening investigations. The generation of wearable sensors represents an innovative platform able to monitor pathological particularities of the human subject. Such devices can also perform a controlled release of pharmaceutical formulations according to the monitored parameters.</p><p>What is clear is the fact that hydrogels have been and are continuing to be relevant &#x0201c;scaffolds&#x0201d; in biomedicine and biomedical research. When it comes to these constructs we have entered an era of fine-tuning already existing structures and technology, where novel hydrogels are quick to reach practical applications in the real world (contact lenses, wound dressing, 3D culture scaffolds) and more exotic ones hold potential in a variety of fields such as robotics, aerospace engineering, solar cells and photoreactors, environmental research and sports science.</p></sec></body><back><notes><title>Funding</title><p>This research was supported by the research grants &#x0201c;Clinical and economic impact of personalized targeted anti-microRNA therapies in reconverting lung cancer chemoresistance&#x0201d;-CANTEMIR, POC-P_37_796/2016, &#x0201c;Innovative advanced approaches for predictive regenerative medicine&#x0201d;-REGMED, no. 65PCCDI/2018; PN-III-P1-1.2-PCCDI-2017-0782 and &#x0201c;The evaluation of cellular death type and rate using nano-luminescent systems as an alternative to conventional fluorophores&#x0201d;-no. 1529/46 PCD founded by &#x0201c;Iuliu Ha&#x0021b;ieganu&#x0201d; University of Medicine and Pharmacy, Cluj-Napoca, Romania.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-pharmaceutics-11-00432"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seliktar</surname><given-names>D.</given-names></name></person-group><article-title>Designing Cell-Compatible Hydrogels for Biomedical Applications</article-title><source>Science</source><year>2012</year><volume>336</volume><fpage>1124</fpage><lpage>1128</lpage><pub-id pub-id-type="doi">10.1126/science.1214804</pub-id><?supplied-pmid 22654050?><pub-id pub-id-type="pmid">22654050</pub-id></element-citation></ref><ref id="B2-pharmaceutics-11-00432"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmed</surname><given-names>E.M.</given-names></name></person-group><article-title>Hydrogel: Preparation, characterization, and applications: A review</article-title><source>J. Adv. Res.</source><year>2015</year><volume>6</volume><fpage>105</fpage><lpage>121</lpage><pub-id pub-id-type="doi">10.1016/j.jare.2013.07.006</pub-id><?supplied-pmid 25750745?><pub-id pub-id-type="pmid">25750745</pub-id></element-citation></ref><ref id="B3-pharmaceutics-11-00432"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>J.Y.</given-names></name><name><surname>Zhao</surname><given-names>X.</given-names></name><name><surname>Illeperuma</surname><given-names>W.R.K.</given-names></name><name><surname>Chaudhuri</surname><given-names>O.</given-names></name><name><surname>Oh</surname><given-names>K.H.</given-names></name><name><surname>Mooney</surname><given-names>D.J.</given-names></name><name><surname>Vlassak</surname><given-names>J.J.</given-names></name><name><surname>Suo</surname><given-names>Z.</given-names></name></person-group><article-title>Highly stretchable and tough hydrogels</article-title><source>Nature</source><year>2012</year><volume>489</volume><fpage>133</fpage><lpage>136</lpage><pub-id pub-id-type="doi">10.1038/nature11409</pub-id><?supplied-pmid 22955625?><pub-id pub-id-type="pmid">22955625</pub-id></element-citation></ref><ref id="B4-pharmaceutics-11-00432"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toh</surname><given-names>W.S.</given-names></name><name><surname>Loh</surname><given-names>X.J.</given-names></name></person-group><article-title>Advances in hydrogel delivery systems for tissue regeneration</article-title><source>Mater. Sci. Eng. C</source><year>2014</year><volume>45</volume><fpage>690</fpage><lpage>697</lpage><pub-id pub-id-type="doi">10.1016/j.msec.2014.04.026</pub-id><?supplied-pmid 25491878?><pub-id pub-id-type="pmid">25491878</pub-id></element-citation></ref><ref id="B5-pharmaceutics-11-00432"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoffman</surname><given-names>A.S.</given-names></name></person-group><article-title>Hydrogels for biomedical applications</article-title><source>Adv. Drug Deliv. Rev.</source><year>2012</year><volume>64</volume><fpage>18</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1016/j.addr.2012.09.010</pub-id></element-citation></ref><ref id="B6-pharmaceutics-11-00432"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhattarai</surname><given-names>N.</given-names></name><name><surname>Gunn</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>M.</given-names></name></person-group><article-title>Chitosan-based hydrogels for controlled, localized drug delivery</article-title><source>Adv. Drug Deliv. Rev.</source><year>2010</year><volume>62</volume><fpage>83</fpage><lpage>99</lpage><pub-id pub-id-type="doi">10.1016/j.addr.2009.07.019</pub-id><?supplied-pmid 19799949?><pub-id pub-id-type="pmid">19799949</pub-id></element-citation></ref><ref id="B7-pharmaceutics-11-00432"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vedadghavami</surname><given-names>A.</given-names></name><name><surname>Minooei</surname><given-names>F.</given-names></name><name><surname>Mohammadi</surname><given-names>M.H.</given-names></name><name><surname>Khetani</surname><given-names>S.</given-names></name><name><surname>Rezaei Kolahchi</surname><given-names>A.</given-names></name><name><surname>Mashayekhan</surname><given-names>S.</given-names></name><name><surname>Sanati-Nezhad</surname><given-names>A.</given-names></name></person-group><article-title>Manufacturing of hydrogel biomaterials with controlled mechanical properties for tissue engineering applications</article-title><source>Acta Biomater.</source><year>2017</year><volume>62</volume><fpage>42</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1016/j.actbio.2017.07.028</pub-id><?supplied-pmid 28736220?><pub-id pub-id-type="pmid">28736220</pub-id></element-citation></ref><ref id="B8-pharmaceutics-11-00432"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>K.Y.</given-names></name><name><surname>Mooney</surname><given-names>D.J.</given-names></name></person-group><article-title>Hydrogels for Tissue Engineering</article-title><source>Chem. Rev.</source><year>2001</year><volume>101</volume><fpage>1869</fpage><lpage>1880</lpage><pub-id pub-id-type="doi">10.1021/cr000108x</pub-id><pub-id pub-id-type="pmid">11710233</pub-id></element-citation></ref><ref id="B9-pharmaceutics-11-00432"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buduru</surname><given-names>S.D.</given-names></name><name><surname>Gulei</surname><given-names>D.</given-names></name><name><surname>Zimta</surname><given-names>A.A.</given-names></name><name><surname>Tigu</surname><given-names>A.B.</given-names></name><name><surname>Cenariu</surname><given-names>D.</given-names></name><name><surname>Berindan-Neagoe</surname><given-names>I.</given-names></name></person-group><article-title>The Potential of Different Origin Stem Cells in Modulating Oral Bone Regeneration Processes</article-title><source>Cells</source><year>2019</year><volume>8</volume><elocation-id>29</elocation-id><pub-id pub-id-type="doi">10.3390/cells8010029</pub-id></element-citation></ref><ref id="B10-pharmaceutics-11-00432"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langhans</surname><given-names>S.A.</given-names></name></person-group><article-title>Three-Dimensional in Vitro Cell Culture Models in Drug Discovery and Drug Repositioning</article-title><source>Front. Pharmacol.</source><year>2018</year><volume>9</volume><fpage>6</fpage><pub-id pub-id-type="doi">10.3389/fphar.2018.00006</pub-id><pub-id pub-id-type="pmid">29410625</pub-id></element-citation></ref><ref id="B11-pharmaceutics-11-00432"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hennink</surname><given-names>W.</given-names></name><name><surname>van Nostrum</surname><given-names>C.</given-names></name></person-group><article-title>Novel crosslinking methods to design hydrogels</article-title><source>Adv. Drug Deliv. Rev.</source><year>2002</year><volume>54</volume><fpage>13</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1016/S0169-409X(01)00240-X</pub-id><pub-id pub-id-type="pmid">11755704</pub-id></element-citation></ref><ref id="B12-pharmaceutics-11-00432"><label>12.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Gulrez</surname><given-names>S.K.</given-names></name><name><surname>Al-Assaf</surname><given-names>S.</given-names></name><name><surname>Phillips</surname><given-names>G.O.</given-names></name></person-group><article-title>Hydrogels: Methods of Preparation, Characterisation and Applications</article-title><source>Progress in Molecular and Environmental Bioengineering&#x02014;From Analysis and Modeling to Technology Applications</source><publisher-name>InTech</publisher-name><publisher-loc>Rijeka, Croatia</publisher-loc><year>2011</year></element-citation></ref><ref id="B13-pharmaceutics-11-00432"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schacht</surname><given-names>E.H.</given-names></name></person-group><article-title>Polymer chemistry and hydrogel systems</article-title><source>J. Phys. Conf. Ser.</source><year>2004</year><volume>3</volume><fpage>22</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1088/1742-6596/3/1/004</pub-id></element-citation></ref><ref id="B14-pharmaceutics-11-00432"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeong</surname><given-names>G.T.</given-names></name><name><surname>Lee</surname><given-names>K.M.</given-names></name><name><surname>Yang</surname><given-names>H.S.</given-names></name><name><surname>Park</surname><given-names>S.H.</given-names></name><name><surname>Park</surname><given-names>J.H.</given-names></name><name><surname>Sunwoo</surname><given-names>C.</given-names></name><name><surname>Ryu</surname><given-names>H.W.</given-names></name><name><surname>Kim</surname><given-names>D.</given-names></name><name><surname>Lee</surname><given-names>W.T.</given-names></name><name><surname>Kim</surname><given-names>H.S.</given-names></name><etal/></person-group><article-title>Synthesis of poly (sorbitan methacrylate) hydrogel by free-radical polymerization</article-title><source>Appl. Biochem. Biotechnol.</source><year>2007</year><volume>137</volume><fpage>935</fpage><lpage>946</lpage><pub-id pub-id-type="doi">10.1007/s12010-007-9109-4</pub-id><?supplied-pmid 18478446?><pub-id pub-id-type="pmid">18478446</pub-id></element-citation></ref><ref id="B15-pharmaceutics-11-00432"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qavi</surname><given-names>S.</given-names></name><name><surname>Pourmahdian</surname><given-names>S.</given-names></name><name><surname>Eslami</surname><given-names>H.</given-names></name></person-group><article-title>Acrylamide Hydrogels Preparation via Free Radical Crosslinking Copolymerization: Kinetic Study and Morphological Investigation</article-title><source>J. Macromol. Sci. Part A</source><year>2014</year><volume>51</volume><fpage>842</fpage><lpage>848</lpage><pub-id pub-id-type="doi">10.1080/10601325.2014.937132</pub-id></element-citation></ref><ref id="B16-pharmaceutics-11-00432"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sawhney</surname><given-names>A.S.</given-names></name><name><surname>Pathak</surname><given-names>C.P.</given-names></name><name><surname>Hubbell</surname><given-names>J.A.</given-names></name></person-group><article-title>Bioerodible hydrogels based on photopolymerized poly (ethylene glycol)-co-poly (.alpha.-hydroxy acid) diacrylate macromers</article-title><source>Macromolecules</source><year>1993</year><volume>26</volume><fpage>581</fpage><lpage>587</lpage><pub-id pub-id-type="doi">10.1021/ma00056a005</pub-id></element-citation></ref><ref id="B17-pharmaceutics-11-00432"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haraguchi</surname><given-names>K.</given-names></name><name><surname>Takada</surname><given-names>T.</given-names></name><name><surname>Haraguchi</surname><given-names>R.</given-names></name></person-group><article-title>Nanocomposite Gels by Initiator-Free Photopolymerization: Role of Plasma-Treated Clay in the Synthesis and Network Formation</article-title><source>ACS Appl. Nano Mater.</source><year>2018</year><volume>1</volume><fpage>418</fpage><lpage>425</lpage><pub-id pub-id-type="doi">10.1021/acsanm.7b00264</pub-id></element-citation></ref><ref id="B18-pharmaceutics-11-00432"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosiak</surname><given-names>J.M.</given-names></name><name><surname>Ula&#x00144;ski</surname><given-names>P.</given-names></name></person-group><article-title>Synthesis of hydrogels by irradiation of polymers in aqueous solution</article-title><source>Radiat. Phys. Chem.</source><year>1999</year><volume>55</volume><fpage>139</fpage><lpage>151</lpage><pub-id pub-id-type="doi">10.1016/S0969-806X(98)00319-3</pub-id></element-citation></ref><ref id="B19-pharmaceutics-11-00432"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ikada</surname><given-names>Y.</given-names></name><name><surname>Mita</surname><given-names>T.</given-names></name><name><surname>Horii</surname><given-names>F.</given-names></name><name><surname>Sakurada</surname><given-names>I.</given-names></name><name><surname>Hatada</surname><given-names>M.</given-names></name></person-group><article-title>Preparation of hydrogels by radiation technique</article-title><source>Radiat. Phys. Chem.</source><year>1977</year><volume>9</volume><fpage>633</fpage><lpage>645</lpage><pub-id pub-id-type="doi">10.1016/0146-5724(77)90177-7</pub-id></element-citation></ref><ref id="B20-pharmaceutics-11-00432"><label>20.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Ghobashy</surname><given-names>M.M.</given-names></name></person-group><article-title>Ionizing Radiation-Induced Polymerization</article-title><source>Ionizing Radiation Effects and Applications</source><publisher-name>InTech</publisher-name><publisher-loc>Rijeka, Croatia</publisher-loc><year>2018</year></element-citation></ref><ref id="B21-pharmaceutics-11-00432"><label>21.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Poon</surname><given-names>K.</given-names></name><name><surname>Castellino</surname><given-names>V.</given-names></name><name><surname>Cheng</surname><given-names>Y.L.</given-names></name></person-group><article-title>Polymeric hydrophilic polymers in targeted drug delivery</article-title><source>Artificial Cells, Cell Engineering and Therapy</source><publisher-name>Elsevier</publisher-name><publisher-loc>Amsterdam, The Netherlands</publisher-loc><year>2007</year><fpage>42</fpage><lpage>71</lpage></element-citation></ref><ref id="B22-pharmaceutics-11-00432"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmidt</surname><given-names>B.V.K.J.</given-names></name></person-group><article-title>Hydrophilic Polymers</article-title><source>Polymers</source><year>2019</year><volume>11</volume><elocation-id>693</elocation-id><pub-id pub-id-type="doi">10.3390/polym11040693</pub-id></element-citation></ref><ref id="B23-pharmaceutics-11-00432"><label>23.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Finch</surname><given-names>C.A.</given-names></name></person-group><article-title>Hydrophilic polymers</article-title><source>Specialty Polymers</source><publisher-name>Springer</publisher-name><publisher-loc>Boston, MA, USA</publisher-loc><year>1987</year><fpage>65</fpage><lpage>82</lpage></element-citation></ref><ref id="B24-pharmaceutics-11-00432"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liechty</surname><given-names>W.B.</given-names></name><name><surname>Kryscio</surname><given-names>D.R.</given-names></name><name><surname>Slaughter</surname><given-names>B.V.</given-names></name><name><surname>Peppas</surname><given-names>N.A.</given-names></name></person-group><article-title>Polymers for Drug Delivery Systems</article-title><source>Annu. Rev. Chem. Biomol. Eng.</source><year>2010</year><volume>1</volume><fpage>149</fpage><lpage>173</lpage><pub-id pub-id-type="doi">10.1146/annurev-chembioeng-073009-100847</pub-id><pub-id pub-id-type="pmid">22432577</pub-id></element-citation></ref><ref id="B25-pharmaceutics-11-00432"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitchell</surname><given-names>H.</given-names></name><name><surname>Hamilton</surname><given-names>T.S.</given-names></name><name><surname>Steggerda</surname><given-names>F.R.</given-names></name><name><surname>Bean</surname><given-names>H.W.</given-names></name></person-group><article-title>The chemical composition of the adult human body and its bearing on the biochemistry of growth</article-title><source>J. Biol. Chem.</source><year>1945</year><volume>158</volume><fpage>625</fpage><lpage>637</lpage></element-citation></ref><ref id="B26-pharmaceutics-11-00432"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>A.</given-names></name></person-group><article-title>Study on superabsorbent composites. IX: Synthesis, characterization and swelling behaviors of polyacrylamide/clay composites based on various clays</article-title><source>React. Funct. Polym.</source><year>2007</year><volume>67</volume><fpage>737</fpage><lpage>745</lpage><pub-id pub-id-type="doi">10.1016/j.reactfunctpolym.2007.05.001</pub-id></element-citation></ref><ref id="B27-pharmaceutics-11-00432"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamath</surname><given-names>K.R.</given-names></name><name><surname>Park</surname><given-names>K.</given-names></name></person-group><article-title>Biodegradable hydrogels in drug delivery</article-title><source>Adv. Drug Deliv. Rev.</source><year>1993</year><volume>11</volume><fpage>59</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.1016/0169-409X(93)90027-2</pub-id></element-citation></ref><ref id="B28-pharmaceutics-11-00432"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jaya</surname><given-names>M.</given-names></name><name><surname>Vivek Kumar</surname><given-names>S.</given-names></name></person-group><article-title>Cross-linking in Hydrogels&#x02014;A Review</article-title><source>Am. J. Polym. Sci.</source><year>2014</year><volume>4</volume><fpage>25</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.5923/j.ajps.20140402.01</pub-id></element-citation></ref><ref id="B29-pharmaceutics-11-00432"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mishra</surname><given-names>B.</given-names></name><name><surname>Upadhyay</surname><given-names>M.</given-names></name><name><surname>Reddy Adena</surname><given-names>S.</given-names></name><name><surname>Vasant</surname><given-names>B.</given-names></name><name><surname>Muthu</surname><given-names>M.</given-names></name></person-group><article-title>Hydrogels: An Introduction to a Controlled Drug Delivery Device, Synthesis and Application in Drug Delivery and Tissue Engineering</article-title><source>Austin. J. Biomed Eng.</source><year>2017</year><volume>4</volume><fpage>1037</fpage><pub-id pub-id-type="doi">10.1006/jjie.1995.1026</pub-id></element-citation></ref><ref id="B30-pharmaceutics-11-00432"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oyen</surname><given-names>M.L.</given-names></name></person-group><article-title>Mechanical characterisation of hydrogel materials</article-title><source>Int. Mater. Rev.</source><year>2013</year><volume>59</volume><fpage>44</fpage><lpage>59</lpage><pub-id pub-id-type="doi">10.1179/1743280413Y.0000000022</pub-id></element-citation></ref><ref id="B31-pharmaceutics-11-00432"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>M.</given-names></name><name><surname>Gao</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Serpe</surname><given-names>M.J.</given-names></name></person-group><article-title>Stimuli-responsive polymers and their applications</article-title><source>Polym. Chem.</source><year>2017</year><volume>8</volume><fpage>127</fpage><lpage>143</lpage><pub-id pub-id-type="doi">10.1039/C6PY01585A</pub-id></element-citation></ref><ref id="B32-pharmaceutics-11-00432"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shin</surname><given-names>J.</given-names></name><name><surname>Braun</surname><given-names>P.V.</given-names></name><name><surname>Lee</surname><given-names>W.</given-names></name></person-group><article-title>Fast response photonic crystal pH sensor based on templated photo-polymerized hydrogel inverse opal</article-title><source>Sens. Actuators B Chem.</source><year>2010</year><volume>150</volume><fpage>183</fpage><lpage>190</lpage><pub-id pub-id-type="doi">10.1016/j.snb.2010.07.018</pub-id></element-citation></ref><ref id="B33-pharmaceutics-11-00432"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiu</surname><given-names>Y.L.</given-names></name><name><surname>Chen</surname><given-names>S.C.</given-names></name><name><surname>Su</surname><given-names>C.J.</given-names></name><name><surname>Hsiao</surname><given-names>C.W.</given-names></name><name><surname>Chen</surname><given-names>Y.M.</given-names></name><name><surname>Chen</surname><given-names>H.L.</given-names></name><name><surname>Sung</surname><given-names>H.W.</given-names></name></person-group><article-title>pH-triggered injectable hydrogels prepared from aqueous N-palmitoyl chitosan: In vitro characteristics and in vivo biocompatibility</article-title><source>Biomaterials</source><year>2009</year><volume>30</volume><fpage>4877</fpage><lpage>4888</lpage><pub-id pub-id-type="doi">10.1016/j.biomaterials.2009.05.052</pub-id><pub-id pub-id-type="pmid">19527916</pub-id></element-citation></ref><ref id="B34-pharmaceutics-11-00432"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ozmen</surname><given-names>M.M.</given-names></name><name><surname>Okay</surname><given-names>O.</given-names></name></person-group><article-title>Superfast Responsive Ionic Hydrogels: Effect of the Monomer Concentration</article-title><source>J. Macromol. Sci. Part A</source><year>2006</year><volume>43</volume><fpage>1215</fpage><lpage>1225</lpage><pub-id pub-id-type="doi">10.1080/10601320600737393</pub-id></element-citation></ref><ref id="B35-pharmaceutics-11-00432"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>S.</given-names></name><name><surname>Oderinde</surname><given-names>O.</given-names></name><name><surname>Hussain</surname><given-names>I.</given-names></name><name><surname>Yao</surname><given-names>F.</given-names></name><name><surname>Fu</surname><given-names>G.</given-names></name></person-group><article-title>Dual ionic cross-linked double network hydrogel with self-healing, conductive, and force sensitive properties</article-title><source>Polymer</source><year>2018</year><volume>144</volume><fpage>111</fpage><lpage>120</lpage><pub-id pub-id-type="doi">10.1016/j.polymer.2018.01.046</pub-id></element-citation></ref><ref id="B36-pharmaceutics-11-00432"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raeburn</surname><given-names>J.</given-names></name><name><surname>Mendoza-Cuenca</surname><given-names>C.</given-names></name><name><surname>Cattoz</surname><given-names>B.N.</given-names></name><name><surname>Little</surname><given-names>M.A.</given-names></name><name><surname>Terry</surname><given-names>A.E.</given-names></name><name><surname>Zamith Cardoso</surname><given-names>A.</given-names></name><name><surname>Griffiths</surname><given-names>P.C.</given-names></name><name><surname>Adams</surname><given-names>D.J.</given-names></name></person-group><article-title>The effect of solvent choice on the gelation and final hydrogel properties of Fmoc-diphenylalanine</article-title><source>Soft Matter</source><year>2015</year><volume>11</volume><fpage>927</fpage><lpage>935</lpage><pub-id pub-id-type="doi">10.1039/C4SM02256D</pub-id><?supplied-pmid 25516486?><pub-id pub-id-type="pmid">25516486</pub-id></element-citation></ref><ref id="B37-pharmaceutics-11-00432"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>F.</given-names></name><name><surname>Ma</surname><given-names>M.L.</given-names></name><name><surname>Xu</surname><given-names>B.</given-names></name></person-group><article-title>Molecular hydrogels of therapeutic agents</article-title><source>Chem. Soc. Rev.</source><year>2009</year><volume>38</volume><fpage>883</fpage><lpage>891</lpage><pub-id pub-id-type="doi">10.1039/b806410p</pub-id><?supplied-pmid 19421568?><pub-id pub-id-type="pmid">19421568</pub-id></element-citation></ref><ref id="B38-pharmaceutics-11-00432"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>C.B.</given-names></name><name><surname>Gong</surname><given-names>C.Y.</given-names></name><name><surname>Huang</surname><given-names>M.J.</given-names></name><name><surname>Wang</surname><given-names>J.W.</given-names></name><name><surname>Pan</surname><given-names>Y.F.</given-names></name><name><surname>Zhang</surname><given-names>Y.D.</given-names></name><name><surname>Li</surname><given-names>G.Z.</given-names></name><name><surname>Gou</surname><given-names>M.L.</given-names></name><name><surname>Wang</surname><given-names>K.</given-names></name><name><surname>Tu</surname><given-names>M.J.</given-names></name><etal/></person-group><article-title>Thermoreversible gel&#x02013;sol behavior of biodegradable PCL-PEG-PCL triblock copolymer in aqueous solutions</article-title><source>J. Biomed. Mater. Res. Part B Appl. Biomater.</source><year>2008</year><volume>84</volume><fpage>165</fpage><lpage>175</lpage><pub-id pub-id-type="doi">10.1002/jbm.b.30858</pub-id><?supplied-pmid 17455282?><pub-id pub-id-type="pmid">17455282</pub-id></element-citation></ref><ref id="B39-pharmaceutics-11-00432"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>H.</given-names></name></person-group><article-title>Kinetics of smart hydrogels responding to electric field: A transient deformation analysis</article-title><source>Int. J. Solids Struct.</source><year>2009</year><volume>46</volume><fpage>1326</fpage><lpage>1333</lpage><pub-id pub-id-type="doi">10.1016/j.ijsolstr.2008.11.001</pub-id></element-citation></ref><ref id="B40-pharmaceutics-11-00432"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Namdeo</surname><given-names>M.</given-names></name><name><surname>Bajpai</surname><given-names>S.K.</given-names></name><name><surname>Kakkar</surname><given-names>S.</given-names></name></person-group><article-title>Preparation of a Magnetic-Field-Sensitive Hydrogel and Preliminary Study of Its Drug Release Behavior</article-title><source>J. Biomater. Sci. Polym.</source><year>2009</year><volume>20</volume><fpage>1747</fpage><lpage>1761</lpage><pub-id pub-id-type="doi">10.1163/156856208X386372</pub-id><?supplied-pmid 19723439?><pub-id pub-id-type="pmid">19723439</pub-id></element-citation></ref><ref id="B41-pharmaceutics-11-00432"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ono</surname><given-names>K.</given-names></name><name><surname>Saito</surname><given-names>Y.</given-names></name><name><surname>Yura</surname><given-names>H.</given-names></name><name><surname>Ishikawa</surname><given-names>K.</given-names></name><name><surname>Kurita</surname><given-names>A.</given-names></name><name><surname>Akaike</surname><given-names>T.</given-names></name><name><surname>Ishihara</surname><given-names>M.</given-names></name></person-group><article-title>Photocrosslinkable chitosan as a biological adhesive</article-title><source>J. Biomed. Mater. Res.</source><year>2000</year><volume>49</volume><fpage>289</fpage><lpage>295</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1097-4636(200002)49:2&#x0003c;289::AID-JBM18&#x0003e;3.0.CO;2-M</pub-id><pub-id pub-id-type="pmid">10571917</pub-id></element-citation></ref><ref id="B42-pharmaceutics-11-00432"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>G.</given-names></name><name><surname>Chang</surname><given-names>S.</given-names></name><name><surname>Hao</surname><given-names>H.</given-names></name><name><surname>Tathireddy</surname><given-names>P.</given-names></name><name><surname>Orthner</surname><given-names>M.</given-names></name><name><surname>Magda</surname><given-names>J.</given-names></name><name><surname>Solzbacher</surname><given-names>F.</given-names></name></person-group><article-title>Osmotic Swelling Pressure Response of Smart Hydrogels Suitable for Chronically-Implantable Glucose Sensors</article-title><source>Sens. Actuators B Chem.</source><year>2010</year><volume>144</volume><fpage>332</fpage><pub-id pub-id-type="doi">10.1016/j.snb.2009.07.054</pub-id><pub-id pub-id-type="pmid">20161690</pub-id></element-citation></ref><ref id="B43-pharmaceutics-11-00432"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chandrawati</surname><given-names>R.</given-names></name></person-group><article-title>Enzyme-responsive polymer hydrogels for therapeutic delivery</article-title><source>Exp. Biol. Med.</source><year>2016</year><volume>241</volume><fpage>972</fpage><lpage>979</lpage><pub-id pub-id-type="doi">10.1177/1535370216647186</pub-id></element-citation></ref><ref id="B44-pharmaceutics-11-00432"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>R.</given-names></name><name><surname>Bowyer</surname><given-names>A.</given-names></name><name><surname>Eisenthal</surname><given-names>R.</given-names></name><name><surname>Hubble</surname><given-names>J.</given-names></name></person-group><article-title>A smart membrane based on an antigen-responsive hydrogel</article-title><source>Biotechnol. Bioeng.</source><year>2007</year><volume>97</volume><fpage>976</fpage><lpage>984</lpage><pub-id pub-id-type="doi">10.1002/bit.21255</pub-id><pub-id pub-id-type="pmid">17149770</pub-id></element-citation></ref><ref id="B45-pharmaceutics-11-00432"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murakami</surname><given-names>Y.</given-names></name><name><surname>Maeda</surname><given-names>M.</given-names></name></person-group><article-title>DNA-Responsive Hydrogels That Can Shrink or Swell</article-title><source>Biomacromolecules</source><year>2005</year><volume>6</volume><fpage>2927</fpage><lpage>2929</lpage><pub-id pub-id-type="doi">10.1021/bm0504330</pub-id><?supplied-pmid 16283709?><pub-id pub-id-type="pmid">16283709</pub-id></element-citation></ref><ref id="B46-pharmaceutics-11-00432"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>W.</given-names></name><name><surname>Veiseh</surname><given-names>O.</given-names></name><name><surname>Appel</surname><given-names>E.A.</given-names></name><name><surname>Xue</surname><given-names>K.</given-names></name><name><surname>Webber</surname><given-names>M.J.</given-names></name><name><surname>Tang</surname><given-names>B.C.</given-names></name><name><surname>Yang</surname><given-names>X.W.</given-names></name><name><surname>Weir</surname><given-names>G.C.</given-names></name><name><surname>Langer</surname><given-names>R.</given-names></name><etal/></person-group><article-title>Injectable and Glucose-Responsive Hydrogels Based on Boronic Acid&#x02013;Glucose Complexation</article-title><source>Langmuir</source><year>2016</year><volume>32</volume><fpage>8743</fpage><lpage>8747</lpage><pub-id pub-id-type="doi">10.1021/acs.langmuir.5b04755</pub-id><?supplied-pmid 27455412?><pub-id pub-id-type="pmid">27455412</pub-id></element-citation></ref><ref id="B47-pharmaceutics-11-00432"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deen</surname><given-names>G.</given-names></name><name><surname>Loh</surname><given-names>X.</given-names></name></person-group><article-title>Stimuli-Responsive Cationic Hydrogels in Drug Delivery Applications</article-title><source>Gels</source><year>2018</year><volume>4</volume><elocation-id>13</elocation-id><pub-id pub-id-type="doi">10.3390/gels4010013</pub-id><?supplied-pmid 30674789?><pub-id pub-id-type="pmid">30674789</pub-id></element-citation></ref><ref id="B48-pharmaceutics-11-00432"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>Shen</surname><given-names>J.</given-names></name><name><surname>Ma</surname><given-names>H.</given-names></name><name><surname>Lu</surname><given-names>X.</given-names></name><name><surname>Shi</surname><given-names>M.</given-names></name><name><surname>Li</surname><given-names>N.</given-names></name><name><surname>Ye</surname><given-names>M.</given-names></name></person-group><article-title>Preparation and characterization of pH- and temperature-responsive hydrogels with surface-functionalized graphene oxide as the crosslinker</article-title><source>Soft Matter</source><year>2012</year><volume>8</volume><fpage>3139</fpage><pub-id pub-id-type="doi">10.1039/c2sm07012j</pub-id></element-citation></ref><ref id="B49-pharmaceutics-11-00432"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kope&#x0010d;ek</surname><given-names>J.</given-names></name><name><surname>Yang</surname><given-names>J.</given-names></name></person-group><article-title>Smart Self-Assembled Hybrid Hydrogel Biomaterials</article-title><source>Angew. Chem. Int.</source><year>2012</year><volume>51</volume><fpage>7396</fpage><lpage>7417</lpage><pub-id pub-id-type="doi">10.1002/anie.201201040</pub-id></element-citation></ref><ref id="B50-pharmaceutics-11-00432"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferreira</surname><given-names>N.N.</given-names></name><name><surname>Ferreira</surname><given-names>L.M.B.</given-names></name><name><surname>Cardoso</surname><given-names>V.M.O.</given-names></name><name><surname>Boni</surname><given-names>F.I.</given-names></name><name><surname>Souza</surname><given-names>A.L.R.</given-names></name><name><surname>Gremi&#x000e3;o</surname><given-names>M.P.D.</given-names></name></person-group><article-title>Recent advances in smart hydrogels for biomedical applications: From self-assembly to functional approaches</article-title><source>Eur. Polym. J.</source><year>2018</year><volume>99</volume><fpage>117</fpage><lpage>133</lpage><pub-id pub-id-type="doi">10.1016/j.eurpolymj.2017.12.004</pub-id></element-citation></ref><ref id="B51-pharmaceutics-11-00432"><label>51.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Deming</surname><given-names>T.</given-names></name></person-group><source>Peptide-Based Materials</source><publisher-name>Springer</publisher-name><publisher-loc>Berlin/Heidelberg, Germany</publisher-loc><year>2012</year></element-citation></ref><ref id="B52-pharmaceutics-11-00432"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>H.</given-names></name><name><surname>Xing</surname><given-names>L.</given-names></name><name><surname>Cao</surname><given-names>Y.</given-names></name><name><surname>Che</surname><given-names>S.</given-names></name></person-group><article-title>Coordination bonding based pH-responsive drug delivery systems</article-title><source>Coord. Chem. Rev.</source><year>2013</year><volume>257</volume><fpage>1933</fpage><lpage>1944</lpage><pub-id pub-id-type="doi">10.1016/j.ccr.2013.03.007</pub-id></element-citation></ref><ref id="B53-pharmaceutics-11-00432"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmaljohann</surname><given-names>D.</given-names></name></person-group><article-title>Thermo- and pH-responsive polymers in drug delivery</article-title><source>Adv. Drug Deliv. Rev.</source><year>2006</year><volume>58</volume><fpage>1655</fpage><lpage>1670</lpage><pub-id pub-id-type="doi">10.1016/j.addr.2006.09.020</pub-id><?supplied-pmid 17125884?><pub-id pub-id-type="pmid">17125884</pub-id></element-citation></ref><ref id="B54-pharmaceutics-11-00432"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rizwan</surname><given-names>M.</given-names></name><name><surname>Yahya</surname><given-names>R.</given-names></name><name><surname>Hassan</surname><given-names>A.</given-names></name><name><surname>Yar</surname><given-names>M.</given-names></name><name><surname>Azzahari</surname><given-names>A.</given-names></name><name><surname>Selvanathan</surname><given-names>V.</given-names></name><name><surname>Sonsudin</surname><given-names>F.</given-names></name><name><surname>Abouloula</surname><given-names>C.</given-names></name></person-group><article-title>pH Sensitive Hydrogels in Drug Delivery: Brief History, Properties, Swelling, and Release Mechanism, Material Selection and Applications</article-title><source>Polymers</source><year>2017</year><volume>9</volume><elocation-id>137</elocation-id><pub-id pub-id-type="doi">10.3390/polym9040137</pub-id></element-citation></ref><ref id="B55-pharmaceutics-11-00432"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peppas</surname><given-names>N.A.</given-names></name><name><surname>Hilt</surname><given-names>J.Z.</given-names></name><name><surname>Khademhosseini</surname><given-names>A.</given-names></name><name><surname>Langer</surname><given-names>R.</given-names></name></person-group><article-title>Hydrogels in biology and medicine: From molecular principles to bionanotechnology</article-title><source>Adv. Mater.</source><year>2006</year><volume>18</volume><fpage>1345</fpage><lpage>1360</lpage><pub-id pub-id-type="doi">10.1002/adma.200501612</pub-id></element-citation></ref><ref id="B56-pharmaceutics-11-00432"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bl&#x000f6;hbaum</surname><given-names>J.</given-names></name><name><surname>Paulus</surname><given-names>I.</given-names></name><name><surname>P&#x000f6;ppler</surname><given-names>A.C.</given-names></name><name><surname>Tessmar</surname><given-names>J.</given-names></name><name><surname>Groll</surname><given-names>J.</given-names></name></person-group><article-title>Influence of charged groups on the cross-linking efficiency and release of guest molecules from thiol&#x02013;ene cross-linked poly (2-oxazoline) hydrogels</article-title><source>J. Mater. Chem. B</source><year>2019</year><volume>7</volume><fpage>1782</fpage><lpage>1794</lpage><pub-id pub-id-type="doi">10.1039/C8TB02575D</pub-id></element-citation></ref><ref id="B57-pharmaceutics-11-00432"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hegger</surname><given-names>P.S.</given-names></name><name><surname>Kupka</surname><given-names>J.</given-names></name><name><surname>Minsky</surname><given-names>B.B.</given-names></name><name><surname>Sch&#x000e4;del</surname><given-names>N.</given-names></name><name><surname>Petri</surname><given-names>N.</given-names></name><name><surname>Laschat</surname><given-names>S.</given-names></name><name><surname>Boehm</surname><given-names>H.</given-names></name></person-group><article-title>Charge Matters: Modulating Secondary Interactions in Hyaluronan Hydrogels</article-title><source>ChemistrySelect</source><year>2017</year><volume>2</volume><fpage>7701</fpage><lpage>7705</lpage><pub-id pub-id-type="doi">10.1002/slct.201701908</pub-id></element-citation></ref><ref id="B58-pharmaceutics-11-00432"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takeda</surname><given-names>K.</given-names></name><name><surname>Kitagawa</surname><given-names>H.</given-names></name><name><surname>Tsuboi</surname><given-names>R.</given-names></name><name><surname>Kiba</surname><given-names>W.</given-names></name><name><surname>Sasaki</surname><given-names>J.I.</given-names></name><name><surname>Hayashi</surname><given-names>M.</given-names></name><name><surname>Imazato</surname><given-names>S.</given-names></name></person-group><article-title>Effectiveness of non-biodegradable poly (2-hydroxyethyl methacrylate)-based hydrogel particles as a fibroblast growth factor-2 releasing carrier</article-title><source>Dent. Mater.</source><year>2015</year><volume>31</volume><fpage>1406</fpage><lpage>1414</lpage><pub-id pub-id-type="doi">10.1016/j.dental.2015.09.007</pub-id><?supplied-pmid 26411646?><pub-id pub-id-type="pmid">26411646</pub-id></element-citation></ref><ref id="B59-pharmaceutics-11-00432"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shastri</surname><given-names>V.</given-names></name></person-group><article-title>Non-Degradable Biocompatible Polymers in Medicine: Past, Present and Future</article-title><source>Curr. Pharm. Biotechnol.</source><year>2005</year><volume>4</volume><fpage>331</fpage><lpage>337</lpage><pub-id pub-id-type="doi">10.2174/1389201033489694</pub-id></element-citation></ref><ref id="B60-pharmaceutics-11-00432"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ninan</surname><given-names>N.</given-names></name><name><surname>Forget</surname><given-names>A.</given-names></name><name><surname>Shastri</surname><given-names>V.P.</given-names></name><name><surname>Voelcker</surname><given-names>N.H.</given-names></name><name><surname>Blencowe</surname><given-names>A.</given-names></name></person-group><article-title>Antibacterial and Anti-Inflammatory pH-Responsive Tannic Acid-Carboxylated Agarose Composite Hydrogels for Wound Healing</article-title><source>ACS Appl. Mater. Interfaces</source><year>2016</year><volume>8</volume><fpage>28511</fpage><lpage>28521</lpage><pub-id pub-id-type="doi">10.1021/acsami.6b10491</pub-id><?supplied-pmid 27704757?><pub-id pub-id-type="pmid">27704757</pub-id></element-citation></ref><ref id="B61-pharmaceutics-11-00432"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nesrinne</surname><given-names>S.</given-names></name><name><surname>Djamel</surname><given-names>A.</given-names></name></person-group><article-title>Synthesis, characterization and rheological behavior of pH sensitive poly (acrylamide-co-acrylic acid) hydrogels</article-title><source>Arab. J. Chem.</source><year>2017</year><volume>10</volume><fpage>539</fpage><lpage>547</lpage><pub-id pub-id-type="doi">10.1016/j.arabjc.2013.11.027</pub-id></element-citation></ref><ref id="B62-pharmaceutics-11-00432"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohmine</surname><given-names>I.</given-names></name><name><surname>Tanaka</surname><given-names>T.</given-names></name></person-group><article-title>Salt effects on the phase transition of ionic gels</article-title><source>J. Chem. Phys.</source><year>1982</year><volume>77</volume><fpage>5725</fpage><lpage>5729</lpage><pub-id pub-id-type="doi">10.1063/1.443780</pub-id></element-citation></ref><ref id="B63-pharmaceutics-11-00432"><label>63.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Peterson</surname><given-names>D.S.</given-names></name></person-group><article-title>pH-Sensitive Hydrogel</article-title><source>Encyclopedia of Microfluidics and Nanofluidics</source><publisher-name>Springer</publisher-name><publisher-loc>Boston, MA, USA</publisher-loc><year>2014</year><fpage>1</fpage><lpage>5</lpage></element-citation></ref><ref id="B64-pharmaceutics-11-00432"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Nie</surname><given-names>J.</given-names></name><name><surname>Du</surname><given-names>B.</given-names></name></person-group><article-title>Poly (N-isopropylacrylamide)-based ionic hydrogels: Synthesis, swelling properties, interfacial adsorption and release of dyes</article-title><source>Polym. J.</source><year>2016</year><volume>48</volume><fpage>431</fpage><lpage>438</lpage><pub-id pub-id-type="doi">10.1038/pj.2015.123</pub-id></element-citation></ref><ref id="B65-pharmaceutics-11-00432"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname><given-names>Y.</given-names></name><name><surname>Kim</surname><given-names>S.M.</given-names></name><name><surname>Lee</surname><given-names>Y.</given-names></name><name><surname>Lee</surname><given-names>W.</given-names></name><name><surname>Yang</surname><given-names>T.</given-names></name><name><surname>Lee</surname><given-names>M.</given-names></name><name><surname>Suh</surname><given-names>H.</given-names></name><name><surname>Park</surname><given-names>J.</given-names></name></person-group><article-title>Cationic hyperbranched poly (amino ester): A novel class of DNA condensing molecule with cationic surface, biodegradable three-dimensional structure, and tertiary amine groups in the interior</article-title><source>J. Am. Chem. Soc.</source><year>2001</year><volume>123</volume><fpage>2460</fpage><lpage>2461</lpage><pub-id pub-id-type="doi">10.1021/ja005715g</pub-id><pub-id pub-id-type="pmid">11456910</pub-id></element-citation></ref><ref id="B66-pharmaceutics-11-00432"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pagonis</surname><given-names>K.</given-names></name><name><surname>Bokias</surname><given-names>G.</given-names></name></person-group><article-title>Temperature- and solvent-sensitive hydrogels based on <italic>N</italic>-isopropylacrylamide and <italic>N</italic>,<italic>N</italic>-dimethylacrylamide</article-title><source>Polym. Bull.</source><year>2007</year><volume>58</volume><fpage>289</fpage><lpage>294</lpage><pub-id pub-id-type="doi">10.1007/s00289-006-0617-0</pub-id></element-citation></ref><ref id="B67-pharmaceutics-11-00432"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X.Z.</given-names></name><name><surname>Yang</surname><given-names>Y.Y.</given-names></name><name><surname>Chung</surname><given-names>T.S.</given-names></name></person-group><article-title>Effect of Mixed Solvents on Characteristics of Poly (N-isopropylacrylamide) Gels</article-title><source>Langmuir</source><year>2002</year><volume>18</volume><fpage>2538</fpage><lpage>2542</lpage><pub-id pub-id-type="doi">10.1021/la011410j</pub-id></element-citation></ref><ref id="B68-pharmaceutics-11-00432"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>D.P.</given-names></name><name><surname>Dolbow</surname><given-names>J.E.</given-names></name><name><surname>Zauscher</surname><given-names>S.</given-names></name></person-group><article-title>Switchable Friction of Stimulus-Responsive Hydrogels</article-title><source>Langmuir</source><year>2007</year><volume>23</volume><fpage>250</fpage><lpage>257</lpage><pub-id pub-id-type="doi">10.1021/la0617006</pub-id><?supplied-pmid 17190511?><pub-id pub-id-type="pmid">17190511</pub-id></element-citation></ref><ref id="B69-pharmaceutics-11-00432"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>Z.R.</given-names></name><name><surname>Kope&#x0010d;kov&#x000e1;</surname><given-names>P.</given-names></name><name><surname>Kope&#x0010d;ek</surname><given-names>J.</given-names></name></person-group><article-title>Antigen Responsive Hydrogels Based on Polymerizable Antibody Fab Fragment</article-title><source>Macromol. Biosci.</source><year>2003</year><volume>3</volume><fpage>296</fpage><lpage>300</lpage><pub-id pub-id-type="doi">10.1002/mabi.200390039</pub-id></element-citation></ref><ref id="B70-pharmaceutics-11-00432"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thornton</surname><given-names>P.D.</given-names></name><name><surname>Mart</surname><given-names>R.J.</given-names></name><name><surname>Ulijn</surname><given-names>R.V.</given-names></name></person-group><article-title>Enzyme-Responsive Polymer Hydrogel Particles for Controlled Release</article-title><source>Adv. Mater.</source><year>2007</year><volume>19</volume><fpage>1252</fpage><lpage>1256</lpage><pub-id pub-id-type="doi">10.1002/adma.200601784</pub-id></element-citation></ref><ref id="B71-pharmaceutics-11-00432"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Culver</surname><given-names>H.R.</given-names></name><name><surname>Clegg</surname><given-names>J.R.</given-names></name><name><surname>Peppas</surname><given-names>N.A.</given-names></name></person-group><article-title>Analyte-Responsive Hydrogels: Intelligent Materials for Biosensing and Drug Delivery</article-title><source>Acc. Chem. Res.</source><year>2017</year><volume>50</volume><fpage>170</fpage><lpage>178</lpage><pub-id pub-id-type="doi">10.1021/acs.accounts.6b00533</pub-id><?supplied-pmid 28170227?><pub-id pub-id-type="pmid">28170227</pub-id></element-citation></ref><ref id="B72-pharmaceutics-11-00432"><label>72.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Abul-Haija</surname><given-names>Y.M.</given-names></name><name><surname>Ulijn</surname><given-names>R.V.</given-names></name></person-group><source>Enzyme-Responsive Hydrogels for Biomedical Applications</source><publisher-name>The Royal Society of Chemistry</publisher-name><publisher-loc>Cambridge, UK</publisher-loc><year>2014</year><comment>Chapter 6</comment><fpage>112</fpage><lpage>134</lpage></element-citation></ref><ref id="B73-pharmaceutics-11-00432"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koetting</surname><given-names>M.C.</given-names></name><name><surname>Peters</surname><given-names>J.T.</given-names></name><name><surname>Steichen</surname><given-names>S.D.</given-names></name><name><surname>Peppas</surname><given-names>N.A.</given-names></name></person-group><article-title>Stimulus-responsive hydrogels: Theory, modern advances, and applications</article-title><source>Mater. Sci. Eng. R Rep.</source><year>2015</year><volume>93</volume><fpage>1</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1016/j.mser.2015.04.001</pub-id><pub-id pub-id-type="pmid">27134415</pub-id></element-citation></ref><ref id="B74-pharmaceutics-11-00432"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nazar</surname><given-names>H.</given-names></name><name><surname>Fatouros</surname><given-names>D.G.</given-names></name><name><surname>van der Merwe</surname><given-names>S.M.</given-names></name><name><surname>Bouropoulos</surname><given-names>N.</given-names></name><name><surname>Avgouropoulos</surname><given-names>G.</given-names></name><name><surname>Tsibouklis</surname><given-names>J.</given-names></name><name><surname>Roldo</surname><given-names>M.</given-names></name></person-group><article-title>Thermosensitive hydrogels for nasal drug delivery: The formulation and characterisation of systems based on N-trimethyl chitosan chloride</article-title><source>Eur. J. Pharm. Biopharm.</source><year>2011</year><volume>77</volume><fpage>225</fpage><lpage>232</lpage><pub-id pub-id-type="doi">10.1016/j.ejpb.2010.11.022</pub-id><pub-id pub-id-type="pmid">21130876</pub-id></element-citation></ref><ref id="B75-pharmaceutics-11-00432"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vihola</surname><given-names>H.</given-names></name><name><surname>Laukkanen</surname><given-names>A.</given-names></name><name><surname>Tenhu</surname><given-names>H.</given-names></name><name><surname>Hirvonen</surname><given-names>J.</given-names></name></person-group><article-title>Drug release characteristics of physically cross-linked thermosensitive poly(N-vinylcaprolactam) hydrogel particles</article-title><source>J. Pharm. Sci.</source><year>2008</year><volume>97</volume><fpage>4783</fpage><lpage>4793</lpage><pub-id pub-id-type="doi">10.1002/jps.21348</pub-id><pub-id pub-id-type="pmid">18306245</pub-id></element-citation></ref><ref id="B76-pharmaceutics-11-00432"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>R.</given-names></name><name><surname>She</surname><given-names>Z.</given-names></name><name><surname>Wang</surname><given-names>M.</given-names></name><name><surname>Fang</surname><given-names>Z.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Feng</surname><given-names>Q.</given-names></name></person-group><article-title>Thermo-sensitive alginate-based injectable hydrogel for tissue engineering</article-title><source>Carbohydr. Polym.</source><year>2012</year><volume>87</volume><fpage>1515</fpage><lpage>1521</lpage><pub-id pub-id-type="doi">10.1016/j.carbpol.2011.09.048</pub-id></element-citation></ref><ref id="B77-pharmaceutics-11-00432"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sala</surname><given-names>R.L.</given-names></name><name><surname>Kwon</surname><given-names>M.Y.</given-names></name><name><surname>Kim</surname><given-names>M.</given-names></name><name><surname>Gullbrand</surname><given-names>S.E.</given-names></name><name><surname>Henning</surname><given-names>E.A.</given-names></name><name><surname>Mauck</surname><given-names>R.L.</given-names></name><name><surname>Camargo</surname><given-names>E.R.</given-names></name><name><surname>Burdick</surname><given-names>J.A.</given-names></name></person-group><article-title>Thermosensitive Poly (N-vinylcaprolactam) Injectable Hydrogels for Cartilage Tissue Engineering</article-title><source>Tissue Eng. Part A</source><year>2017</year><volume>23</volume><fpage>935</fpage><lpage>945</lpage><pub-id pub-id-type="doi">10.1089/ten.tea.2016.0464</pub-id><pub-id pub-id-type="pmid">28384053</pub-id></element-citation></ref><ref id="B78-pharmaceutics-11-00432"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname><given-names>T.S.</given-names></name><name><surname>Wei</surname><given-names>Y.H.</given-names></name><name><surname>Cheng</surname><given-names>P.Y.</given-names></name><name><surname>Chu</surname><given-names>I.M.</given-names></name><name><surname>Chen</surname><given-names>W.C.</given-names></name></person-group><article-title>A Novel Biodegradable and Thermosensitive Poly (Ester-Amide) Hydrogel for Cartilage Tissue Engineering</article-title><source>Biomed. Res. Int.</source><year>2018</year><volume>2018</volume><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1155/2018/2710892</pub-id><?supplied-pmid 30662902?><pub-id pub-id-type="pmid">30662902</pub-id></element-citation></ref><ref id="B79-pharmaceutics-11-00432"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klouda</surname><given-names>L.</given-names></name><name><surname>Mikos</surname><given-names>A.G.</given-names></name></person-group><article-title>Thermoresponsive hydrogels in biomedical applications</article-title><source>Eur. J. Pharm. Biopharm.</source><year>2008</year><volume>68</volume><fpage>34</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1016/j.ejpb.2007.02.025</pub-id><?supplied-pmid 17881200?><pub-id pub-id-type="pmid">17881200</pub-id></element-citation></ref><ref id="B80-pharmaceutics-11-00432"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gong</surname><given-names>C.</given-names></name><name><surname>Qi</surname><given-names>T.</given-names></name><name><surname>Wei</surname><given-names>X.</given-names></name><name><surname>Qu</surname><given-names>Y.</given-names></name><name><surname>Wu</surname><given-names>Q.</given-names></name><name><surname>Luo</surname><given-names>F.</given-names></name><name><surname>Qian</surname><given-names>Z.</given-names></name></person-group><article-title>Thermosensitive polymeric hydrogels as drug delivery systems</article-title><source>Curr. Med. Chem.</source><year>2013</year><volume>20</volume><fpage>79</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.2174/0929867311302010009</pub-id><?supplied-pmid 23092130?><pub-id pub-id-type="pmid">23092130</pub-id></element-citation></ref><ref id="B81-pharmaceutics-11-00432"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Yu</surname><given-names>J.</given-names></name><name><surname>Ren</surname><given-names>K.</given-names></name><name><surname>Zuo</surname><given-names>J.</given-names></name><name><surname>Ding</surname><given-names>J.</given-names></name><name><surname>Chen</surname><given-names>X.</given-names></name></person-group><article-title>Thermosensitive Hydrogels as Scaffolds for Cartilage Tissue Engineering</article-title><source>Biomacromolecules</source><year>2019</year><volume>20</volume><fpage>1478</fpage><lpage>1492</lpage><pub-id pub-id-type="doi">10.1021/acs.biomac.9b00043</pub-id><?supplied-pmid 30843390?><pub-id pub-id-type="pmid">30843390</pub-id></element-citation></ref><ref id="B82-pharmaceutics-11-00432"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tahrir</surname><given-names>F.G.</given-names></name><name><surname>Ganji</surname><given-names>F.</given-names></name><name><surname>Ahooyi</surname><given-names>T.M.</given-names></name></person-group><article-title>Injectable thermosensitive chitosan/glycerophosphate-based hydrogels for tissue engineering and drug delivery applications: A review</article-title><source>Recent Pat. Drug Deliv.</source><year>2015</year><volume>9</volume><fpage>107</fpage><lpage>120</lpage><pub-id pub-id-type="doi">10.2174/1872211308666141028145651</pub-id></element-citation></ref><ref id="B83-pharmaceutics-11-00432"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ge</surname><given-names>J.</given-names></name><name><surname>Neofytou</surname><given-names>E.</given-names></name><name><surname>Cahill</surname><given-names>T.J.</given-names></name><name><surname>Beygui</surname><given-names>R.E.</given-names></name><name><surname>Zare</surname><given-names>R.N.</given-names></name></person-group><article-title>Drug Release from Electric-Field-Responsive Nanoparticles</article-title><source>ACS Nano</source><year>2012</year><volume>6</volume><fpage>227</fpage><lpage>233</lpage><pub-id pub-id-type="doi">10.1021/nn203430m</pub-id><pub-id pub-id-type="pmid">22111891</pub-id></element-citation></ref><ref id="B84-pharmaceutics-11-00432"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Servant</surname><given-names>A.</given-names></name><name><surname>Guy</surname><given-names>O.J.</given-names></name><name><surname>Al-Jamal</surname><given-names>K.T.</given-names></name><name><surname>Williams</surname><given-names>P.R.</given-names></name><name><surname>Hawkins</surname><given-names>K.M.</given-names></name><name><surname>Kostarelos</surname><given-names>K.</given-names></name></person-group><article-title>An Electric-Field Responsive Microsystem for Controllable Miniaturised Drug Delivery Applications</article-title><source>Procedia Eng.</source><year>2011</year><volume>25</volume><fpage>984</fpage><lpage>987</lpage><pub-id pub-id-type="doi">10.1016/j.proeng.2011.12.242</pub-id></element-citation></ref><ref id="B85-pharmaceutics-11-00432"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>W.</given-names></name><name><surname>Odelius</surname><given-names>K.</given-names></name><name><surname>Edlund</surname><given-names>U.</given-names></name><name><surname>Zhao</surname><given-names>C.</given-names></name><name><surname>Albertsson</surname><given-names>A.C.</given-names></name></person-group><article-title>In Situ Synthesis of Magnetic Field-Responsive Hemicellulose Hydrogels for Drug Delivery</article-title><source>Biomacromolecules</source><year>2015</year><volume>16</volume><fpage>2522</fpage><lpage>2528</lpage><pub-id pub-id-type="doi">10.1021/acs.biomac.5b00801</pub-id><pub-id pub-id-type="pmid">26196600</pub-id></element-citation></ref><ref id="B86-pharmaceutics-11-00432"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ara&#x000fa;jo-Cust&#x000f3;dio</surname><given-names>S.</given-names></name><name><surname>Gomez-Florit</surname><given-names>M.</given-names></name><name><surname>Tom&#x000e1;s</surname><given-names>A.R.</given-names></name><name><surname>Mendes</surname><given-names>B.B.</given-names></name><name><surname>Babo</surname><given-names>P.S.</given-names></name><name><surname>Mithieux</surname><given-names>S.M.</given-names></name><name><surname>Weiss</surname><given-names>A.</given-names></name><name><surname>Domingues</surname><given-names>R.M.A.</given-names></name><name><surname>Reis</surname><given-names>R.L.</given-names></name><name><surname>Gomes</surname><given-names>M.E.</given-names></name></person-group><article-title>Injectable and Magnetic Responsive Hydrogels with Bioinspired Ordered Structures</article-title><source>ACS Biomater. Sci. Eng.</source><year>2019</year><volume>5</volume><fpage>1392</fpage><lpage>1404</lpage><pub-id pub-id-type="doi">10.1021/acsbiomaterials.8b01179</pub-id></element-citation></ref><ref id="B87-pharmaceutics-11-00432"><label>87.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Filipcsei</surname><given-names>G.</given-names></name><name><surname>Csetneki</surname><given-names>I.</given-names></name><name><surname>Szil&#x000e1;gyi</surname><given-names>A.</given-names></name><name><surname>Zr&#x000ed;nyi</surname><given-names>M.</given-names></name></person-group><article-title>Magnetic Field-Responsive Smart Polymer Composites</article-title><source>Oligomers-Polymer Composites-Molecular Imprinting</source><publisher-name>Springer</publisher-name><publisher-loc>Berlin/Heidelberg, Germany</publisher-loc><year>2007</year><fpage>137</fpage><lpage>189</lpage></element-citation></ref><ref id="B88-pharmaceutics-11-00432"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ilg</surname><given-names>P.</given-names></name></person-group><article-title>Stimuli-responsive hydrogels cross-linked by magnetic nanoparticles</article-title><source>Soft Matter</source><year>2013</year><volume>9</volume><fpage>3465</fpage><pub-id pub-id-type="doi">10.1039/c3sm27809c</pub-id></element-citation></ref><ref id="B89-pharmaceutics-11-00432"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El-Leithy</surname><given-names>E.S.</given-names></name><name><surname>Shaker</surname><given-names>D.S.</given-names></name><name><surname>Ghorab</surname><given-names>M.K.</given-names></name><name><surname>Abdel-Rashid</surname><given-names>R.S.</given-names></name></person-group><article-title>Evaluation of Mucoadhesive Hydrogels Loaded with Diclofenac Sodium&#x02013;Chitosan Microspheres for Rectal Administration</article-title><source>AAPS PharmSciTech</source><year>2010</year><volume>11</volume><fpage>1695</fpage><lpage>1702</lpage><pub-id pub-id-type="doi">10.1208/s12249-010-9544-3</pub-id><?supplied-pmid 21108027?><pub-id pub-id-type="pmid">21108027</pub-id></element-citation></ref><ref id="B90-pharmaceutics-11-00432"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Q.</given-names></name><name><surname>Liu</surname><given-names>L.</given-names></name></person-group><article-title>Novel Light-Responsive Hydrogels with Antimicrobial and Antifouling Capabilities</article-title><source>Langmuir</source><year>2019</year><volume>35</volume><fpage>1450</fpage><lpage>1457</lpage><pub-id pub-id-type="doi">10.1021/acs.langmuir.8b01663</pub-id><?supplied-pmid 30056704?><pub-id pub-id-type="pmid">30056704</pub-id></element-citation></ref><ref id="B91-pharmaceutics-11-00432"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>L.</given-names></name><name><surname>Scheiger</surname><given-names>J.M.</given-names></name><name><surname>Levkin</surname><given-names>P.A.</given-names></name></person-group><article-title>Design and Applications of Photoresponsive Hydrogels</article-title><source>Adv. Mater.</source><year>2019</year><fpage>1807333</fpage><pub-id pub-id-type="doi">10.1002/adma.201807333</pub-id><?supplied-pmid 30848524?><pub-id pub-id-type="pmid">30848524</pub-id></element-citation></ref><ref id="B92-pharmaceutics-11-00432"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>ter Schiphorst</surname><given-names>J.</given-names></name><name><surname>Coleman</surname><given-names>S.</given-names></name><name><surname>Stumpel</surname><given-names>J.E.</given-names></name><name><surname>Ben Azouz</surname><given-names>A.</given-names></name><name><surname>Diamond</surname><given-names>D.</given-names></name><name><surname>Schenning</surname><given-names>A.P.H.J.</given-names></name></person-group><article-title>Molecular Design of Light-Responsive Hydrogels, For in Situ Generation of Fast and Reversible Valves for Microfluidic Applications</article-title><source>Chem. Mater.</source><year>2015</year><volume>27</volume><fpage>5925</fpage><lpage>5931</lpage><pub-id pub-id-type="doi">10.1021/acs.chemmater.5b01860</pub-id></element-citation></ref><ref id="B93-pharmaceutics-11-00432"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ba&#x000ef;t</surname><given-names>N.</given-names></name><name><surname>Grassl</surname><given-names>B.</given-names></name><name><surname>Derail</surname><given-names>C.</given-names></name><name><surname>Benaboura</surname><given-names>A.</given-names></name></person-group><article-title>Hydrogel nanocomposites as pressure-sensitive adhesives for skin-contact applications</article-title><source>Soft Matter</source><year>2011</year><volume>7</volume><fpage>2025</fpage><pub-id pub-id-type="doi">10.1039/c0sm01123a</pub-id></element-citation></ref><ref id="B94-pharmaceutics-11-00432"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ilic-Stojanovic</surname><given-names>S.</given-names></name><name><surname>Nikolic</surname><given-names>L.</given-names></name><name><surname>Nikolic</surname><given-names>V.</given-names></name><name><surname>Petrovic</surname><given-names>S.</given-names></name><name><surname>Stankovic</surname><given-names>M.</given-names></name><name><surname>Mladenovic-Ranisavljevic</surname><given-names>I.</given-names></name></person-group><article-title>Stimuli-sensitive hydrogels for pharmaceutical and medical applications</article-title><source>Facta Univ. Ser. Phys. Chem. Technol.</source><year>2011</year><volume>9</volume><fpage>37</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.2298/FUPCT1101037I</pub-id></element-citation></ref><ref id="B95-pharmaceutics-11-00432"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peppas</surname><given-names>N.A.</given-names></name><name><surname>Van Blarcom</surname><given-names>D.S.</given-names></name></person-group><article-title>Hydrogel-based biosensors and sensing devices for drug delivery</article-title><source>J. Control. Release</source><year>2016</year><volume>240</volume><fpage>142</fpage><lpage>150</lpage><pub-id pub-id-type="doi">10.1016/j.jconrel.2015.11.022</pub-id><?supplied-pmid 26611939?><pub-id pub-id-type="pmid">26611939</pub-id></element-citation></ref><ref id="B96-pharmaceutics-11-00432"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qiu</surname><given-names>Y.</given-names></name><name><surname>Park</surname><given-names>K.</given-names></name></person-group><article-title>Environment-sensitive hydrogels for drug delivery</article-title><source>Adv. Drug Deliv. Rev.</source><year>2001</year><volume>53</volume><fpage>321</fpage><lpage>339</lpage><pub-id pub-id-type="doi">10.1016/S0169-409X(01)00203-4</pub-id><pub-id pub-id-type="pmid">11744175</pub-id></element-citation></ref><ref id="B97-pharmaceutics-11-00432"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhattacharya</surname><given-names>M.</given-names></name><name><surname>Malinen</surname><given-names>M.M.</given-names></name><name><surname>Lauren</surname><given-names>P.</given-names></name><name><surname>Lou</surname><given-names>Y.R.</given-names></name><name><surname>Kuisma</surname><given-names>S.W.</given-names></name><name><surname>Kanninen</surname><given-names>L.</given-names></name><name><surname>Lille</surname><given-names>M.</given-names></name><name><surname>Corlu</surname><given-names>A.</given-names></name><name><surname>GuGuen-Guillouzo</surname><given-names>C.</given-names></name><name><surname>Ikkala</surname><given-names>O.</given-names></name><etal/></person-group><article-title>Nanofibrillar cellulose hydrogel promotes three-dimensional liver cell culture</article-title><source>J. Control. Release</source><year>2012</year><volume>164</volume><fpage>291</fpage><lpage>298</lpage><pub-id pub-id-type="doi">10.1016/j.jconrel.2012.06.039</pub-id><pub-id pub-id-type="pmid">22776290</pub-id></element-citation></ref><ref id="B98-pharmaceutics-11-00432"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname><given-names>Y.</given-names></name><name><surname>Xu</surname><given-names>K.</given-names></name><name><surname>Zheng</surname><given-names>X.</given-names></name><name><surname>Giacomin</surname><given-names>A.J.</given-names></name><name><surname>Mix</surname><given-names>A.W.</given-names></name><name><surname>Kao</surname><given-names>W.J.</given-names></name></person-group><article-title>3D cell entrapment in crosslinked thiolated gelatin-poly(ethylene glycol) diacrylate hydrogels</article-title><source>Biomaterials</source><year>2012</year><volume>33</volume><fpage>48</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1016/j.biomaterials.2011.09.031</pub-id><pub-id pub-id-type="pmid">21955690</pub-id></element-citation></ref><ref id="B99-pharmaceutics-11-00432"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>R.Z.</given-names></name><name><surname>Chen</surname><given-names>Y.C.</given-names></name><name><surname>Moreno-Luna</surname><given-names>R.</given-names></name><name><surname>Khademhosseini</surname><given-names>A.</given-names></name><name><surname>Melero-Martin</surname><given-names>J.M.</given-names></name></person-group><article-title>Transdermal regulation of vascular network bioengineering using a photopolymerizable methacrylated gelatin hydrogel</article-title><source>Biomaterials</source><year>2013</year><volume>34</volume><fpage>6785</fpage><lpage>6796</lpage><pub-id pub-id-type="doi">10.1016/j.biomaterials.2013.05.060</pub-id><?supplied-pmid 23773819?><pub-id pub-id-type="pmid">23773819</pub-id></element-citation></ref><ref id="B100-pharmaceutics-11-00432"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pok</surname><given-names>S.</given-names></name><name><surname>Myers</surname><given-names>J.D.</given-names></name><name><surname>Madihally</surname><given-names>S.V.</given-names></name><name><surname>Jacot</surname><given-names>J.G.</given-names></name></person-group><article-title>A multilayered scaffold of a chitosan and gelatin hydrogel supported by a PCL core for cardiac tissue engineering</article-title><source>Acta Biomater.</source><year>2013</year><volume>9</volume><fpage>5630</fpage><lpage>5642</lpage><pub-id pub-id-type="doi">10.1016/j.actbio.2012.10.032</pub-id><?supplied-pmid 23128158?><pub-id pub-id-type="pmid">23128158</pub-id></element-citation></ref><ref id="B101-pharmaceutics-11-00432"><label>101.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>M.R.</given-names></name><name><surname>Patel</surname><given-names>S.</given-names></name><name><surname>Singh</surname><given-names>D.</given-names></name></person-group><article-title>Natural polymer-based hydrogels as scaffolds for tissue engineering</article-title><source>Nanobiomaterials in Soft Tissue Engineering</source><publisher-name>Elsevier</publisher-name><publisher-loc>Amsterdam, The Netherlands</publisher-loc><year>2016</year><fpage>231</fpage><lpage>260</lpage></element-citation></ref><ref id="B102-pharmaceutics-11-00432"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chai</surname><given-names>Q.</given-names></name><name><surname>Jiao</surname><given-names>Y.</given-names></name><name><surname>Yu</surname><given-names>X.</given-names></name></person-group><article-title>Hydrogels for Biomedical Applications: Their Characteristics and the Mechanisms behind Them</article-title><source>Gels</source><year>2017</year><volume>3</volume><elocation-id>6</elocation-id><pub-id pub-id-type="doi">10.3390/gels3010006</pub-id><?supplied-pmid 30920503?><pub-id pub-id-type="pmid">30920503</pub-id></element-citation></ref><ref id="B103-pharmaceutics-11-00432"><label>103.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Vieira</surname><given-names>S.</given-names></name><name><surname>da Silva Morais</surname><given-names>A.</given-names></name><name><surname>Silva-Correia</surname><given-names>J.</given-names></name><name><surname>Oliveira</surname><given-names>J.M.</given-names></name><name><surname>Reis</surname><given-names>R.L.</given-names></name></person-group><article-title>Natural-Based Hydrogels: From Processing to Applications</article-title><source>Encyclopedia of Polymer Science and Technology</source><publisher-name>John Wiley &#x00026; Sons, Inc.</publisher-name><publisher-loc>Hoboken, NJ, USA</publisher-loc><year>2017</year><fpage>1</fpage><lpage>27</lpage></element-citation></ref><ref id="B104-pharmaceutics-11-00432"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>J.</given-names></name><name><surname>Marchant</surname><given-names>R.E.</given-names></name></person-group><article-title>Design properties of hydrogel tissue-engineering scaffolds</article-title><source>Expert Rev. Med. Devices</source><year>2011</year><volume>8</volume><fpage>607</fpage><lpage>626</lpage><pub-id pub-id-type="doi">10.1586/erd.11.27</pub-id><?supplied-pmid 22026626?><pub-id pub-id-type="pmid">22026626</pub-id></element-citation></ref><ref id="B105-pharmaceutics-11-00432"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pereira</surname><given-names>D.R.</given-names></name><name><surname>Canadas</surname><given-names>R.F.</given-names></name><name><surname>Silva-Correia</surname><given-names>J.</given-names></name><name><surname>Marques</surname><given-names>A.P.</given-names></name><name><surname>Reis</surname><given-names>R.L.</given-names></name><name><surname>Oliveira</surname><given-names>J.M.</given-names></name></person-group><article-title>Gellan Gum-Based Hydrogel Bilayered Scaffolds for Osteochondral Tissue Engineering</article-title><source>Key Eng. Mater.</source><year>2013</year><volume>587</volume><fpage>255</fpage><lpage>260</lpage><pub-id pub-id-type="doi">10.4028/www.scientific.net/KEM.587.255</pub-id></element-citation></ref><ref id="B106-pharmaceutics-11-00432"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mila&#x00161;inovi&#x00107;</surname><given-names>N.</given-names></name><name><surname>Kalagasidis Kru&#x00161;i&#x00107;</surname><given-names>M.</given-names></name><name><surname>Kne&#x0017e;evi&#x00107;-Jugovi&#x00107;</surname><given-names>Z.</given-names></name><name><surname>Filipovi&#x00107;</surname><given-names>J.</given-names></name></person-group><article-title>Hydrogels of N-isopropylacrylamide copolymers with controlled release of a model protein</article-title><source>Int. J. Pharm.</source><year>2010</year><volume>383</volume><fpage>53</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1016/j.ijpharm.2009.09.001</pub-id><pub-id pub-id-type="pmid">19747965</pub-id></element-citation></ref><ref id="B107-pharmaceutics-11-00432"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anghelache</surname><given-names>A.</given-names></name><name><surname>Teodorescu</surname><given-names>M.</given-names></name><name><surname>St&#x001ce;nescu</surname><given-names>P.O.</given-names></name><name><surname>Dr&#x001ce;ghici</surname><given-names>C.</given-names></name><name><surname>Vuluga</surname><given-names>D.M.</given-names></name></person-group><article-title>Novel crosslinked thermoresponsive hydrogels with controlled poly (ethylene glycol)&#x02014;Poly (propylene glycol) multiblock copolymer structure</article-title><source>Colloid Polym. Sci.</source><year>2014</year><volume>292</volume><fpage>829</fpage><lpage>838</lpage><pub-id pub-id-type="doi">10.1007/s00396-013-3128-1</pub-id></element-citation></ref><ref id="B108-pharmaceutics-11-00432"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geckil</surname><given-names>H.</given-names></name><name><surname>Xu</surname><given-names>F.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Moon</surname><given-names>S.</given-names></name><name><surname>Demirci</surname><given-names>U.</given-names></name></person-group><article-title>Engineering hydrogels as extracellular matrix mimics</article-title><source>Nanomedicine</source><year>2010</year><volume>5</volume><fpage>469</fpage><lpage>484</lpage><pub-id pub-id-type="doi">10.2217/nnm.10.12</pub-id><pub-id pub-id-type="pmid">20394538</pub-id></element-citation></ref><ref id="B109-pharmaceutics-11-00432"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stagnaro</surname><given-names>P.</given-names></name><name><surname>Schizzi</surname><given-names>I.</given-names></name><name><surname>Utzeri</surname><given-names>R.</given-names></name><name><surname>Marsano</surname><given-names>E.</given-names></name><name><surname>Castellano</surname><given-names>M.</given-names></name></person-group><article-title>Alginate-polymethacrylate hybrid hydrogels for potential osteochondral tissue regeneration</article-title><source>Carbohydr. Polym.</source><year>2018</year><volume>185</volume><fpage>56</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1016/j.carbpol.2018.01.012</pub-id><pub-id pub-id-type="pmid">29421060</pub-id></element-citation></ref><ref id="B110-pharmaceutics-11-00432"><label>110.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anjum</surname><given-names>F.</given-names></name><name><surname>Lienemann</surname><given-names>P.S.</given-names></name><name><surname>Metzger</surname><given-names>S.</given-names></name><name><surname>Biernaskie</surname><given-names>J.</given-names></name><name><surname>Kallos</surname><given-names>M.S.</given-names></name><name><surname>Ehrbar</surname><given-names>M.</given-names></name></person-group><article-title>Enzyme responsive GAG-based natural-synthetic hybrid hydrogel for tunable growth factor delivery and stem cell differentiation</article-title><source>Biomaterials</source><year>2016</year><volume>87</volume><fpage>104</fpage><lpage>117</lpage><pub-id pub-id-type="doi">10.1016/j.biomaterials.2016.01.050</pub-id><pub-id pub-id-type="pmid">26914701</pub-id></element-citation></ref><ref id="B111-pharmaceutics-11-00432"><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>J.</given-names></name><name><surname>Ren</surname><given-names>J.</given-names></name><name><surname>Chen</surname><given-names>G.</given-names></name><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>G.</given-names></name><name><surname>Wu</surname><given-names>X.</given-names></name></person-group><article-title>Tunable sequential drug delivery system based on chitosan/hyaluronic acid hydrogels and PLGA microspheres for management of non-healing infected wounds</article-title><source>Mater. Sci. Eng. C</source><year>2018</year><volume>89</volume><fpage>213</fpage><lpage>222</lpage><pub-id pub-id-type="doi">10.1016/j.msec.2018.04.009</pub-id><?supplied-pmid 29752091?><pub-id pub-id-type="pmid">29752091</pub-id></element-citation></ref><ref id="B112-pharmaceutics-11-00432"><label>112.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jia</surname><given-names>X.</given-names></name><name><surname>Kiick</surname><given-names>K.L.</given-names></name></person-group><article-title>Hybrid Multicomponent Hydrogels for Tissue Engineering</article-title><source>Macromol. Biosci.</source><year>2009</year><volume>9</volume><fpage>140</fpage><lpage>156</lpage><pub-id pub-id-type="doi">10.1002/mabi.200800284</pub-id><?supplied-pmid 19107720?><pub-id pub-id-type="pmid">19107720</pub-id></element-citation></ref><ref id="B113-pharmaceutics-11-00432"><label>113.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aigner</surname><given-names>T.</given-names></name><name><surname>St&#x000f6;ve</surname><given-names>J.</given-names></name></person-group><article-title>Collagens--major component of the physiological cartilage matrix, major target of cartilage degeneration, major tool in cartilage repair</article-title><source>Adv. Drug Deliv. Rev.</source><year>2003</year><volume>55</volume><fpage>1569</fpage><lpage>1593</lpage><pub-id pub-id-type="doi">10.1016/j.addr.2003.08.009</pub-id><?supplied-pmid 14623402?><pub-id pub-id-type="pmid">14623402</pub-id></element-citation></ref><ref id="B114-pharmaceutics-11-00432"><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kopecek</surname><given-names>J.</given-names></name></person-group><article-title>Smart and genetically engineered biomaterials and drug delivery systems</article-title><source>Eur. J. Pharm. Sci.</source><year>2003</year><volume>20</volume><fpage>1</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1016/S0928-0987(03)00164-7</pub-id><pub-id pub-id-type="pmid">13678788</pub-id></element-citation></ref><ref id="B115-pharmaceutics-11-00432"><label>115.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>Y.</given-names></name><name><surname>Onyeri</surname><given-names>S.</given-names></name><name><surname>Siewe</surname><given-names>M.</given-names></name><name><surname>Moshfeghian</surname><given-names>A.</given-names></name><name><surname>Madihally</surname><given-names>S.V.</given-names></name></person-group><article-title>In vitro characterization of chitosan&#x02013;gelatin scaffolds for tissue engineering</article-title><source>Biomaterials</source><year>2005</year><volume>26</volume><fpage>7616</fpage><lpage>7627</lpage><pub-id pub-id-type="doi">10.1016/j.biomaterials.2005.05.036</pub-id><?supplied-pmid 16005510?><pub-id pub-id-type="pmid">16005510</pub-id></element-citation></ref><ref id="B116-pharmaceutics-11-00432"><label>116.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Minhas</surname><given-names>M.U.</given-names></name><name><surname>Ahmad</surname><given-names>M.</given-names></name><name><surname>Anwar</surname><given-names>J.</given-names></name><name><surname>Khan</surname><given-names>S.</given-names></name></person-group><article-title>Synthesis and Characterization of Biodegradable Hydrogels for Oral Delivery of 5-Fluorouracil Targeted to Colon: Screening with Preliminary In Vivo Studies</article-title><source>Adv. Polym. Technol.</source><year>2018</year><volume>37</volume><fpage>221</fpage><lpage>229</lpage><pub-id pub-id-type="doi">10.1002/adv.21659</pub-id></element-citation></ref><ref id="B117-pharmaceutics-11-00432"><label>117.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>H.</given-names></name><name><surname>Marra</surname><given-names>K.G.</given-names></name></person-group><article-title>Injectable, Biodegradable Hydrogels for Tissue Engineering Applications</article-title><source>Materials</source><year>2010</year><volume>3</volume><fpage>1746</fpage><lpage>1767</lpage><pub-id pub-id-type="doi">10.3390/ma3031746</pub-id></element-citation></ref><ref id="B118-pharmaceutics-11-00432"><label>118.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>M.K.</given-names></name><name><surname>Lee</surname><given-names>D.S.</given-names></name></person-group><article-title>Injectable Biodegradable Hydrogels</article-title><source>Macromol. Biosci.</source><year>2010</year><volume>10</volume><fpage>563</fpage><lpage>579</lpage><pub-id pub-id-type="doi">10.1002/mabi.200900402</pub-id><pub-id pub-id-type="pmid">20196065</pub-id></element-citation></ref><ref id="B119-pharmaceutics-11-00432"><label>119.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kitagawa</surname><given-names>H.</given-names></name><name><surname>Takeda</surname><given-names>K.</given-names></name><name><surname>Kitagawa</surname><given-names>R.</given-names></name><name><surname>Izutani</surname><given-names>N.</given-names></name><name><surname>Miki</surname><given-names>S.</given-names></name><name><surname>Hirose</surname><given-names>N.</given-names></name><name><surname>Hayashi</surname><given-names>M.</given-names></name><name><surname>Imazato</surname><given-names>S.</given-names></name></person-group><article-title>Development of sustained antimicrobial-release systems using poly(2-hydroxyethyl methacrylate)/trimethylolpropane trimethacrylate hydrogels</article-title><source>Acta Biomater.</source><year>2014</year><volume>10</volume><fpage>4285</fpage><lpage>4295</lpage><pub-id pub-id-type="doi">10.1016/j.actbio.2014.06.016</pub-id><pub-id pub-id-type="pmid">24952074</pub-id></element-citation></ref><ref id="B120-pharmaceutics-11-00432"><label>120.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de C&#x000e1;ssia Novaes</surname><given-names>W.</given-names></name><name><surname>Berg</surname><given-names>A.</given-names></name></person-group><article-title>Experiences with a New Nonbiodegradable Hydrogel (Aquamid): A Pilot Study</article-title><source>Aesthetic Plast Surg</source><year>2003</year><volume>27</volume><fpage>376</fpage><lpage>380</lpage><pub-id pub-id-type="doi">10.1007/s00266-003-2119-x</pub-id><pub-id pub-id-type="pmid">14612994</pub-id></element-citation></ref><ref id="B121-pharmaceutics-11-00432"><label>121.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>P&#x000e9;rez-Luna</surname><given-names>V.</given-names></name><name><surname>Gonz&#x000e1;lez-Reynoso</surname><given-names>O.</given-names></name></person-group><article-title>Encapsulation of Biological Agents in Hydrogels for Therapeutic Applications</article-title><source>Gels</source><year>2018</year><volume>4</volume><elocation-id>61</elocation-id><pub-id pub-id-type="doi">10.3390/gels4030061</pub-id><?supplied-pmid 30674837?><pub-id pub-id-type="pmid">30674837</pub-id></element-citation></ref><ref id="B122-pharmaceutics-11-00432"><label>122.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>C.C.</given-names></name><name><surname>Metters</surname><given-names>A.T.</given-names></name></person-group><article-title>Hydrogels in controlled release formulations: Network design and mathematical modeling</article-title><source>Adv. Drug Deliv. Rev.</source><year>2006</year><volume>58</volume><fpage>1379</fpage><lpage>1408</lpage><pub-id pub-id-type="doi">10.1016/j.addr.2006.09.004</pub-id><?supplied-pmid 17081649?><pub-id pub-id-type="pmid">17081649</pub-id></element-citation></ref><ref id="B123-pharmaceutics-11-00432"><label>123.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>R.S.H.</given-names></name><name><surname>Dodou</surname><given-names>K.</given-names></name></person-group><article-title>Effect of Drug Loading Method and Drug Physicochemical Properties on the Material and Drug Release Properties of Poly (Ethylene Oxide) Hydrogels for Transdermal Delivery</article-title><source>Polymers</source><year>2017</year><volume>9</volume><elocation-id>286</elocation-id><pub-id pub-id-type="doi">10.3390/polym9070286</pub-id><?supplied-pmid 30970963?><pub-id pub-id-type="pmid">30970963</pub-id></element-citation></ref><ref id="B124-pharmaceutics-11-00432"><label>124.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prince</surname><given-names>D.A.</given-names></name><name><surname>Villamagna</surname><given-names>I.J.</given-names></name><name><surname>Hopkins</surname><given-names>C.C.</given-names></name><name><surname>de Bruyn</surname><given-names>J.R.</given-names></name><name><surname>Gillies</surname><given-names>E.R.</given-names></name></person-group><article-title>Effect of drug loading on the properties of temperature-responsive polyester&#x02013;poly(ethylene glycol)&#x02013;polyester hydrogels</article-title><source>Polym. Int.</source><year>2019</year><volume>68</volume><fpage>1074</fpage><lpage>1083</lpage><pub-id pub-id-type="doi">10.1002/pi.5797</pub-id></element-citation></ref><ref id="B125-pharmaceutics-11-00432"><label>125.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boca</surname><given-names>S.</given-names></name><name><surname>Berce</surname><given-names>C.</given-names></name><name><surname>Jurj</surname><given-names>A.</given-names></name><name><surname>Petrushev</surname><given-names>B.</given-names></name><name><surname>Pop</surname><given-names>L.</given-names></name><name><surname>Gafencu</surname><given-names>G.A.</given-names></name><name><surname>Selicean</surname><given-names>S.</given-names></name><name><surname>Moisoiu</surname><given-names>V.</given-names></name><name><surname>Temian</surname><given-names>D.</given-names></name><name><surname>Micu</surname><given-names>W.T.</given-names></name><etal/></person-group><article-title>Ruxolitinib-conjugated gold nanoparticles for topical administration: An alternative for treating alopecia?</article-title><source>Med. Hypotheses</source><year>2017</year><volume>109</volume><fpage>42</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1016/j.mehy.2017.09.023</pub-id><?supplied-pmid 29150291?><pub-id pub-id-type="pmid">29150291</pub-id></element-citation></ref><ref id="B126-pharmaceutics-11-00432"><label>126.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allen</surname><given-names>T.M.</given-names></name><name><surname>Cullis</surname><given-names>P.R.</given-names></name></person-group><article-title>Liposomal drug delivery systems: From concept to clinical applications</article-title><source>Adv. Drug Deliv. Rev.</source><year>2013</year><volume>65</volume><fpage>36</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.1016/j.addr.2012.09.037</pub-id><?supplied-pmid 23036225?><pub-id pub-id-type="pmid">23036225</pub-id></element-citation></ref><ref id="B127-pharmaceutics-11-00432"><label>127.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kataoka</surname><given-names>K.</given-names></name><name><surname>Harada</surname><given-names>A.</given-names></name><name><surname>Nagasaki</surname><given-names>Y.</given-names></name></person-group><article-title>Block copolymer micelles for drug delivery: Design, characterization and biological significance</article-title><source>Adv. Drug Deliv. Rev.</source><year>2012</year><volume>64</volume><fpage>37</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.1016/j.addr.2012.09.013</pub-id></element-citation></ref><ref id="B128-pharmaceutics-11-00432"><label>128.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pan</surname><given-names>L.</given-names></name><name><surname>He</surname><given-names>Q.</given-names></name><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Ma</surname><given-names>M.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Shi</surname><given-names>J.</given-names></name></person-group><article-title>Nuclear-Targeted Drug Delivery of TAT Peptide-Conjugated Monodisperse Mesoporous Silica Nanoparticles</article-title><source>J. Am. Chem. Soc.</source><year>2012</year><volume>134</volume><fpage>5722</fpage><lpage>5725</lpage><pub-id pub-id-type="doi">10.1021/ja211035w</pub-id><?supplied-pmid 22420312?><pub-id pub-id-type="pmid">22420312</pub-id></element-citation></ref><ref id="B129-pharmaceutics-11-00432"><label>129.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jurj</surname><given-names>A.</given-names></name><name><surname>Braicu</surname><given-names>C.</given-names></name><name><surname>Pop</surname><given-names>L.A.</given-names></name><name><surname>Tomuleasa</surname><given-names>C.</given-names></name><name><surname>Gherman</surname><given-names>C.</given-names></name><name><surname>Berindan-Neagoe</surname><given-names>I.</given-names></name></person-group><article-title>The new era of nanotechnology, an alternative to change cancer treatment</article-title><source>Drug Des. Devel. Ther.</source><year>2017</year><volume>11</volume><fpage>2871</fpage><lpage>2890</lpage><pub-id pub-id-type="doi">10.2147/DDDT.S142337</pub-id><?supplied-pmid 29033548?><pub-id pub-id-type="pmid">29033548</pub-id></element-citation></ref><ref id="B130-pharmaceutics-11-00432"><label>130.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riggio</surname><given-names>C.</given-names></name><name><surname>Pagni</surname><given-names>E.</given-names></name><name><surname>Raffa</surname><given-names>V.</given-names></name><name><surname>Cuschieri</surname><given-names>A.</given-names></name></person-group><article-title>Nano-Oncology: Clinical Application for Cancer Therapy and Future Perspectives</article-title><source>J. Nanomater.</source><year>2011</year><volume>2011</volume><fpage>17</fpage><pub-id pub-id-type="doi">10.1155/2011/164506</pub-id></element-citation></ref><ref id="B131-pharmaceutics-11-00432"><label>131.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schexnailder</surname><given-names>P.</given-names></name><name><surname>Schmidt</surname><given-names>G.</given-names></name></person-group><article-title>Nanocomposite polymer hydrogels</article-title><source>Colloid Polym. Sci.</source><year>2009</year><volume>287</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1007/s00396-008-1949-0</pub-id></element-citation></ref><ref id="B132-pharmaceutics-11-00432"><label>132.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Appel</surname><given-names>E.A.</given-names></name><name><surname>Tibbitt</surname><given-names>M.W.</given-names></name><name><surname>Webber</surname><given-names>M.J.</given-names></name><name><surname>Mattix</surname><given-names>B.A.</given-names></name><name><surname>Veiseh</surname><given-names>O.</given-names></name><name><surname>Langer</surname><given-names>R.</given-names></name></person-group><article-title>Self-assembled hydrogels utilizing polymer&#x02013;nanoparticle interactions</article-title><source>Nat. Commun.</source><year>2015</year><volume>6</volume><fpage>6295</fpage><pub-id pub-id-type="doi">10.1038/ncomms7295</pub-id><?supplied-pmid 25695516?><pub-id pub-id-type="pmid">25695516</pub-id></element-citation></ref><ref id="B133-pharmaceutics-11-00432"><label>133.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bahari Javan</surname><given-names>N.</given-names></name><name><surname>Montazeri</surname><given-names>H.</given-names></name><name><surname>Rezaie Shirmard</surname><given-names>L.</given-names></name><name><surname>Jafary Omid</surname><given-names>N.</given-names></name><name><surname>Barbari</surname><given-names>G.R.</given-names></name><name><surname>Amini</surname><given-names>M.</given-names></name><name><surname>Ghahremani</surname><given-names>M.H.</given-names></name><name><surname>Rafiee-Tehrani</surname><given-names>M.</given-names></name><name><surname>Abedin Dorkoosh</surname><given-names>F.</given-names></name></person-group><article-title>Preparation, characterization and in vivo evaluation of a combination delivery system based on hyaluronic acid/jeffamine hydrogel loaded with PHBV/PLGA blend nanoparticles for prolonged delivery of Teriparatide</article-title><source>Eur. J. Pharm. Sci.</source><year>2017</year><volume>101</volume><fpage>167</fpage><lpage>181</lpage><pub-id pub-id-type="doi">10.1016/j.ejps.2017.02.018</pub-id><?supplied-pmid 28193537?><pub-id pub-id-type="pmid">28193537</pub-id></element-citation></ref><ref id="B134-pharmaceutics-11-00432"><label>134.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pozzo</surname><given-names>D.C.</given-names></name><name><surname>Walker</surname><given-names>L.M.</given-names></name></person-group><article-title>Shear Orientation of Nanoparticle Arrays Templated in a Thermoreversible Block Copolymer Micellar Crystal</article-title><source>Macromolecules</source><year>2007</year><volume>40</volume><fpage>5801</fpage><lpage>5811</lpage><pub-id pub-id-type="doi">10.1021/ma0700173</pub-id></element-citation></ref><ref id="B135-pharmaceutics-11-00432"><label>135.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>W.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>Q.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name></person-group><article-title>Nanoparticle-Hydrogel: A Hybrid Biomaterial System for Localized Drug Delivery</article-title><source>Ann. Biomed. Eng.</source><year>2016</year><volume>44</volume><fpage>2049</fpage><lpage>2061</lpage><pub-id pub-id-type="doi">10.1007/s10439-016-1583-9</pub-id><?supplied-pmid 26951462?><pub-id pub-id-type="pmid">26951462</pub-id></element-citation></ref><ref id="B136-pharmaceutics-11-00432"><label>136.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baumann</surname><given-names>M.D.</given-names></name><name><surname>Kang</surname><given-names>C.E.</given-names></name><name><surname>Tator</surname><given-names>C.H.</given-names></name><name><surname>Shoichet</surname><given-names>M.S.</given-names></name></person-group><article-title>Intrathecal delivery of a polymeric nanocomposite hydrogel after spinal cord injury</article-title><source>Biomaterials</source><year>2010</year><volume>31</volume><fpage>7631</fpage><lpage>7639</lpage><pub-id pub-id-type="doi">10.1016/j.biomaterials.2010.07.004</pub-id><pub-id pub-id-type="pmid">20656347</pub-id></element-citation></ref><ref id="B137-pharmaceutics-11-00432"><label>137.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>W.</given-names></name><name><surname>Vecchio</surname><given-names>D.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Zhu</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>Q.</given-names></name><name><surname>Fu</surname><given-names>V.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Thamphiwatana</surname><given-names>S.</given-names></name><name><surname>Lu</surname><given-names>D.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name></person-group><article-title>Hydrogel Containing Nanoparticle-Stabilized Liposomes for Topical Antimicrobial Delivery</article-title><source>ACS Nano</source><year>2014</year><volume>8</volume><fpage>2900</fpage><lpage>2907</lpage><pub-id pub-id-type="doi">10.1021/nn500110a</pub-id><pub-id pub-id-type="pmid">24483239</pub-id></element-citation></ref><ref id="B138-pharmaceutics-11-00432"><label>138.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jung</surname><given-names>H.J.</given-names></name><name><surname>Abou-Jaoude</surname><given-names>M.</given-names></name><name><surname>Carbia</surname><given-names>B.E.</given-names></name><name><surname>Plummer</surname><given-names>C.</given-names></name><name><surname>Chauhan</surname><given-names>A.</given-names></name></person-group><article-title>Glaucoma therapy by extended release of timolol from nanoparticle loaded silicone-hydrogel contact lenses</article-title><source>J. Control. Release</source><year>2013</year><volume>165</volume><fpage>82</fpage><lpage>89</lpage><pub-id pub-id-type="doi">10.1016/j.jconrel.2012.10.010</pub-id><pub-id pub-id-type="pmid">23123188</pub-id></element-citation></ref><ref id="B139-pharmaceutics-11-00432"><label>139.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>F.</given-names></name><name><surname>Gao</surname><given-names>W.</given-names></name><name><surname>Thamphiwatana</surname><given-names>S.</given-names></name><name><surname>Luk</surname><given-names>B.T.</given-names></name><name><surname>Angsantikul</surname><given-names>P.</given-names></name><name><surname>Zhang</surname><given-names>Q.</given-names></name><name><surname>Hu</surname><given-names>C.M.J.</given-names></name><name><surname>Fang</surname><given-names>R.H.</given-names></name><name><surname>Copp</surname><given-names>J.A.</given-names></name><name><surname>Pornpattananangkul</surname><given-names>D.</given-names></name><etal/></person-group><article-title>Hydrogel Retaining Toxin-Absorbing Nanosponges for Local Treatment of Methicillin-Resistant Staphylococcus aureus Infection</article-title><source>Adv. Mater.</source><year>2015</year><volume>27</volume><fpage>3437</fpage><lpage>3443</lpage><pub-id pub-id-type="doi">10.1002/adma.201501071</pub-id><pub-id pub-id-type="pmid">25931231</pub-id></element-citation></ref><ref id="B140-pharmaceutics-11-00432"><label>140.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Rahman</surname><given-names>M.S.</given-names></name><name><surname>Islam</surname><given-names>M.M.</given-names></name><name><surname>Islam</surname><given-names>M.S.</given-names></name><name><surname>Zaman</surname><given-names>A.</given-names></name><name><surname>Ahmed</surname><given-names>T.</given-names></name><name><surname>Biswas</surname><given-names>S.</given-names></name><name><surname>Sharmeen</surname><given-names>S.</given-names></name><name><surname>Rashid</surname><given-names>T.U.</given-names></name><name><surname>Rahman</surname><given-names>M.M.</given-names></name></person-group><article-title>Morphological Characterization of Hydrogels</article-title><source>Cellulose-Based Superabsorbent Hydrogels</source><person-group person-group-type="editor"><name><surname>Mondal</surname><given-names>M.</given-names></name></person-group><series>Polymers and Polymeric Composites: A Reference Series</series><publisher-name>Springer</publisher-name><publisher-loc>Cham, Switzerland</publisher-loc><year>2019</year><fpage>819</fpage><lpage>863</lpage></element-citation></ref><ref id="B141-pharmaceutics-11-00432"><label>141.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Linnes</surname><given-names>M.P.</given-names></name><name><surname>Ratner</surname><given-names>B.D.</given-names></name><name><surname>Giachelli</surname><given-names>C.M.</given-names></name></person-group><article-title>A fibrinogen-based precision microporous scaffold for tissue engineering</article-title><source>Biomaterials</source><year>2007</year><volume>28</volume><fpage>5298</fpage><lpage>5306</lpage><pub-id pub-id-type="doi">10.1016/j.biomaterials.2007.08.020</pub-id><pub-id pub-id-type="pmid">17765302</pub-id></element-citation></ref><ref id="B142-pharmaceutics-11-00432"><label>142.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>J.</given-names></name><name><surname>Yan</surname><given-names>B.</given-names></name><name><surname>Li</surname><given-names>T.</given-names></name><name><surname>Long</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>N.</given-names></name><name><surname>Ye</surname><given-names>M.</given-names></name></person-group><article-title>Study on graphene-oxide-based polyacrylamide composite hydrogels</article-title><source>Compos. Part A Appl. Sci. Manuf.</source><year>2012</year><volume>43</volume><fpage>1476</fpage><lpage>1481</lpage><pub-id pub-id-type="doi">10.1016/j.compositesa.2012.04.006</pub-id></element-citation></ref><ref id="B143-pharmaceutics-11-00432"><label>143.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aston</surname><given-names>R.</given-names></name><name><surname>Sewell</surname><given-names>K.</given-names></name><name><surname>Klein</surname><given-names>T.</given-names></name><name><surname>Lawrie</surname><given-names>G.</given-names></name><name><surname>Gr&#x000f8;ndahl</surname><given-names>L.</given-names></name></person-group><article-title>Evaluation of the impact of freezing preparation techniques on the characterisation of alginate hydrogels by cryo-SEM</article-title><source>Eur. Polym. J.</source><year>2016</year><volume>82</volume><fpage>1</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1016/j.eurpolymj.2016.06.025</pub-id></element-citation></ref><ref id="B144-pharmaceutics-11-00432"><label>144.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McMahon</surname><given-names>R.</given-names></name><name><surname>Hahn</surname><given-names>M.</given-names></name><name><surname>Pendleton</surname><given-names>M.</given-names></name><name><surname>Ellis</surname><given-names>E.</given-names></name></person-group><article-title>A Simple Preparation Method for Mesh Fibrin Hydrogel Composites for Conventional SEM</article-title><source>Microsc. Microanal.</source><year>2010</year><volume>16</volume><fpage>1030</fpage><lpage>1031</lpage><pub-id pub-id-type="doi">10.1017/S1431927610058484</pub-id></element-citation></ref><ref id="B145-pharmaceutics-11-00432"><label>145.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barker</surname><given-names>K.</given-names></name><name><surname>Rastogi</surname><given-names>S.K.</given-names></name><name><surname>Dominguez</surname><given-names>J.</given-names></name><name><surname>Cantu</surname><given-names>T.</given-names></name><name><surname>Brittain</surname><given-names>W.</given-names></name><name><surname>Irvin</surname><given-names>J.</given-names></name><name><surname>Betancourt</surname><given-names>T.</given-names></name></person-group><article-title>Biodegradable DNA-enabled poly(ethylene glycol) hydrogels prepared by copper-free click chemistry</article-title><source>J. Biomater. Sci. Polym. Ed.</source><year>2016</year><volume>27</volume><fpage>22</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1080/09205063.2015.1103590</pub-id><?supplied-pmid 26541212?><pub-id pub-id-type="pmid">26541212</pub-id></element-citation></ref><ref id="B146-pharmaceutics-11-00432"><label>146.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soares</surname><given-names>P.A.G.</given-names></name><name><surname>CDe Seixas</surname><given-names>J.R.P.</given-names></name><name><surname>Albuquerque</surname><given-names>P.B.S.</given-names></name><name><surname>Santos</surname><given-names>G.R.C.</given-names></name><name><surname>Mour&#x000e3;o</surname><given-names>P.A.S.</given-names></name><name><surname>Barros</surname><given-names>W.</given-names></name><name><surname>Correia</surname><given-names>M.T.S.</given-names></name><name><surname>Carneiro-Da-Cunha</surname><given-names>M.G.</given-names></name></person-group><article-title>Development and characterization of a new hydrogel based on galactomannan and &#x003ba;-carrageenan</article-title><source>Carbohydr. Polym.</source><year>2015</year><volume>134</volume><fpage>673</fpage><lpage>679</lpage><pub-id pub-id-type="doi">10.1016/j.carbpol.2015.08.042</pub-id><?supplied-pmid 26428171?><pub-id pub-id-type="pmid">26428171</pub-id></element-citation></ref><ref id="B147-pharmaceutics-11-00432"><label>147.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Treesuppharat</surname><given-names>W.</given-names></name><name><surname>Rojanapanthu</surname><given-names>P.</given-names></name><name><surname>Siangsanoh</surname><given-names>C.</given-names></name><name><surname>Manuspiya</surname><given-names>H.</given-names></name><name><surname>Ummartyotin</surname><given-names>S.</given-names></name></person-group><article-title>Synthesis and characterization of bacterial cellulose and gelatin-based hydrogel composites for drug-delivery systems</article-title><source>Biotechnol. Rep.</source><year>2017</year><volume>15</volume><fpage>84</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1016/j.btre.2017.07.002</pub-id><?supplied-pmid 28736723?><pub-id pub-id-type="pmid">28736723</pub-id></element-citation></ref><ref id="B148-pharmaceutics-11-00432"><label>148.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fergg</surname><given-names>F.</given-names></name><name><surname>Keil</surname><given-names>F.J.</given-names></name><name><surname>Quader</surname><given-names>H.</given-names></name></person-group><article-title>Investigations of the microscopic structure of poly(vinyl alcohol) hydrogels by confocal laser scanning microscopy</article-title><source>Colloid Polym. Sci.</source><year>2001</year><volume>279</volume><fpage>61</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.1007/s003960000398</pub-id></element-citation></ref><ref id="B149-pharmaceutics-11-00432"><label>149.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watkins</surname><given-names>A.W.</given-names></name><name><surname>Southard</surname><given-names>S.L.</given-names></name><name><surname>Anseth</surname><given-names>K.S.</given-names></name></person-group><article-title>Characterizing multilaminated hydrogels with spatially varying network structure and solute loading using confocal laser scanning microscopy</article-title><source>Acta Biomater.</source><year>2007</year><volume>3</volume><fpage>439</fpage><lpage>448</lpage><pub-id pub-id-type="doi">10.1016/j.actbio.2006.11.006</pub-id><pub-id pub-id-type="pmid">17236830</pub-id></element-citation></ref><ref id="B150-pharmaceutics-11-00432"><label>150.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watkins</surname><given-names>A.W.</given-names></name><name><surname>Anseth</surname><given-names>K.S.</given-names></name></person-group><article-title>Investigation of molecular transport and distributions in poly(ethylene glycol) hydrogels with confocal laser scanning microscopy</article-title><source>Macromolecules</source><year>2005</year><volume>38</volume><fpage>1326</fpage><lpage>1334</lpage><pub-id pub-id-type="doi">10.1021/ma0475232</pub-id></element-citation></ref><ref id="B151-pharmaceutics-11-00432"><label>151.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Belmar</surname><given-names>L.</given-names></name><name><surname>Toledo</surname><given-names>L.</given-names></name><name><surname>S&#x000e1;nchez</surname><given-names>S.A.</given-names></name><name><surname>Urbano</surname><given-names>B.F.</given-names></name></person-group><article-title>Fluorescent nanotubes in PHEMA hydrogels: Visualizing aggregation and distribution by confocal fluorescence microscopy</article-title><source>Mater. Today Commun.</source><year>2018</year><volume>16</volume><fpage>285</fpage><lpage>292</lpage><pub-id pub-id-type="doi">10.1016/j.mtcomm.2018.07.002</pub-id></element-citation></ref><ref id="B152-pharmaceutics-11-00432"><label>152.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Engler</surname><given-names>A.J.</given-names></name><name><surname>Sen</surname><given-names>S.</given-names></name><name><surname>Sweeney</surname><given-names>H.L.</given-names></name><name><surname>Discher</surname><given-names>D.E.</given-names></name></person-group><article-title>Matrix elasticity directs stem cell lineage specification</article-title><source>Cell</source><year>2006</year><volume>126</volume><fpage>677</fpage><lpage>689</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2006.06.044</pub-id><pub-id pub-id-type="pmid">16923388</pub-id></element-citation></ref><ref id="B153-pharmaceutics-11-00432"><label>153.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>J.Y.</given-names></name><name><surname>Velasco</surname><given-names>A.</given-names></name><name><surname>Rajagopalan</surname><given-names>P.</given-names></name><name><surname>Pham</surname><given-names>Q.</given-names></name></person-group><article-title>Directed movement of vascular smooth muscle cells on gradient-compliant hydrogels</article-title><source>Langmuir</source><year>2003</year><volume>19</volume><fpage>1908</fpage><lpage>1913</lpage><pub-id pub-id-type="doi">10.1021/la026403p</pub-id></element-citation></ref><ref id="B154-pharmaceutics-11-00432"><label>154.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kloxin</surname><given-names>A.M.</given-names></name><name><surname>Kloxin</surname><given-names>C.J.</given-names></name><name><surname>Bowman</surname><given-names>C.N.</given-names></name><name><surname>Anseth</surname><given-names>K.S.</given-names></name></person-group><article-title>Mechanical properties of cellularly responsive hydrogels and their experimental determination</article-title><source>Adv. Mater.</source><year>2010</year><volume>22</volume><fpage>3484</fpage><lpage>3494</lpage><pub-id pub-id-type="doi">10.1002/adma.200904179</pub-id><pub-id pub-id-type="pmid">20473984</pub-id></element-citation></ref><ref id="B155-pharmaceutics-11-00432"><label>155.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zustiak</surname><given-names>S.P.</given-names></name><name><surname>Boukari</surname><given-names>H.</given-names></name><name><surname>Leach</surname><given-names>J.B.</given-names></name></person-group><article-title>Solute diffusion and interactions in cross-linked poly(ethylene glycol) hydrogels studied by Fluorescence Correlation Spectroscopy</article-title><source>Soft Matter</source><year>2010</year><volume>6</volume><fpage>3609</fpage><lpage>3618</lpage><pub-id pub-id-type="doi">10.1039/c0sm00111b</pub-id></element-citation></ref><ref id="B156-pharmaceutics-11-00432"><label>156.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abuelfilat</surname><given-names>A.Y.</given-names></name><name><surname>Kim</surname><given-names>Y.</given-names></name><name><surname>Miller</surname><given-names>P.</given-names></name><name><surname>Hoo</surname><given-names>S.P.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Chan</surname><given-names>P.</given-names></name><name><surname>Fu</surname><given-names>J.</given-names></name></person-group><article-title>Bridging structure and mechanics of three-dimensional porous hydrogel with X-ray ultramicroscopy and atomic force microscopy</article-title><source>RSC Adv.</source><year>2015</year><volume>5</volume><fpage>63909</fpage><lpage>63916</lpage><pub-id pub-id-type="doi">10.1039/C5RA10942F</pub-id></element-citation></ref><ref id="B157-pharmaceutics-11-00432"><label>157.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cocarta</surname><given-names>A.I.</given-names></name><name><surname>Hobzova</surname><given-names>R.</given-names></name><name><surname>Sirc</surname><given-names>J.</given-names></name><name><surname>Cerna</surname><given-names>T.</given-names></name><name><surname>Hrabeta</surname><given-names>J.</given-names></name><name><surname>Svojgr</surname><given-names>K.</given-names></name><name><surname>Pochop</surname><given-names>P.</given-names></name><name><surname>Kodetova</surname><given-names>M.</given-names></name><name><surname>Jedelska</surname><given-names>J.</given-names></name><name><surname>Bakowsky</surname><given-names>U.</given-names></name><etal/></person-group><article-title>Hydrogel implants for transscleral drug delivery for retinoblastoma treatment</article-title><source>Mater. Sci. Eng. C</source><year>2019</year><volume>103</volume><fpage>109799</fpage><pub-id pub-id-type="doi">10.1016/j.msec.2019.109799</pub-id><?supplied-pmid 31349439?><pub-id pub-id-type="pmid">31349439</pub-id></element-citation></ref><ref id="B158-pharmaceutics-11-00432"><label>158.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Longchamp</surname><given-names>A.</given-names></name><name><surname>Kaur</surname><given-names>K.</given-names></name><name><surname>Macabrey</surname><given-names>D.</given-names></name><name><surname>Dubuis</surname><given-names>C.</given-names></name><name><surname>Corpataux</surname><given-names>J.M.</given-names></name><name><surname>D&#x000e9;glise</surname><given-names>S.</given-names></name><name><surname>Matson</surname><given-names>J.B.</given-names></name><name><surname>Allagnat</surname><given-names>F.</given-names></name></person-group><article-title>Hydrogen Sulfide-releasing peptide hydrogel limits the development of intimal hyperplasia in human vein segments</article-title><source>Acta Biomater.</source><year>2019</year><pub-id pub-id-type="doi">10.1016/j.actbio.2019.07.042</pub-id><?supplied-pmid 31352106?><pub-id pub-id-type="pmid">31352106</pub-id></element-citation></ref><ref id="B159-pharmaceutics-11-00432"><label>159.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishihara</surname><given-names>M.</given-names></name><name><surname>Obara</surname><given-names>K.</given-names></name><name><surname>Ishizuka</surname><given-names>T.</given-names></name><name><surname>Fujita</surname><given-names>M.</given-names></name><name><surname>Sato</surname><given-names>M.</given-names></name><name><surname>Masuoka</surname><given-names>K.</given-names></name><name><surname>Saito</surname><given-names>Y.</given-names></name><name><surname>Yura</surname><given-names>H.</given-names></name><name><surname>Matsui</surname><given-names>T.</given-names></name><name><surname>Hattori</surname><given-names>H.</given-names></name><etal/></person-group><article-title>Controlled release of fibroblast growth factors and heparin from photocrosslinked chitosan hydrogels and subsequent effect onin vivo vascularization</article-title><source>J. Biomed. Mater. Res.</source><year>2003</year><volume>64</volume><fpage>551</fpage><lpage>559</lpage><pub-id pub-id-type="doi">10.1002/jbm.a.10427</pub-id></element-citation></ref><ref id="B160-pharmaceutics-11-00432"><label>160.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Um</surname><given-names>S.H.</given-names></name><name><surname>Lee</surname><given-names>J.B.</given-names></name><name><surname>Park</surname><given-names>N.</given-names></name><name><surname>Kwon</surname><given-names>S.Y.</given-names></name><name><surname>Umbach</surname><given-names>C.C.</given-names></name><name><surname>Luo</surname><given-names>D.</given-names></name></person-group><article-title>Enzyme-catalysed assembly of DNA hydrogel</article-title><source>Nat. Mater.</source><year>2006</year><volume>5</volume><fpage>797</fpage><lpage>801</lpage><pub-id pub-id-type="doi">10.1038/nmat1741</pub-id><pub-id pub-id-type="pmid">16998469</pub-id></element-citation></ref><ref id="B161-pharmaceutics-11-00432"><label>161.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lutolf</surname><given-names>M.P.</given-names></name><name><surname>Lauer-Fields</surname><given-names>J.L.</given-names></name><name><surname>Schmoekel</surname><given-names>H.G.</given-names></name><name><surname>Metters</surname><given-names>A.T.</given-names></name><name><surname>Weber</surname><given-names>F.E.</given-names></name><name><surname>Fields</surname><given-names>G.B.</given-names></name><name><surname>Hubbell</surname><given-names>J.A.</given-names></name></person-group><article-title>Synthetic matrix metalloproteinase-sensitive hydrogels for the conduction of tissue regeneration: Engineering cell-invasion characteristics</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2003</year><volume>100</volume><fpage>5413</fpage><lpage>5418</lpage><pub-id pub-id-type="doi">10.1073/pnas.0737381100</pub-id><pub-id pub-id-type="pmid">12686696</pub-id></element-citation></ref><ref id="B162-pharmaceutics-11-00432"><label>162.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Podual</surname><given-names>K.</given-names></name><name><surname>Doyle</surname><given-names>F.J.</given-names></name><name><surname>Peppas</surname><given-names>N.A.</given-names></name></person-group><article-title>Glucose-sensitivity of glucose oxidase-containing cationic copolymer hydrogels having poly (ethylene glycol) grafts</article-title><source>J. Control. Release</source><year>2000</year><volume>67</volume><fpage>9</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1016/S0168-3659(00)00195-4</pub-id><pub-id pub-id-type="pmid">10773324</pub-id></element-citation></ref><ref id="B163-pharmaceutics-11-00432"><label>163.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maitz</surname><given-names>M.F.</given-names></name><name><surname>Freudenberg</surname><given-names>U.</given-names></name><name><surname>Tsurkan</surname><given-names>M.V.</given-names></name><name><surname>Fischer</surname><given-names>M.</given-names></name><name><surname>Beyrich</surname><given-names>T.</given-names></name><name><surname>Werner</surname><given-names>C.</given-names></name></person-group><article-title>Bio-responsive polymer hydrogels homeostatically regulate blood coagulation</article-title><source>Nat. Commun.</source><year>2013</year><volume>4</volume><fpage>2168</fpage><pub-id pub-id-type="doi">10.1038/ncomms3168</pub-id><?supplied-pmid 23868446?><pub-id pub-id-type="pmid">23868446</pub-id></element-citation></ref><ref id="B164-pharmaceutics-11-00432"><label>164.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>B.</given-names></name><name><surname>Boyer</surname><given-names>J.C.</given-names></name><name><surname>Habault</surname><given-names>D.</given-names></name><name><surname>Branda</surname><given-names>N.R.</given-names></name><name><surname>Zhao</surname><given-names>Y.</given-names></name></person-group><article-title>Near Infrared Light Triggered Release of Biomacromolecules from Hydrogels Loaded with Upconversion Nanoparticles</article-title><source>J. Am. Chem. Soc.</source><year>2012</year><volume>134</volume><fpage>16558</fpage><lpage>16561</lpage><pub-id pub-id-type="doi">10.1021/ja308876j</pub-id><?supplied-pmid 23013429?><pub-id pub-id-type="pmid">23013429</pub-id></element-citation></ref><ref id="B165-pharmaceutics-11-00432"><label>165.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>R.</given-names></name><name><surname>Hua</surname><given-names>Y.</given-names></name><name><surname>Baumgartner</surname><given-names>R.</given-names></name><name><surname>Cheng</surname><given-names>J.</given-names></name></person-group><article-title>Trigger-Responsive Poly(&#x003b2;-amino ester) Hydrogels</article-title><source>ACS Macro Lett.</source><year>2014</year><volume>3</volume><fpage>693</fpage><lpage>697</lpage><pub-id pub-id-type="doi">10.1021/mz500277j</pub-id></element-citation></ref><ref id="B166-pharmaceutics-11-00432"><label>166.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Caccavo</surname><given-names>D.</given-names></name><name><surname>Cascone</surname><given-names>S.</given-names></name><name><surname>Lamberti</surname><given-names>G.</given-names></name><name><surname>Barba</surname><given-names>A.A.</given-names></name><name><surname>Larsson</surname><given-names>A.</given-names></name></person-group><article-title>Swellable Hydrogel-based Systems for Controlled Drug Delivery</article-title><source>Smart Drug Delivery System</source><publisher-name>InTech</publisher-name><publisher-loc>Rijeka, Croatia</publisher-loc><year>2016</year></element-citation></ref><ref id="B167-pharmaceutics-11-00432"><label>167.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>W.Y.</given-names></name><name><surname>Zeng</surname><given-names>G.S.</given-names></name></person-group><article-title>Stimulus-responsive hydrogels reinforced by cellulose nanowhisker for controlled drug release</article-title><source>RSC Adv.</source><year>2016</year><volume>6</volume><fpage>87422</fpage><lpage>87432</lpage><pub-id pub-id-type="doi">10.1039/C6RA14421G</pub-id></element-citation></ref><ref id="B168-pharmaceutics-11-00432"><label>168.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>T.Y.</given-names></name><name><surname>Hu</surname><given-names>S.H.</given-names></name><name><surname>Liu</surname><given-names>T.Y.</given-names></name><name><surname>Liu</surname><given-names>D.M.</given-names></name><name><surname>Chen</surname><given-names>S.Y.</given-names></name></person-group><article-title>Magnetic-Sensitive Behavior of Intelligent Ferrogels for Controlled Release of Drug</article-title><source>Langmuir</source><year>2006</year><volume>22</volume><fpage>5974</fpage><lpage>5978</lpage><pub-id pub-id-type="doi">10.1021/la060371e</pub-id><?supplied-pmid 16800645?><pub-id pub-id-type="pmid">16800645</pub-id></element-citation></ref><ref id="B169-pharmaceutics-11-00432"><label>169.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huebsch</surname><given-names>N.</given-names></name><name><surname>Kearney</surname><given-names>C.J.</given-names></name><name><surname>Zhao</surname><given-names>X.</given-names></name><name><surname>Kim</surname><given-names>J.</given-names></name><name><surname>Cezar</surname><given-names>C.A.</given-names></name><name><surname>Suo</surname><given-names>Z.</given-names></name><name><surname>Mooney</surname><given-names>D.J.</given-names></name></person-group><article-title>Ultrasound-triggered disruption and self-healing of reversibly cross-linked hydrogels for drug delivery and enhanced chemotherapy</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2014</year><volume>111</volume><fpage>9762</fpage><lpage>9767</lpage><pub-id pub-id-type="doi">10.1073/pnas.1405469111</pub-id><pub-id pub-id-type="pmid">24961369</pub-id></element-citation></ref><ref id="B170-pharmaceutics-11-00432"><label>170.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caccavo</surname><given-names>D.</given-names></name><name><surname>Cascone</surname><given-names>S.</given-names></name><name><surname>Lamberti</surname><given-names>G.</given-names></name><name><surname>Barba</surname><given-names>A.A.</given-names></name></person-group><article-title>Modeling the Drug Release from Hydrogel-Based Matrices</article-title><source>Mol. Pharm.</source><year>2015</year><volume>12</volume><fpage>474</fpage><lpage>483</lpage><pub-id pub-id-type="doi">10.1021/mp500563n</pub-id><pub-id pub-id-type="pmid">25495793</pub-id></element-citation></ref><ref id="B171-pharmaceutics-11-00432"><label>171.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>T.S.</given-names></name><name><surname>Hur</surname><given-names>K.</given-names></name><name><surname>Choi</surname><given-names>B.</given-names></name><name><surname>Lee</surname><given-names>J.Y.</given-names></name><name><surname>Byeon</surname><given-names>S.J.</given-names></name><name><surname>Min</surname><given-names>J.</given-names></name><name><surname>Yu</surname><given-names>J.</given-names></name><name><surname>Cho</surname><given-names>J.K.</given-names></name><name><surname>Hong</surname><given-names>J.</given-names></name><name><surname>Lee</surname><given-names>H.J.</given-names></name><etal/></person-group><article-title>Improvement of anti-cancer drug efficacy via thermosensitive hydrogel in peritoneal carcinomatosis in gastric cancer</article-title><source>Oncotarget</source><year>2017</year><volume>8</volume><fpage>108848</fpage><lpage>108858</lpage><pub-id pub-id-type="doi">10.18632/oncotarget.22312</pub-id><pub-id pub-id-type="pmid">29312573</pub-id></element-citation></ref><ref id="B172-pharmaceutics-11-00432"><label>172.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naahidi</surname><given-names>S.</given-names></name><name><surname>Jafari</surname><given-names>M.</given-names></name><name><surname>Logan</surname><given-names>M.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Yuan</surname><given-names>Y.</given-names></name><name><surname>Bae</surname><given-names>H.</given-names></name><name><surname>Dixon</surname><given-names>B.</given-names></name><name><surname>Chen</surname><given-names>P.</given-names></name></person-group><article-title>Biocompatibility of hydrogel-based scaffolds for tissue engineering applications</article-title><source>Biotechnol. Adv.</source><year>2017</year><volume>35</volume><fpage>530</fpage><lpage>544</lpage><pub-id pub-id-type="doi">10.1016/j.biotechadv.2017.05.006</pub-id><pub-id pub-id-type="pmid">28558979</pub-id></element-citation></ref><ref id="B173-pharmaceutics-11-00432"><label>173.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palmer</surname><given-names>B.</given-names></name><name><surname>DeLouise</surname><given-names>L.</given-names></name><name><surname>Palmer</surname><given-names>B.C.</given-names></name><name><surname>DeLouise</surname><given-names>L.A.</given-names></name></person-group><article-title>Nanoparticle-Enabled Transdermal Drug Delivery Systems for Enhanced Dose Control and Tissue Targeting</article-title><source>Molecules</source><year>2016</year><volume>21</volume><elocation-id>1719</elocation-id><pub-id pub-id-type="doi">10.3390/molecules21121719</pub-id><?supplied-pmid 27983701?><pub-id pub-id-type="pmid">27983701</pub-id></element-citation></ref><ref id="B174-pharmaceutics-11-00432"><label>174.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomes</surname><given-names>M.</given-names></name><name><surname>Azevedo</surname><given-names>H.</given-names></name><name><surname>Malafaya</surname><given-names>P.</given-names></name><name><surname>Silva</surname><given-names>S.</given-names></name><name><surname>Oliveira</surname><given-names>J.</given-names></name><name><surname>Silva</surname><given-names>G.</given-names></name><name><surname>Sousa</surname><given-names>R.</given-names></name><name><surname>Mano</surname><given-names>J.</given-names></name><name><surname>Reis</surname><given-names>R.</given-names></name></person-group><article-title>Natural Polymers in tissue engineering applications</article-title><source>Tissue Eng.</source><year>2008</year><fpage>145</fpage><lpage>192</lpage><pub-id pub-id-type="doi">10.1016/B978-0-12-370869-4.00006-9</pub-id></element-citation></ref><ref id="B175-pharmaceutics-11-00432"><label>175.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>X.</given-names></name><name><surname>Sun</surname><given-names>X.</given-names></name><name><surname>Hargrove</surname><given-names>D.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Song</surname><given-names>D.</given-names></name><name><surname>Dong</surname><given-names>Q.</given-names></name><name><surname>Lu</surname><given-names>X.</given-names></name><name><surname>Fan</surname><given-names>T.H.</given-names></name><name><surname>Fu</surname><given-names>Y.</given-names></name><name><surname>Lei</surname><given-names>Y.</given-names></name></person-group><article-title>A Biocompatible and Biodegradable Protein Hydrogel with Green and Red Autofluorescence: Preparation, Characterization and In Vivo Biodegradation Tracking and Modeling</article-title><source>Sci. Rep.</source><year>2016</year><volume>6</volume><fpage>19370</fpage><pub-id pub-id-type="doi">10.1038/srep19370</pub-id><?supplied-pmid 26813916?><pub-id pub-id-type="pmid">26813916</pub-id></element-citation></ref><ref id="B176-pharmaceutics-11-00432"><label>176.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>H.A.</given-names></name><name><surname>Varma</surname><given-names>D.M.</given-names></name><name><surname>Hom</surname><given-names>W.W.</given-names></name><name><surname>Cruz</surname><given-names>M.A.</given-names></name><name><surname>Nasser</surname><given-names>P.R.</given-names></name><name><surname>Phelps</surname><given-names>R.G.</given-names></name><name><surname>Iatridis</surname><given-names>J.C.</given-names></name><name><surname>Nicoll</surname><given-names>S.B.</given-names></name></person-group><article-title>Injectable cellulose-based hydrogels as nucleus pulposus replacements: Assessment of in vitro structural stability, ex vivo herniation risk, and in vivo biocompatibility</article-title><source>J. Mech. Behav. Biomed. Mater.</source><year>2019</year><volume>96</volume><fpage>204</fpage><lpage>213</lpage><pub-id pub-id-type="doi">10.1016/j.jmbbm.2019.04.021</pub-id><?supplied-pmid 31054515?><pub-id pub-id-type="pmid">31054515</pub-id></element-citation></ref><ref id="B177-pharmaceutics-11-00432"><label>177.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hyun</surname><given-names>H.</given-names></name><name><surname>Kim</surname><given-names>Y.H.</given-names></name><name><surname>Song</surname><given-names>I.B.</given-names></name><name><surname>Lee</surname><given-names>J.W.</given-names></name><name><surname>Kim</surname><given-names>M.S.</given-names></name><name><surname>Khang</surname><given-names>G.</given-names></name><name><surname>Park</surname><given-names>K.</given-names></name><name><surname>Lee</surname><given-names>H.B.</given-names></name></person-group><article-title>In Vitro and in Vivo Release of Albumin Using a Biodegradable MPEG-PCL Diblock Copolymer as an in Situ Gel-Forming Carrier</article-title><source>Biomacromolecules</source><year>2007</year><volume>8</volume><fpage>1093</fpage><lpage>1100</lpage><pub-id pub-id-type="doi">10.1021/bm060991u</pub-id><?supplied-pmid 17326678?><pub-id pub-id-type="pmid">17326678</pub-id></element-citation></ref><ref id="B178-pharmaceutics-11-00432"><label>178.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Tan</surname><given-names>L.</given-names></name><name><surname>Zhao</surname><given-names>Q.</given-names></name><name><surname>Luo</surname><given-names>F.</given-names></name><name><surname>Wei</surname><given-names>Y.</given-names></name><name><surname>Qian</surname><given-names>Z.</given-names></name></person-group><article-title>PEG&#x02013;PCL based micelle hydrogels as oral docetaxel delivery systems for breast cancer therapy</article-title><source>Biomaterials</source><year>2014</year><volume>35</volume><fpage>6972</fpage><lpage>6985</lpage><pub-id pub-id-type="doi">10.1016/j.biomaterials.2014.04.099</pub-id><?supplied-pmid 24836952?><pub-id pub-id-type="pmid">24836952</pub-id></element-citation></ref><ref id="B179-pharmaceutics-11-00432"><label>179.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramadan</surname><given-names>A.A.</given-names></name><name><surname>Elbakry</surname><given-names>A.M.</given-names></name><name><surname>Esmaeil</surname><given-names>A.H.</given-names></name><name><surname>Khaleel</surname><given-names>S.A.</given-names></name></person-group><article-title>Pharmaceutical and pharmacokinetic evaluation of novel rectal mucoadhesive hydrogels containing tolmetin sodium</article-title><source>J. Pharm. Investig.</source><year>2018</year><volume>48</volume><fpage>673</fpage><lpage>683</lpage><pub-id pub-id-type="doi">10.1007/s40005-017-0365-1</pub-id><?supplied-pmid 30595939?><pub-id pub-id-type="pmid">30595939</pub-id></element-citation></ref><ref id="B180-pharmaceutics-11-00432"><label>180.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhaskar</surname><given-names>K.</given-names></name><name><surname>Mohan</surname><given-names>C.K.</given-names></name><name><surname>Lingam</surname><given-names>M.</given-names></name><name><surname>Mohan</surname><given-names>S.J.</given-names></name><name><surname>Venkateswarlu</surname><given-names>V.</given-names></name><name><surname>Rao</surname><given-names>Y.M.</given-names></name><name><surname>Bhaskar</surname><given-names>K.</given-names></name><name><surname>Anbu</surname><given-names>J.</given-names></name><name><surname>Ravichandran</surname><given-names>V.</given-names></name></person-group><article-title>Development of SLN and NLC Enriched Hydrogels for Transdermal Delivery of Nitrendipine: In Vitro and In Vivo Characteristics</article-title><source>Drug Dev. Ind. Pharm.</source><year>2009</year><volume>35</volume><fpage>98</fpage><lpage>113</lpage><pub-id pub-id-type="doi">10.1080/03639040802192822</pub-id><?supplied-pmid 18665979?><pub-id pub-id-type="pmid">18665979</pub-id></element-citation></ref><ref id="B181-pharmaceutics-11-00432"><label>181.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>Q.</given-names></name><name><surname>Wang</surname><given-names>N.</given-names></name><name><surname>He</surname><given-names>T.</given-names></name><name><surname>Shang</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>L.</given-names></name><name><surname>Song</surname><given-names>L.</given-names></name><name><surname>Yang</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Luo</surname><given-names>N.</given-names></name><name><surname>Zhang</surname><given-names>W.</given-names></name><etal/></person-group><article-title>Thermosensitive hydrogel containing dexamethasone micelles for preventing postsurgical adhesion in a repeated-injury model</article-title><source>Sci. Rep.</source><year>2015</year><volume>5</volume><fpage>13553</fpage><pub-id pub-id-type="doi">10.1038/srep13553</pub-id><pub-id pub-id-type="pmid">26324090</pub-id></element-citation></ref><ref id="B182-pharmaceutics-11-00432"><label>182.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohta</surname><given-names>S.</given-names></name><name><surname>Hiramoto</surname><given-names>S.</given-names></name><name><surname>Amano</surname><given-names>Y.</given-names></name><name><surname>Emoto</surname><given-names>S.</given-names></name><name><surname>Yamaguchi</surname><given-names>H.</given-names></name><name><surname>Ishigami</surname><given-names>H.</given-names></name><name><surname>Kitayama</surname><given-names>J.</given-names></name><name><surname>Ito</surname><given-names>T.</given-names></name></person-group><article-title>Intraperitoneal Delivery of Cisplatin via a Hyaluronan-Based Nanogel/ in Situ Cross-Linkable Hydrogel Hybrid System for Peritoneal Dissemination of Gastric Cancer</article-title><source>Mol. Pharm.</source><year>2017</year><volume>14</volume><fpage>3105</fpage><lpage>3113</lpage><pub-id pub-id-type="doi">10.1021/acs.molpharmaceut.7b00349</pub-id><pub-id pub-id-type="pmid">28806513</pub-id></element-citation></ref><ref id="B183-pharmaceutics-11-00432"><label>183.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hosny</surname><given-names>K.M.</given-names></name></person-group><article-title>Ciprofloxacin as Ocular Liposomal Hydrogel</article-title><source>AAPS PharmSciTech</source><year>2010</year><volume>11</volume><fpage>241</fpage><lpage>246</lpage><pub-id pub-id-type="doi">10.1208/s12249-009-9373-4</pub-id><?supplied-pmid 20151337?><pub-id pub-id-type="pmid">20151337</pub-id></element-citation></ref><ref id="B184-pharmaceutics-11-00432"><label>184.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schellini</surname><given-names>S.A.</given-names></name><name><surname>Zimmermann</surname><given-names>G.P.M.</given-names></name><name><surname>Hoyama</surname><given-names>E.</given-names></name><name><surname>Pellizon</surname><given-names>C.H.</given-names></name><name><surname>Padovani</surname><given-names>C.R.</given-names></name><name><surname>Selva</surname><given-names>D.</given-names></name></person-group><article-title>Polyethylene Gel in the Subcutaneous Tissue of Rats: Histopathologic and Systemic Evaluation</article-title><source>Orbit</source><year>2008</year><volume>27</volume><fpage>153</fpage><lpage>156</lpage><pub-id pub-id-type="doi">10.1080/01676830701555246</pub-id><?supplied-pmid 18569818?><pub-id pub-id-type="pmid">18569818</pub-id></element-citation></ref><ref id="B185-pharmaceutics-11-00432"><label>185.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>G.</given-names></name><name><surname>Italia</surname><given-names>J.L.</given-names></name><name><surname>Sonaje</surname><given-names>K.</given-names></name><name><surname>Tikoo</surname><given-names>K.</given-names></name><name><surname>Ravi Kumar</surname><given-names>M.N.V.</given-names></name></person-group><article-title>Biodegradable in situ gelling system for subcutaneous administration of ellagic acid and ellagic acid loaded nanoparticles: Evaluation of their antioxidant potential against cyclosporine induced nephrotoxicity in rats</article-title><source>J. Control. Release</source><year>2007</year><volume>118</volume><fpage>27</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1016/j.jconrel.2006.11.026</pub-id><?supplied-pmid 17258836?><pub-id pub-id-type="pmid">17258836</pub-id></element-citation></ref><ref id="B186-pharmaceutics-11-00432"><label>186.</label><element-citation publication-type="confproc"><person-group person-group-type="author"><name><surname>Takahashi</surname><given-names>M.</given-names></name><name><surname>Heo</surname><given-names>Y.J.</given-names></name><name><surname>Shibata</surname><given-names>H.</given-names></name><name><surname>Satou</surname><given-names>H.</given-names></name><name><surname>Kawanishi</surname><given-names>T.</given-names></name><name><surname>Okitsu</surname><given-names>T.</given-names></name><name><surname>Takeuchi</surname><given-names>S.</given-names></name></person-group><article-title>Nano-patterned hydrogel reduced inflammatory effects in subcutaneous tissue</article-title><source>Proceedings of the 2012 IEEE 25th International Conference on Micro Electro Mechanical Systems (MEMS)</source><conf-loc>Paris, France</conf-loc><conf-date>29 January&#x02013;2 February 2012</conf-date><fpage>973</fpage><lpage>976</lpage></element-citation></ref><ref id="B187-pharmaceutics-11-00432"><label>187.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hou</surname><given-names>H.Y.</given-names></name><name><surname>Fu</surname><given-names>S.H.</given-names></name><name><surname>Liu</surname><given-names>C.H.</given-names></name><name><surname>Chen</surname><given-names>J.P.</given-names></name><name><surname>Ray-Sea Hsu</surname><given-names>B.</given-names></name></person-group><article-title>The graft survival protection of subcutaneous allogeneic islets with hydrogel grafting and encapsulated by CTLA4Ig and IL1ra</article-title><source>Polym. J.</source><year>2014</year><volume>46</volume><fpage>136</fpage><lpage>144</lpage><pub-id pub-id-type="doi">10.1038/pj.2013.71</pub-id></element-citation></ref><ref id="B188-pharmaceutics-11-00432"><label>188.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bae</surname><given-names>J.H.</given-names></name><name><surname>Shrestha</surname><given-names>K.R.</given-names></name><name><surname>Park</surname><given-names>Y.H.</given-names></name><name><surname>Kim</surname><given-names>I.G.</given-names></name><name><surname>Piao</surname><given-names>S.</given-names></name><name><surname>Jung</surname><given-names>A.R.</given-names></name><name><surname>Jeon</surname><given-names>S.H.</given-names></name><name><surname>Park</surname><given-names>K.D.</given-names></name><name><surname>Lee</surname><given-names>J.Y.</given-names></name></person-group><article-title>Comparison between subcutaneous injection of basic fibroblast growth factor-hydrogel and intracavernous injection of adipose-derived stem cells in a rat model of cavernous nerve injury</article-title><source>Urology</source><year>2014</year><volume>84</volume><fpage>1248-e1</fpage><pub-id pub-id-type="doi">10.1016/j.urology.2014.07.028</pub-id><?supplied-pmid 25443945?><pub-id pub-id-type="pmid">25443945</pub-id></element-citation></ref><ref id="B189-pharmaceutics-11-00432"><label>189.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halberstadt</surname><given-names>C.</given-names></name><name><surname>Austin</surname><given-names>C.</given-names></name><name><surname>Rowley</surname><given-names>J.</given-names></name><name><surname>Culberson</surname><given-names>C.</given-names></name><name><surname>Loebsack</surname><given-names>A.</given-names></name><name><surname>Wyatt</surname><given-names>S.</given-names></name><name><surname>Coleman</surname><given-names>S.</given-names></name><name><surname>Blacksten</surname><given-names>L.</given-names></name><name><surname>Burg</surname><given-names>K.</given-names></name><name><surname>Mooney</surname><given-names>D.</given-names></name><etal/></person-group><article-title>A Hydrogel Material for Plastic and Reconstructive Applications Injected into the Subcutaneous Space of a Sheep</article-title><source>Tissue Eng.</source><year>2002</year><volume>8</volume><fpage>309</fpage><lpage>319</lpage><pub-id pub-id-type="doi">10.1089/107632702753725067</pub-id><?supplied-pmid 12031119?><pub-id pub-id-type="pmid">12031119</pub-id></element-citation></ref><ref id="B190-pharmaceutics-11-00432"><label>190.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Markov</surname><given-names>P.A.</given-names></name><name><surname>Khramova</surname><given-names>D.S.</given-names></name><name><surname>Shumikhin</surname><given-names>K.V.</given-names></name><name><surname>Nikitina</surname><given-names>I.R.</given-names></name><name><surname>Beloserov</surname><given-names>V.S.</given-names></name><name><surname>Martinson</surname><given-names>E.A.</given-names></name><name><surname>Litvinets</surname><given-names>S.G.</given-names></name><name><surname>Popov</surname><given-names>S.V.</given-names></name></person-group><article-title>Mechanical properties of the pectin hydrogels and inflammation response to their subcutaneous implantation</article-title><source>J. Biomed. Mater. Res. Part A</source><year>2019</year><fpage>36721</fpage><pub-id pub-id-type="doi">10.1002/jbm.a.36721</pub-id></element-citation></ref><ref id="B191-pharmaceutics-11-00432"><label>191.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khafagy</surname><given-names>E.S.</given-names></name><name><surname>Morishita</surname><given-names>M.</given-names></name><name><surname>Onuki</surname><given-names>Y.</given-names></name><name><surname>Takayama</surname><given-names>K.</given-names></name></person-group><article-title>Current challenges in non-invasive insulin delivery systems: A comparative review</article-title><source>Adv. Drug Deli Rev.</source><year>2007</year><volume>59</volume><fpage>1521</fpage><lpage>1546</lpage><pub-id pub-id-type="doi">10.1016/j.addr.2007.08.019</pub-id></element-citation></ref><ref id="B192-pharmaceutics-11-00432"><label>192.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tulain</surname><given-names>U.R.</given-names></name><name><surname>Ahmad</surname><given-names>M.</given-names></name><name><surname>Rashid</surname><given-names>A.</given-names></name><name><surname>Malik</surname><given-names>M.Z.</given-names></name><name><surname>Iqbal</surname><given-names>F.M.</given-names></name></person-group><article-title>Fabrication of pH-Responsive Hydrogel and Its In Vitro and In Vivo Evaluation</article-title><source>Adv. Polym. Technol.</source><year>2018</year><volume>37</volume><fpage>290</fpage><lpage>304</lpage><pub-id pub-id-type="doi">10.1002/adv.21668</pub-id></element-citation></ref><ref id="B193-pharmaceutics-11-00432"><label>193.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>L.</given-names></name><name><surname>Xu</surname><given-names>X.</given-names></name><name><surname>Song</surname><given-names>J.</given-names></name><name><surname>Luo</surname><given-names>F.</given-names></name><name><surname>Qian</surname><given-names>Z.</given-names></name></person-group><article-title>Synthesis, characterization, and acute oral toxicity evaluation of pH-sensitive hydrogel based on MPEG, poly (&#x003b5;-caprolactone), and itaconic acid</article-title><source>Biomed. Res. Int.</source><year>2013</year><volume>2013</volume><fpage>239838</fpage><pub-id pub-id-type="doi">10.1155/2013/239838</pub-id><pub-id pub-id-type="pmid">24364030</pub-id></element-citation></ref><ref id="B194-pharmaceutics-11-00432"><label>194.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharpe</surname><given-names>L.A.</given-names></name><name><surname>Daily</surname><given-names>A.M.</given-names></name><name><surname>Horava</surname><given-names>S.D.</given-names></name><name><surname>Peppas</surname><given-names>N.A.</given-names></name></person-group><article-title>Therapeutic applications of hydrogels in oral drug delivery</article-title><source>Expert Opin. Drug Deliv.</source><year>2014</year><volume>11</volume><fpage>901</fpage><lpage>915</lpage><pub-id pub-id-type="doi">10.1517/17425247.2014.902047</pub-id><pub-id pub-id-type="pmid">24848309</pub-id></element-citation></ref><ref id="B195-pharmaceutics-11-00432"><label>195.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>K.</given-names></name><name><surname>Kim</surname><given-names>K.</given-names></name><name><surname>Ryu</surname><given-names>J.H.</given-names></name><name><surname>Lee</surname><given-names>H.</given-names></name></person-group><article-title>Chitosan-catechol: A polymer with long-lasting mucoadhesive properties</article-title><source>Biomaterials</source><year>2015</year><volume>52</volume><fpage>161</fpage><lpage>170</lpage><pub-id pub-id-type="doi">10.1016/j.biomaterials.2015.02.010</pub-id><?supplied-pmid 25818422?><pub-id pub-id-type="pmid">25818422</pub-id></element-citation></ref><ref id="B196-pharmaceutics-11-00432"><label>196.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>J.</given-names></name><name><surname>Tam</surname><given-names>M.</given-names></name><name><surname>Samaei</surname><given-names>S.</given-names></name><name><surname>Lerouge</surname><given-names>S.</given-names></name><name><surname>Barralet</surname><given-names>J.</given-names></name><name><surname>Stevenson</surname><given-names>M.M.</given-names></name><name><surname>Cerruti</surname><given-names>M.</given-names></name></person-group><article-title>Mucoadhesive chitosan hydrogels as rectal drug delivery vessels to treat ulcerative colitis</article-title><source>Acta Biomater.</source><year>2017</year><volume>48</volume><fpage>247</fpage><lpage>257</lpage><pub-id pub-id-type="doi">10.1016/j.actbio.2016.10.026</pub-id><?supplied-pmid 27769943?><pub-id pub-id-type="pmid">27769943</pub-id></element-citation></ref><ref id="B197-pharmaceutics-11-00432"><label>197.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chakrabarti</surname><given-names>S.</given-names></name><name><surname>Islam</surname><given-names>J.</given-names></name><name><surname>Hazarika</surname><given-names>H.</given-names></name><name><surname>Mazumder</surname><given-names>B.</given-names></name><name><surname>Raju</surname><given-names>P.S.</given-names></name><name><surname>Chattopadhyay</surname><given-names>P.</given-names></name></person-group><article-title>Safety profile of silver sulfadiazine-bFGF-loaded hydrogel for partial thickness burn wounds</article-title><source>Cutan. Ocul. Toxicol.</source><year>2018</year><volume>37</volume><fpage>258</fpage><lpage>266</lpage><pub-id pub-id-type="doi">10.1080/15569527.2018.1442843</pub-id><?supplied-pmid 29480078?><pub-id pub-id-type="pmid">29480078</pub-id></element-citation></ref><ref id="B198-pharmaceutics-11-00432"><label>198.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poh Yuen Wen</surname><given-names>A.</given-names></name><name><surname>Halim</surname><given-names>A.S.</given-names></name><name><surname>Mat Saad</surname><given-names>A.Z.</given-names></name><name><surname>Mohd Nor</surname><given-names>F.</given-names></name><name><surname>Wan Sulaiman</surname><given-names>W.A.</given-names></name></person-group><article-title>A prospective study evaluating wound healing with sea cucumber gel compared with hydrogel in treatment of skin graft donor sites</article-title><source>Complement. Med.</source><year>2018</year><volume>41</volume><fpage>261</fpage><lpage>266</lpage><pub-id pub-id-type="doi">10.1016/j.ctim.2018.10.006</pub-id><?supplied-pmid 30477850?><pub-id pub-id-type="pmid">30477850</pub-id></element-citation></ref><ref id="B199-pharmaceutics-11-00432"><label>199.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fernandes</surname><given-names>R.</given-names></name><name><surname>Smyth</surname><given-names>N.R.</given-names></name><name><surname>Muskens</surname><given-names>O.L.</given-names></name><name><surname>Nitti</surname><given-names>S.</given-names></name><name><surname>Heuer-Jungemann</surname><given-names>A.</given-names></name><name><surname>Ardern-Jones</surname><given-names>M.R.</given-names></name><name><surname>Kanaras</surname><given-names>A.G.</given-names></name></person-group><article-title>Interactions of Skin with Gold Nanoparticles of Different Surface Charge, Shape, and Functionality</article-title><source>Small</source><year>2015</year><volume>11</volume><fpage>713</fpage><lpage>721</lpage><pub-id pub-id-type="doi">10.1002/smll.201401913</pub-id><pub-id pub-id-type="pmid">25288531</pub-id></element-citation></ref><ref id="B200-pharmaceutics-11-00432"><label>200.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Basso</surname><given-names>J.</given-names></name><name><surname>Miranda</surname><given-names>A.</given-names></name><name><surname>Nunes</surname><given-names>S.</given-names></name><name><surname>Cova</surname><given-names>T.</given-names></name><name><surname>Sousa</surname><given-names>J.</given-names></name><name><surname>Vitorino</surname><given-names>C.</given-names></name><name><surname>Pais</surname><given-names>A.</given-names></name><name><surname>Basso</surname><given-names>J.</given-names></name><name><surname>Miranda</surname><given-names>A.</given-names></name><name><surname>Nunes</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Hydrogel-Based Drug Delivery Nanosystems for the Treatment of Brain Tumors</article-title><source>Gels</source><year>2018</year><volume>4</volume><elocation-id>62</elocation-id><pub-id pub-id-type="doi">10.3390/gels4030062</pub-id></element-citation></ref><ref id="B201-pharmaceutics-11-00432"><label>201.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>M.</given-names></name><name><surname>Danhier</surname><given-names>F.</given-names></name><name><surname>Bastiancich</surname><given-names>C.</given-names></name><name><surname>Joudiou</surname><given-names>N.</given-names></name><name><surname>Ganipineni</surname><given-names>L.P.</given-names></name><name><surname>Tsakiris</surname><given-names>N.</given-names></name><name><surname>Gallez</surname><given-names>B.</given-names></name><name><surname>des Rieux</surname><given-names>A.</given-names></name><name><surname>Jankovski</surname><given-names>A.</given-names></name><name><surname>Bianco</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Post-resection treatment of glioblastoma with an injectable nanomedicine-loaded photopolymerizable hydrogel induces long-term survival</article-title><source>Int. J. Pharm.</source><year>2018</year><volume>548</volume><fpage>522</fpage><lpage>529</lpage><pub-id pub-id-type="doi">10.1016/j.ijpharm.2018.07.033</pub-id><pub-id pub-id-type="pmid">30017818</pub-id></element-citation></ref><ref id="B202-pharmaceutics-11-00432"><label>202.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bastiancich</surname><given-names>C.</given-names></name><name><surname>Bianco</surname><given-names>J.</given-names></name><name><surname>Vanvarenberg</surname><given-names>K.</given-names></name><name><surname>Ucakar</surname><given-names>B.</given-names></name><name><surname>Joudiou</surname><given-names>N.</given-names></name><name><surname>Gallez</surname><given-names>B.</given-names></name><name><surname>Bastiat</surname><given-names>G.</given-names></name><name><surname>Lagarce</surname><given-names>F.</given-names></name><name><surname>Pr&#x000e9;at</surname><given-names>V.</given-names></name><name><surname>Danhier</surname><given-names>F.</given-names></name></person-group><article-title>Injectable nanomedicine hydrogel for local chemotherapy of glioblastoma after surgical resection</article-title><source>J. Control. Release</source><year>2017</year><volume>264</volume><fpage>45</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1016/j.jconrel.2017.08.019</pub-id><pub-id pub-id-type="pmid">28830791</pub-id></element-citation></ref><ref id="B203-pharmaceutics-11-00432"><label>203.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>C.H.</given-names></name><name><surname>Kuo</surname><given-names>C.Y.</given-names></name><name><surname>Chen</surname><given-names>S.H.</given-names></name><name><surname>Mao</surname><given-names>S.H.</given-names></name><name><surname>Chang</surname><given-names>C.Y.</given-names></name><name><surname>Shalumon</surname><given-names>K.</given-names></name><name><surname>Chen</surname><given-names>J.P.</given-names></name><name><surname>Chen</surname><given-names>C.H.</given-names></name><name><surname>Kuo</surname><given-names>C.Y.</given-names></name><name><surname>Chen</surname><given-names>S.H.</given-names></name><etal/></person-group><article-title>Thermosensitive Injectable Hydrogel for Simultaneous Intraperitoneal Delivery of Doxorubicin and Prevention of Peritoneal Adhesion</article-title><source>Int. J. Mol. Sci.</source><year>2018</year><volume>19</volume><elocation-id>1373</elocation-id><pub-id pub-id-type="doi">10.3390/ijms19051373</pub-id></element-citation></ref><ref id="B204-pharmaceutics-11-00432"><label>204.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamashita</surname><given-names>K.</given-names></name><name><surname>Tsunoda</surname><given-names>S.</given-names></name><name><surname>Gunji</surname><given-names>S.</given-names></name><name><surname>Murakami</surname><given-names>T.</given-names></name><name><surname>Suzuki</surname><given-names>T.</given-names></name><name><surname>Tabata</surname><given-names>Y.</given-names></name><name><surname>Sakai</surname><given-names>Y.</given-names></name></person-group><article-title>Intraperitoneal chemotherapy for peritoneal metastases using sustained release formula of cisplatin-incorporated gelatin hydrogel granules</article-title><source>Surg. Today</source><year>2019</year><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1007/s00595-019-01792-y</pub-id><?supplied-pmid 30847629?><pub-id pub-id-type="pmid">29644440</pub-id></element-citation></ref><ref id="B205-pharmaceutics-11-00432"><label>205.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mandal</surname><given-names>A.</given-names></name><name><surname>Bisht</surname><given-names>R.</given-names></name><name><surname>Rupenthal</surname><given-names>I.D.</given-names></name><name><surname>Mitra</surname><given-names>A.K.</given-names></name></person-group><article-title>Polymeric micelles for ocular drug delivery: From structural frameworks to recent preclinical studies</article-title><source>J. Control. Release</source><year>2017</year><volume>248</volume><fpage>96</fpage><lpage>116</lpage><pub-id pub-id-type="doi">10.1016/j.jconrel.2017.01.012</pub-id><?supplied-pmid 28087407?><pub-id pub-id-type="pmid">28087407</pub-id></element-citation></ref><ref id="B206-pharmaceutics-11-00432"><label>206.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bisht</surname><given-names>R.</given-names></name><name><surname>Jaiswal</surname><given-names>J.K.</given-names></name><name><surname>Chen</surname><given-names>Y.S.</given-names></name><name><surname>Jin</surname><given-names>J.</given-names></name><name><surname>Rupenthal</surname><given-names>I.D.</given-names></name></person-group><article-title>Light-responsive in situ forming injectable implants for effective drug delivery to the posterior segment of the eye</article-title><source>Expert Opin. Drug Deliv.</source><year>2016</year><volume>13</volume><fpage>953</fpage><lpage>962</lpage><pub-id pub-id-type="doi">10.1517/17425247.2016.1163334</pub-id><?supplied-pmid 26967153?><pub-id pub-id-type="pmid">26967153</pub-id></element-citation></ref><ref id="B207-pharmaceutics-11-00432"><label>207.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacob</surname><given-names>J.T.</given-names></name></person-group><article-title>Biocompatibility in the Development of Silicone-Hydrogel Lenses</article-title><source>Eye Contact Lens Sci. Clin. Pract.</source><year>2013</year><volume>39</volume><fpage>12</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1097/ICL.0b013e31827dbb00</pub-id><?supplied-pmid 23271477?><pub-id pub-id-type="pmid">23271477</pub-id></element-citation></ref><ref id="B208-pharmaceutics-11-00432"><label>208.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hall</surname><given-names>B.J.</given-names></name><name><surname>Jones</surname><given-names>L.W.</given-names></name><name><surname>Dixon</surname><given-names>B.</given-names></name></person-group><article-title>Silicone allergies and the eye: Fact or fiction?</article-title><source>Eye Contact Lens</source><year>2014</year><volume>40</volume><fpage>51</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1097/ICL.0000000000000010</pub-id><?supplied-pmid 24362631?><pub-id pub-id-type="pmid">24362631</pub-id></element-citation></ref><ref id="B209-pharmaceutics-11-00432"><label>209.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>M.</given-names></name><name><surname>Zeng</surname><given-names>X.</given-names></name><name><surname>Ma</surname><given-names>C.</given-names></name><name><surname>Yi</surname><given-names>H.</given-names></name><name><surname>Ali</surname><given-names>Z.</given-names></name><name><surname>Mou</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>S.</given-names></name><name><surname>Deng</surname><given-names>Y.</given-names></name><name><surname>He</surname><given-names>N.</given-names></name></person-group><article-title>Injectable hydrogels for cartilage and bone tissue engineering</article-title><source>Bone Res.</source><year>2017</year><volume>5</volume><fpage>17014</fpage><pub-id pub-id-type="doi">10.1038/boneres.2017.14</pub-id><?supplied-pmid 28584674?><pub-id pub-id-type="pmid">28584674</pub-id></element-citation></ref><ref id="B210-pharmaceutics-11-00432"><label>210.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Budama-Kilinc</surname><given-names>Y.</given-names></name><name><surname>Cakir-Koc</surname><given-names>R.</given-names></name><name><surname>Aslan</surname><given-names>B.</given-names></name><name><surname>&#x000d6;zkan</surname><given-names>B.</given-names></name><name><surname>Mutlu</surname><given-names>H.</given-names></name><name><surname>&#x000dc;st&#x000fc;n</surname><given-names>E.</given-names></name></person-group><article-title>Hydrogels in Regenerative Medicine</article-title><source>Biomaterials in Regenerative Medicine</source><publisher-name>InTech</publisher-name><publisher-loc>Rijeka, Croatia</publisher-loc><year>2018</year></element-citation></ref><ref id="B211-pharmaceutics-11-00432"><label>211.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gutowska</surname><given-names>A.</given-names></name><name><surname>Jeong</surname><given-names>B.</given-names></name><name><surname>Jasionowski</surname><given-names>M.</given-names></name></person-group><article-title>Injectable gels for tissue engineering</article-title><source>Anat. Rec.</source><year>2001</year><volume>263</volume><fpage>342</fpage><lpage>349</lpage><pub-id pub-id-type="doi">10.1002/ar.1115</pub-id><pub-id pub-id-type="pmid">11500810</pub-id></element-citation></ref><ref id="B212-pharmaceutics-11-00432"><label>212.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kofron</surname><given-names>M.D.</given-names></name><name><surname>Laurencin</surname><given-names>C.T.</given-names></name></person-group><article-title>Bone tissue engineering by gene delivery</article-title><source>Adv. Drug Deliv. Rev.</source><year>2006</year><volume>58</volume><fpage>555</fpage><lpage>576</lpage><pub-id pub-id-type="doi">10.1016/j.addr.2006.03.008</pub-id><pub-id pub-id-type="pmid">16790291</pub-id></element-citation></ref><ref id="B213-pharmaceutics-11-00432"><label>213.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hong</surname><given-names>Y.</given-names></name><name><surname>Gong</surname><given-names>Y.</given-names></name><name><surname>Gao</surname><given-names>C.</given-names></name><name><surname>Shen</surname><given-names>J.</given-names></name></person-group><article-title>Collagen-coated polylactide microcarriers/chitosan hydrogel composite: Injectable scaffold for cartilage regeneration</article-title><source>J. Biomed. Mater. Res. A</source><year>2008</year><volume>85</volume><fpage>628</fpage><lpage>637</lpage><pub-id pub-id-type="doi">10.1002/jbm.a.31603</pub-id><pub-id pub-id-type="pmid">17806117</pub-id></element-citation></ref><ref id="B214-pharmaceutics-11-00432"><label>214.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>R.</given-names></name><name><surname>Moreira Teixeira</surname><given-names>L.S.</given-names></name><name><surname>Dijkstra</surname><given-names>P.J.</given-names></name><name><surname>Karperien</surname><given-names>M.</given-names></name><name><surname>van Blitterswijk</surname><given-names>C.A.</given-names></name><name><surname>Zhong</surname><given-names>Z.Y.</given-names></name><name><surname>Feijen</surname><given-names>J.</given-names></name></person-group><article-title>Injectable chitosan-based hydrogels for cartilage tissue engineering</article-title><source>Biomaterials</source><year>2009</year><volume>30</volume><fpage>2544</fpage><lpage>2551</lpage><pub-id pub-id-type="doi">10.1016/j.biomaterials.2009.01.020</pub-id><pub-id pub-id-type="pmid">19176242</pub-id></element-citation></ref><ref id="B215-pharmaceutics-11-00432"><label>215.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>Z.S.</given-names></name><name><surname>Cui</surname><given-names>X.</given-names></name><name><surname>Hou</surname><given-names>R.X.</given-names></name><name><surname>Li</surname><given-names>Q.</given-names></name><name><surname>Deng</surname><given-names>H.X.</given-names></name><name><surname>Fu</surname><given-names>J.</given-names></name></person-group><article-title>Tough biodegradable chitosan&#x02013;gelatin hydrogels via in situ precipitation for potential cartilage tissue engineering</article-title><source>RSC Adv.</source><year>2015</year><volume>5</volume><fpage>55640</fpage><lpage>55647</lpage><pub-id pub-id-type="doi">10.1039/C5RA06835E</pub-id></element-citation></ref><ref id="B216-pharmaceutics-11-00432"><label>216.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>H.</given-names></name><name><surname>Lee</surname><given-names>K.Y.</given-names></name></person-group><article-title>Cartilage regeneration using biodegradable oxidized alginate/hyaluronate hydrogels</article-title><source>J. Biomed. Mater. Res. A</source><year>2014</year><volume>102</volume><fpage>4519</fpage><lpage>4525</lpage><pub-id pub-id-type="doi">10.1002/jbm.a.35126</pub-id><?supplied-pmid 24677739?><pub-id pub-id-type="pmid">24677739</pub-id></element-citation></ref><ref id="B217-pharmaceutics-11-00432"><label>217.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>X.</given-names></name><name><surname>Liu</surname><given-names>S.</given-names></name><name><surname>Yildirimer</surname><given-names>L.</given-names></name><name><surname>Zhao</surname><given-names>H.</given-names></name><name><surname>Ding</surname><given-names>R.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Cui</surname><given-names>W.</given-names></name><name><surname>Weitz</surname><given-names>D.</given-names></name></person-group><article-title>Injectable Stem Cell-Laden Photocrosslinkable Microspheres Fabricated Using Microfluidics for Rapid Generation of Osteogenic Tissue Constructs</article-title><source>Adv. Funct. Mater.</source><year>2016</year><volume>26</volume><fpage>2809</fpage><lpage>2819</lpage><pub-id pub-id-type="doi">10.1002/adfm.201504943</pub-id></element-citation></ref><ref id="B218-pharmaceutics-11-00432"><label>218.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perrier-Groult</surname><given-names>E.</given-names></name><name><surname>P&#x000e9;r&#x000e8;s</surname><given-names>E.</given-names></name><name><surname>Pasdeloup</surname><given-names>M.</given-names></name><name><surname>Gazzolo</surname><given-names>L.</given-names></name><name><surname>Duc Dodon</surname><given-names>M.</given-names></name><name><surname>Mallein-Gerin</surname><given-names>F.</given-names></name></person-group><article-title>Evaluation of the biocompatibility and stability of allogeneic tissue-engineered cartilage in humanized mice</article-title><source>PLoS ONE</source><year>2019</year><volume>14</volume><elocation-id>e0217183</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0217183</pub-id><?supplied-pmid 31107916?><pub-id pub-id-type="pmid">31107916</pub-id></element-citation></ref><ref id="B219-pharmaceutics-11-00432"><label>219.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patzelt</surname><given-names>A.</given-names></name><name><surname>Mak</surname><given-names>W.C.</given-names></name><name><surname>Jung</surname><given-names>S.</given-names></name><name><surname>Knorr</surname><given-names>F.</given-names></name><name><surname>Meinke</surname><given-names>M.C.</given-names></name><name><surname>Richter</surname><given-names>H.</given-names></name><name><surname>R&#x000fc;hl</surname><given-names>E.</given-names></name><name><surname>Cheung</surname><given-names>K.Y.</given-names></name><name><surname>Tran</surname><given-names>N.B.N.N.</given-names></name><name><surname>Lademann</surname><given-names>J.</given-names></name></person-group><article-title>Do nanoparticles have a future in dermal drug delivery?</article-title><source>J. Control. Release</source><year>2017</year><volume>246</volume><fpage>174</fpage><lpage>182</lpage><pub-id pub-id-type="doi">10.1016/j.jconrel.2016.09.015</pub-id><?supplied-pmid 27641832?><pub-id pub-id-type="pmid">27641832</pub-id></element-citation></ref><ref id="B220-pharmaceutics-11-00432"><label>220.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Du</surname><given-names>Q.</given-names></name><name><surname>Jiang</surname><given-names>L.</given-names></name><name><surname>Wang</surname><given-names>X.Q.</given-names></name><name><surname>Pan</surname><given-names>W.</given-names></name><name><surname>She</surname><given-names>F.F.</given-names></name><name><surname>Chen</surname><given-names>Y.L.</given-names></name></person-group><article-title>Establishment of and comparison between orthotopic xenograft and subcutaneous xenograft models of gallbladder carcinoma</article-title><source>Asian Pac. J. Cancer Prev.</source><year>2014</year><volume>15</volume><fpage>3747</fpage><lpage>3752</lpage><pub-id pub-id-type="doi">10.7314/APJCP.2014.15.8.3747</pub-id><?supplied-pmid 24870787?><pub-id pub-id-type="pmid">24870787</pub-id></element-citation></ref><ref id="B221-pharmaceutics-11-00432"><label>221.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Gysen</surname><given-names>K.</given-names></name><name><surname>Kneebone</surname><given-names>A.</given-names></name><name><surname>Alfieri</surname><given-names>F.</given-names></name><name><surname>Guo</surname><given-names>L.</given-names></name><name><surname>Eade</surname><given-names>T.</given-names></name></person-group><article-title>Feasibility of and rectal dosimetry improvement with the use of SpaceOAR<sup>&#x000ae;</sup> hydrogel for dose-escalated prostate cancer radiotherapy</article-title><source>J. Med. Imaging Radiat. Oncol.</source><year>2014</year><volume>58</volume><fpage>511</fpage><lpage>516</lpage><pub-id pub-id-type="doi">10.1111/1754-9485.12152</pub-id><?supplied-pmid 24580893?><pub-id pub-id-type="pmid">24580893</pub-id></element-citation></ref><ref id="B222-pharmaceutics-11-00432"><label>222.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Juneja</surname><given-names>P.</given-names></name><name><surname>Kneebone</surname><given-names>A.</given-names></name><name><surname>Booth</surname><given-names>J.T.</given-names></name><name><surname>Thwaites</surname><given-names>D.I.</given-names></name><name><surname>Kaur</surname><given-names>R.</given-names></name><name><surname>Colvill</surname><given-names>E.</given-names></name><name><surname>Ng</surname><given-names>J.A.</given-names></name><name><surname>Keall</surname><given-names>P.J.</given-names></name><name><surname>Eade</surname><given-names>T.</given-names></name></person-group><article-title>Prostate motion during radiotherapy of prostate cancer patients with and without application of a hydrogel spacer: A comparative study</article-title><source>Radiat. Oncol.</source><year>2015</year><volume>10</volume><fpage>215</fpage><pub-id pub-id-type="doi">10.1186/s13014-015-0526-1</pub-id><pub-id pub-id-type="pmid">26499473</pub-id></element-citation></ref><ref id="B223-pharmaceutics-11-00432"><label>223.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>C.</given-names></name><name><surname>Lu</surname><given-names>Q.</given-names></name><name><surname>Zhang</surname><given-names>Z.</given-names></name><name><surname>Xue</surname><given-names>M.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Zhou</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>Z.</given-names></name><etal/></person-group><article-title>A Randomized Controlled Trial on the Efficacy and Safety of a New Crosslinked Hyaluronan Gel in Reducing Adhesions after Gynecologic Laparoscopic Surgeries</article-title><source>J. Minim. Invasive Gynecol.</source><year>2015</year><volume>22</volume><fpage>853</fpage><lpage>863</lpage><pub-id pub-id-type="doi">10.1016/j.jmig.2015.04.011</pub-id><pub-id pub-id-type="pmid">25906706</pub-id></element-citation></ref><ref id="B224-pharmaceutics-11-00432"><label>224.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>M.C.</given-names></name><name><surname>French</surname><given-names>H.M.</given-names></name><name><surname>Graham</surname><given-names>A.D.</given-names></name><name><surname>Sanders</surname><given-names>T.L.</given-names></name></person-group><article-title>Effects of Daily Irrigation on Corneal Epithelial Permeability and Adverse Events With Silicone Hydrogel Contact Lens Continuous Wear</article-title><source>Investig. Ophthalmol. Vis. Sci.</source><year>2014</year><volume>55</volume><fpage>776</fpage><pub-id pub-id-type="doi">10.1167/iovs.13-13508</pub-id><pub-id pub-id-type="pmid">24425854</pub-id></element-citation></ref><ref id="B225-pharmaceutics-11-00432"><label>225.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tagliaferri</surname><given-names>A.</given-names></name><name><surname>Love</surname><given-names>T.E.</given-names></name><name><surname>Szczotka-Flynn</surname><given-names>L.B.</given-names></name></person-group><article-title>Risk Factors for Contact Lens&#x02013;Induced Papillary Conjunctivitis Associated With Silicone Hydrogel Contact Lens Wear</article-title><source>Eye Contact Lens Sci. Clin. Pract.</source><year>2014</year><volume>40</volume><fpage>117</fpage><lpage>122</lpage><pub-id pub-id-type="doi">10.1097/ICL.0000000000000019</pub-id><?supplied-pmid 24681609?><pub-id pub-id-type="pmid">24681609</pub-id></element-citation></ref><ref id="B226-pharmaceutics-11-00432"><label>226.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szczotka-Flynn</surname><given-names>L.</given-names></name><name><surname>Lass</surname><given-names>J.H.</given-names></name><name><surname>Sethi</surname><given-names>A.</given-names></name><name><surname>Debanne</surname><given-names>S.</given-names></name><name><surname>Benetz</surname><given-names>B.A.</given-names></name><name><surname>Albright</surname><given-names>M.</given-names></name><name><surname>Gillespie</surname><given-names>B.</given-names></name><name><surname>Kuo</surname><given-names>J.</given-names></name><name><surname>Jacobs</surname><given-names>M.R.</given-names></name><name><surname>Rimm</surname><given-names>A.</given-names></name></person-group><article-title>Risk Factors for Corneal Infiltrative Events during Continuous Wear of Silicone Hydrogel Contact Lenses</article-title><source>Investig. Ophthalmol. Vis. Sci.</source><year>2010</year><volume>51</volume><fpage>5421</fpage><pub-id pub-id-type="doi">10.1167/iovs.10-5456</pub-id><?supplied-pmid 20538985?><pub-id pub-id-type="pmid">20538985</pub-id></element-citation></ref><ref id="B227-pharmaceutics-11-00432"><label>227.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Varikooty</surname><given-names>J.</given-names></name><name><surname>Keir</surname><given-names>N.</given-names></name><name><surname>Richter</surname><given-names>D.</given-names></name><name><surname>Jones</surname><given-names>L.W.</given-names></name><name><surname>Woods</surname><given-names>C.</given-names></name><name><surname>Fonn</surname><given-names>D.</given-names></name></person-group><article-title>Comfort Response of Three Silicone Hydrogel Daily Disposable Contact Lenses</article-title><source>Optom. Vis. Sci.</source><year>2013</year><volume>90</volume><fpage>945</fpage><lpage>953</lpage><pub-id pub-id-type="doi">10.1097/OPX.0b013e31829d8dbf</pub-id><?supplied-pmid 23892493?><pub-id pub-id-type="pmid">23892493</pub-id></element-citation></ref><ref id="B228-pharmaceutics-11-00432"><label>228.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fallacara</surname><given-names>A.</given-names></name><name><surname>Vertuani</surname><given-names>S.</given-names></name><name><surname>Panozzo</surname><given-names>G.</given-names></name><name><surname>Pecorelli</surname><given-names>A.</given-names></name><name><surname>Valacchi</surname><given-names>G.</given-names></name><name><surname>Manfredini</surname><given-names>S.</given-names></name></person-group><article-title>Novel Artificial Tears Containing Cross-Linked Hyaluronic Acid: An In Vitro Re-Epithelialization Study</article-title><source>Molecules</source><year>2017</year><volume>22</volume><elocation-id>2104</elocation-id><pub-id pub-id-type="doi">10.3390/molecules22122104</pub-id><?supplied-pmid 29189737?><pub-id pub-id-type="pmid">29189737</pub-id></element-citation></ref><ref id="B229-pharmaceutics-11-00432"><label>229.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Altman</surname><given-names>D.</given-names></name><name><surname>Ghilotti</surname><given-names>F.</given-names></name><name><surname>Bellocco</surname><given-names>R.</given-names></name><name><surname>Zetterstr&#x000f6;m</surname><given-names>J.</given-names></name><name><surname>Kopp Kallner</surname><given-names>H.</given-names></name></person-group><article-title>Transurethral Polyacrylamide Hydrogel Injection Therapy in Women Not Eligible for Midurethral Sling Surgery</article-title><source>Female Pelvic Med. Reconstr. Surg.</source><year>2017</year><volume>23</volume><fpage>318</fpage><lpage>323</lpage><pub-id pub-id-type="doi">10.1097/SPV.0000000000000385</pub-id><?supplied-pmid 28106655?><pub-id pub-id-type="pmid">28106655</pub-id></element-citation></ref><ref id="B230-pharmaceutics-11-00432"><label>230.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Green</surname><given-names>A.L.</given-names></name><name><surname>Arnaud</surname><given-names>A.</given-names></name><name><surname>Batiller</surname><given-names>J.</given-names></name><name><surname>Eljamel</surname><given-names>S.</given-names></name><name><surname>Gauld</surname><given-names>J.</given-names></name><name><surname>Jones</surname><given-names>P.</given-names></name><name><surname>Martin</surname><given-names>D.</given-names></name><name><surname>Mehdorn</surname><given-names>M.</given-names></name><name><surname>Ohman</surname><given-names>J.</given-names></name><name><surname>Weyns</surname><given-names>F.</given-names></name></person-group><article-title>A multicentre, prospective, randomized, controlled study to evaluate the use of a fibrin sealant as an adjunct to sutured dural repair</article-title><source>Br. J. Neurosurg.</source><year>2015</year><volume>29</volume><fpage>11</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.3109/02688697.2014.948808</pub-id><?supplied-pmid 25112563?><pub-id pub-id-type="pmid">25112563</pub-id></element-citation></ref><ref id="B231-pharmaceutics-11-00432"><label>231.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agren</surname><given-names>M.S.</given-names></name></person-group><article-title>An amorphous hydrogel enhances epithelialisation of wounds</article-title><source>Acta Derm. Venereol.</source><year>1998</year><volume>78</volume><fpage>119</fpage><lpage>122</lpage><?supplied-pmid 9534889?><pub-id pub-id-type="pmid">9534889</pub-id></element-citation></ref><ref id="B232-pharmaceutics-11-00432"><label>232.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naggara</surname><given-names>O.</given-names></name><name><surname>Darsaut</surname><given-names>T.</given-names></name><name><surname>Trystram</surname><given-names>D.</given-names></name><name><surname>Tselikas</surname><given-names>L.</given-names></name><name><surname>Raymond</surname><given-names>J.</given-names></name></person-group><article-title>Unruptured intracranial aneurysms: Why we must not perpetuate the impasse for another 25 years</article-title><source>Lancet Neurol.</source><year>2014</year><volume>13</volume><fpage>537</fpage><lpage>538</lpage><pub-id pub-id-type="doi">10.1016/S1474-4422(14)70091-2</pub-id><pub-id pub-id-type="pmid">24849854</pub-id></element-citation></ref><ref id="B233-pharmaceutics-11-00432"><label>233.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>White</surname><given-names>P.M.</given-names></name><name><surname>Lewis</surname><given-names>S.C.</given-names></name><name><surname>Gholkar</surname><given-names>A.</given-names></name><name><surname>Sellar</surname><given-names>R.J.</given-names></name><name><surname>Nahser</surname><given-names>H.</given-names></name><name><surname>Cognard</surname><given-names>C.</given-names></name><name><surname>Forrester</surname><given-names>L.</given-names></name><name><surname>Wardlaw</surname><given-names>J.M.</given-names></name></person-group><article-title>Hydrogel-coated coils versus bare platinum coils for the endovascular treatment of intracranial aneurysms (HELPS): A randomised controlled trial</article-title><source>Lancet</source><year>2011</year><volume>377</volume><fpage>1655</fpage><lpage>1662</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(11)60408-X</pub-id><pub-id pub-id-type="pmid">21571149</pub-id></element-citation></ref><ref id="B234-pharmaceutics-11-00432"><label>234.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kusano</surname><given-names>T.</given-names></name><name><surname>Etoh</surname><given-names>T.</given-names></name><name><surname>Akagi</surname><given-names>T.</given-names></name><name><surname>Ueda</surname><given-names>Y.</given-names></name><name><surname>Shiroshita</surname><given-names>H.</given-names></name><name><surname>Yasuda</surname><given-names>K.</given-names></name><name><surname>Satoh</surname><given-names>M.</given-names></name><name><surname>Inomata</surname><given-names>M.</given-names></name><name><surname>Shiraishi</surname><given-names>N.</given-names></name><name><surname>Kitano</surname><given-names>S.</given-names></name></person-group><article-title>Evaluation of 0.6% sodium alginate as a submucosal injection material in endoscopic submucosal dissection for early gastric cancer</article-title><source>Dig. Endosc.</source><year>2014</year><volume>26</volume><fpage>638</fpage><lpage>645</lpage><pub-id pub-id-type="doi">10.1111/den.12268</pub-id><pub-id pub-id-type="pmid">24655031</pub-id></element-citation></ref><ref id="B235-pharmaceutics-11-00432"><label>235.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allison</surname><given-names>R.R.</given-names></name><name><surname>Ambrad</surname><given-names>A.A.</given-names></name><name><surname>Arshoun</surname><given-names>Y.</given-names></name><name><surname>Carmel</surname><given-names>R.J.</given-names></name><name><surname>Ciuba</surname><given-names>D.F.</given-names></name><name><surname>Feldman</surname><given-names>E.</given-names></name><name><surname>Finkelstein</surname><given-names>S.E.</given-names></name><name><surname>Gandhavadi</surname><given-names>R.</given-names></name><name><surname>Heron</surname><given-names>D.E.</given-names></name><name><surname>Lane</surname><given-names>S.C.</given-names></name><etal/></person-group><article-title>Multi-institutional, randomized, double-blind, placebo-controlled trial to assess the efficacy of a mucoadhesive hydrogel (MuGard) in mitigating oral mucositis symptoms in patients being treated with chemoradiation therapy for cancers of the head and neck</article-title><source>Cancer</source><year>2014</year><volume>120</volume><fpage>1433</fpage><lpage>1440</lpage><pub-id pub-id-type="doi">10.1002/cncr.28553</pub-id><?supplied-pmid 24877167?><pub-id pub-id-type="pmid">24877167</pub-id></element-citation></ref><ref id="B236-pharmaceutics-11-00432"><label>236.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mettler</surname><given-names>L.</given-names></name><name><surname>Hucke</surname><given-names>J.</given-names></name><name><surname>Bojahr</surname><given-names>B.</given-names></name><name><surname>Tinneberg</surname><given-names>H.R.</given-names></name><name><surname>Leyland</surname><given-names>N.</given-names></name><name><surname>Avelar</surname><given-names>R.</given-names></name></person-group><article-title>A safety and efficacy study of a resorbable hydrogel for reduction of post-operative adhesions following myomectomy</article-title><source>Hum. Reprod.</source><year>2008</year><volume>23</volume><fpage>1093</fpage><lpage>1100</lpage><pub-id pub-id-type="doi">10.1093/humrep/den080</pub-id><?supplied-pmid 18346996?><pub-id pub-id-type="pmid">18346996</pub-id></element-citation></ref><ref id="B237-pharmaceutics-11-00432"><label>237.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ingenito</surname><given-names>E.P.</given-names></name><name><surname>Berger</surname><given-names>R.L.</given-names></name><name><surname>Henderson</surname><given-names>A.C.</given-names></name><name><surname>Reilly</surname><given-names>J.J.</given-names></name><name><surname>Tsai</surname><given-names>L.</given-names></name><name><surname>Hoffman</surname><given-names>A.</given-names></name></person-group><article-title>Bronchoscopic Lung Volume Reduction Using Tissue Engineering Principles</article-title><source>Am. J. Respir. Crit. Care Med.</source><year>2003</year><volume>167</volume><fpage>771</fpage><lpage>778</lpage><pub-id pub-id-type="doi">10.1164/rccm.200208-842OC</pub-id><?supplied-pmid 12406835?><pub-id pub-id-type="pmid">12406835</pub-id></element-citation></ref><ref id="B238-pharmaceutics-11-00432"><label>238.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reilly</surname><given-names>J.</given-names></name><name><surname>Washko</surname><given-names>G.</given-names></name><name><surname>Pinto-Plata</surname><given-names>V.</given-names></name><name><surname>Velez</surname><given-names>E.</given-names></name><name><surname>Kenney</surname><given-names>L.</given-names></name><name><surname>Berger</surname><given-names>R.</given-names></name><name><surname>Celli</surname><given-names>B.</given-names></name></person-group><article-title>Biological Lung Volume Reduction</article-title><source>Chest</source><year>2007</year><volume>131</volume><fpage>1108</fpage><lpage>1113</lpage><pub-id pub-id-type="doi">10.1378/chest.06-1754</pub-id><?supplied-pmid 17426216?><pub-id pub-id-type="pmid">17426216</pub-id></element-citation></ref><ref id="B239-pharmaceutics-11-00432"><label>239.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zaetta</surname><given-names>J.M.</given-names></name><name><surname>Licht</surname><given-names>M.O.</given-names></name><name><surname>Fisher</surname><given-names>J.S.</given-names></name><name><surname>Avelar</surname><given-names>R.L.</given-names></name></person-group><article-title>A Lung Biopsy Tract Plug for Reduction of Postbiopsy Pneumothorax and Other Complications: Results of a Prospective, Multicenter, Randomized, Controlled Clinical Study</article-title><source>J. Vasc. Interv. Radiol.</source><year>2010</year><volume>21</volume><fpage>1235</fpage><lpage>1243</lpage><pub-id pub-id-type="doi">10.1016/j.jvir.2010.04.021</pub-id><?supplied-pmid 20656223?><pub-id pub-id-type="pmid">20656223</pub-id></element-citation></ref><ref id="B240-pharmaceutics-11-00432"><label>240.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takehara</surname><given-names>N.</given-names></name><name><surname>Tsutsumi</surname><given-names>Y.</given-names></name><name><surname>Tateishi</surname><given-names>K.</given-names></name><name><surname>Ogata</surname><given-names>T.</given-names></name><name><surname>Tanaka</surname><given-names>H.</given-names></name><name><surname>Ueyama</surname><given-names>T.</given-names></name><name><surname>Takahashi</surname><given-names>T.</given-names></name><name><surname>Takamatsu</surname><given-names>T.</given-names></name><name><surname>Fukushima</surname><given-names>M.</given-names></name><name><surname>Komeda</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Controlled Delivery of Basic Fibroblast Growth Factor Promotes Human Cardiosphere-Derived Cell Engraftment to Enhance Cardiac Repair for Chronic Myocardial Infarction</article-title><source>J. Am. Coll. Cardiol.</source><year>2008</year><volume>52</volume><fpage>1858</fpage><lpage>1865</lpage><pub-id pub-id-type="doi">10.1016/j.jacc.2008.06.052</pub-id><pub-id pub-id-type="pmid">19038683</pub-id></element-citation></ref><ref id="B241-pharmaceutics-11-00432"><label>241.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mann</surname><given-names>D.L.</given-names></name><name><surname>Lee</surname><given-names>R.J.</given-names></name><name><surname>Coats</surname><given-names>A.J.S.</given-names></name><name><surname>Neagoe</surname><given-names>G.</given-names></name><name><surname>Dragomir</surname><given-names>D.</given-names></name><name><surname>Pusineri</surname><given-names>E.</given-names></name><name><surname>Piredda</surname><given-names>M.</given-names></name><name><surname>Bettari</surname><given-names>L.</given-names></name><name><surname>Kirwan</surname><given-names>B.-A.</given-names></name><name><surname>Dowling</surname><given-names>R.</given-names></name><etal/></person-group><article-title>One-year follow-up results from AUGMENT-HF: A multicentre randomized controlled clinical trial of the efficacy of left ventricular augmentation with Algisyl in the treatment of heart failure</article-title><source>Eur. J. Heart Fail.</source><year>2016</year><volume>18</volume><fpage>314</fpage><lpage>325</lpage><pub-id pub-id-type="doi">10.1002/ejhf.449</pub-id><pub-id pub-id-type="pmid">26555602</pub-id></element-citation></ref><ref id="B242-pharmaceutics-11-00432"><label>242.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anker</surname><given-names>S.D.</given-names></name><name><surname>Coats</surname><given-names>A.J.S.</given-names></name><name><surname>Cristian</surname><given-names>G.</given-names></name><name><surname>Dragomir</surname><given-names>D.</given-names></name><name><surname>Pusineri</surname><given-names>E.</given-names></name><name><surname>Piredda</surname><given-names>M.</given-names></name><name><surname>Bettari</surname><given-names>L.</given-names></name><name><surname>Dowling</surname><given-names>R.</given-names></name><name><surname>Volterrani</surname><given-names>M.</given-names></name><name><surname>Kirwan</surname><given-names>B.A.</given-names></name><etal/></person-group><article-title>A prospective comparison of alginate-hydrogel with standard medical therapy to determine impact on functional capacity and clinical outcomes in patients with advanced heart failure (AUGMENT-HF trial)</article-title><source>Eur. Heart J.</source><year>2015</year><volume>36</volume><fpage>2297</fpage><lpage>2309</lpage><pub-id pub-id-type="doi">10.1093/eurheartj/ehv259</pub-id><pub-id pub-id-type="pmid">26082085</pub-id></element-citation></ref><ref id="B243-pharmaceutics-11-00432"><label>243.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Osbun</surname><given-names>J.W.</given-names></name><name><surname>Ellenbogen</surname><given-names>R.G.</given-names></name><name><surname>Chesnut</surname><given-names>R.M.</given-names></name><name><surname>Chin</surname><given-names>L.S.</given-names></name><name><surname>Connolly</surname><given-names>P.J.</given-names></name><name><surname>Cosgrove</surname><given-names>G.R.</given-names></name><name><surname>Delashaw</surname><given-names>J.B.</given-names></name><name><surname>Golfinos</surname><given-names>J.G.</given-names></name><name><surname>Greenlee</surname><given-names>J.D.W.</given-names></name><name><surname>Haines</surname><given-names>S.J.</given-names></name><etal/></person-group><article-title>A Multicenter, Single-Blind, Prospective Randomized Trial to Evaluate the Safety of a Polyethylene Glycol Hydrogel (Duraseal Dural Sealant System) as a Dural Sealant in Cranial Surgery</article-title><source>World Neurosurg.</source><year>2012</year><volume>78</volume><fpage>498</fpage><lpage>504</lpage><pub-id pub-id-type="doi">10.1016/j.wneu.2011.12.011</pub-id><pub-id pub-id-type="pmid">22381303</pub-id></element-citation></ref><ref id="B244-pharmaceutics-11-00432"><label>244.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palladini</surname><given-names>M.</given-names></name><name><surname>Boesl</surname><given-names>I.</given-names></name><name><surname>Koenig</surname><given-names>S.</given-names></name><name><surname>Buchheister</surname><given-names>B.</given-names></name><name><surname>Attal</surname><given-names>N.</given-names></name></person-group><article-title>Lidocaine medicated plaster, an additional potential treatment option for localized post-surgical neuropathic pain: Efficacy and safety results of a randomized, placebo-controlled trial</article-title><source>Curr. Med. Res. Opin.</source><year>2019</year><volume>35</volume><fpage>757</fpage><lpage>766</lpage><pub-id pub-id-type="doi">10.1080/03007995.2019.1565709</pub-id><pub-id pub-id-type="pmid">30614286</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="pharmaceutics-11-00432-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Hydrogel medical applications.</p></caption><graphic xlink:href="pharmaceutics-11-00432-g001"/></fig><fig id="pharmaceutics-11-00432-f002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Stimuli sensitive hydrogels structural changes. (<bold>A</bold>) Stimuli categories: physical, biological and chemical. (<bold>B</bold>) Physical hydrogels are non-covalently crosslinked and in an aqueous environment, they swell. Under various stimuli presence, they undergo reversible structure modifications and release the compound. (<bold>C</bold>) Chemical hydrogels describes covalently crosslinked formulation that swells in aqueous conditions and then suffers reversible or irreversible alterations depending on stimuli presence and crosslinking strength, which influence their discharge.</p></caption><graphic xlink:href="pharmaceutics-11-00432-g002"/></fig><fig id="pharmaceutics-11-00432-f003" orientation="portrait" position="float"><label>Figure 3</label><caption><p>In vivo drug delivery hydrogel routes of administration. There are various methods for in vivo administration of hydrogel based products depending on the pathological conditions and their localization. Subcutaneous injection plays a crucial role in toxicological effects evaluation. Topical or transdermal application is preferred for skin associated problems. Orthotopic and intraperitoneal injections are non-invasive techniques which ensure good therapy results. On the other hand, oral administration has some limitations because of digestive enzymes.</p></caption><graphic xlink:href="pharmaceutics-11-00432-g003"/></fig><table-wrap id="pharmaceutics-11-00432-t001" orientation="portrait" position="float"><object-id pub-id-type="pii">pharmaceutics-11-00432-t001_Table 1</object-id><label>Table 1</label><caption><p>Hydrogel classification according various parameters, their properties and corresponding applications.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Parameter </th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Hydrogel Type</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Hydrogel Composition</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Properties </th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Applications </th></tr></thead><tbody><tr><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Chemical stimuli</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">pH responsive </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Carboxylated agarose/tannic acid hydrogel scaffolds cross-linked with zinc ions [<xref rid="B60-pharmaceutics-11-00432" ref-type="bibr">60</xref>]<break/>Poly(acrylamide-<italic>co</italic>-acrylic acid) poly(AAm-<italic>co</italic>-AAc) hydrogels [<xref rid="B61-pharmaceutics-11-00432" ref-type="bibr">61</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sustained release of the incorporated drugs [<xref rid="B60-pharmaceutics-11-00432" ref-type="bibr">60</xref>]<break/>Biocompatibility [<xref rid="B60-pharmaceutics-11-00432" ref-type="bibr">60</xref>]<break/>Strong electrostatic interactions and stability [<xref rid="B61-pharmaceutics-11-00432" ref-type="bibr">61</xref>]<break/>Increased hydrophilicity and swelling [<xref rid="B62-pharmaceutics-11-00432" ref-type="bibr">62</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Drug delivery [<xref rid="B54-pharmaceutics-11-00432" ref-type="bibr">54</xref>,<xref rid="B60-pharmaceutics-11-00432" ref-type="bibr">60</xref>]<break/>Sensing [<xref rid="B63-pharmaceutics-11-00432" ref-type="bibr">63</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ionic strength responsive</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2-acrylamido-2-methylpropane sulfonic acid crosslinked with <italic>N</italic>,<italic>N</italic>&#x02019;-methylene(bis)acrylamide [<xref rid="B34-pharmaceutics-11-00432" ref-type="bibr">34</xref>]<break/>Poly(<italic>N</italic>-isopropylacrylamide) crosslinked with imidazolium-based dicationic ionic liquid [<xref rid="B64-pharmaceutics-11-00432" ref-type="bibr">64</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Increased swelling properties [<xref rid="B34-pharmaceutics-11-00432" ref-type="bibr">34</xref>]<break/>Controllable porous structure [<xref rid="B34-pharmaceutics-11-00432" ref-type="bibr">34</xref>]<break/>Biodegradability [<xref rid="B65-pharmaceutics-11-00432" ref-type="bibr">65</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Depollution of aqueous ecosystems [<xref rid="B64-pharmaceutics-11-00432" ref-type="bibr">64</xref>]<break/>Drug and gene delivery [<xref rid="B47-pharmaceutics-11-00432" ref-type="bibr">47</xref>]<break/>Tissue engineering [<xref rid="B47-pharmaceutics-11-00432" ref-type="bibr">47</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Solvent composition responsive</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fluorenylmethoxycarbonyl diphenylalanine [<xref rid="B36-pharmaceutics-11-00432" ref-type="bibr">36</xref>]<break/>Poly(<italic>N</italic>-isopropylacrylamide) and poly(<italic>N</italic>,Ndimethylacrylamide) mixtures [<xref rid="B66-pharmaceutics-11-00432" ref-type="bibr">66</xref>]<break/>Poly(<italic>N</italic>-isopropylacrylamide) [<xref rid="B67-pharmaceutics-11-00432" ref-type="bibr">67</xref>,<xref rid="B68-pharmaceutics-11-00432" ref-type="bibr">68</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Uniform networks [<xref rid="B36-pharmaceutics-11-00432" ref-type="bibr">36</xref>]<break/>Swelling behaviour responsive to temperature too [<xref rid="B66-pharmaceutics-11-00432" ref-type="bibr">66</xref>]<break/>High porosity, Heterogeneous structure [<xref rid="B67-pharmaceutics-11-00432" ref-type="bibr">67</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sensing [<xref rid="B68-pharmaceutics-11-00432" ref-type="bibr">68</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Molecules responsive</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>N</italic>-isopropylacrylamide crosslinked with <italic>N</italic>,<italic>N</italic>&#x02032;-methylenebis(acrylamide) [<xref rid="B69-pharmaceutics-11-00432" ref-type="bibr">69</xref>]<break/>Acrylamide crosslinked with polyethylene glycol [<xref rid="B70-pharmaceutics-11-00432" ref-type="bibr">70</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Achieves molecular recognition, High affinity and specificity [<xref rid="B71-pharmaceutics-11-00432" ref-type="bibr">71</xref>]<break/>Controlled assembly [<xref rid="B72-pharmaceutics-11-00432" ref-type="bibr">72</xref>]<break/>Controlled release [<xref rid="B43-pharmaceutics-11-00432" ref-type="bibr">43</xref>]<break/>Enzyme responsive [<xref rid="B70-pharmaceutics-11-00432" ref-type="bibr">70</xref>]<break/>Antigen responsive [<xref rid="B69-pharmaceutics-11-00432" ref-type="bibr">69</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sensing [<xref rid="B73-pharmaceutics-11-00432" ref-type="bibr">73</xref>]<break/>Drug delivery [<xref rid="B37-pharmaceutics-11-00432" ref-type="bibr">37</xref>]<break/>Cell culture [<xref rid="B72-pharmaceutics-11-00432" ref-type="bibr">72</xref>]</td></tr><tr><td rowspan="5" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Physical stimuli</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Temperature responsive</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>N</italic>-trimethyl chitosan chloride polymers crosslinked with poly(ethylene glycol) and glycerophosphate [<xref rid="B74-pharmaceutics-11-00432" ref-type="bibr">74</xref>]<break/>Poly(<italic>N</italic>-vinylcaprolactam) grafted with poly(ethylene oxide) [<xref rid="B75-pharmaceutics-11-00432" ref-type="bibr">75</xref>]<break/>Poly(<italic>N</italic>-isopropylacrylamide) and aminated alginate [<xref rid="B76-pharmaceutics-11-00432" ref-type="bibr">76</xref>]<break/>Poly(<italic>N</italic>-vinylcaprolactam) [<xref rid="B77-pharmaceutics-11-00432" ref-type="bibr">77</xref>]<break/>Methoxy poly(ethylene glycol)-poly(pyrrolidone-<italic>co</italic>-lactide) [<xref rid="B78-pharmaceutics-11-00432" ref-type="bibr">78</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Two categories: low critical solution temperature [<xref rid="B74-pharmaceutics-11-00432" ref-type="bibr">74</xref>] and upper critical solution temperature [<xref rid="B75-pharmaceutics-11-00432" ref-type="bibr">75</xref>]<break/>Sol &#x02013;gel transition at 37 &#x000b0;C [<xref rid="B79-pharmaceutics-11-00432" ref-type="bibr">79</xref>]<break/>Easy functionalization with drug molecules [<xref rid="B80-pharmaceutics-11-00432" ref-type="bibr">80</xref>] Unique physical properties similar to extracellular matrix [<xref rid="B81-pharmaceutics-11-00432" ref-type="bibr">81</xref>]<break/>Controlled degradation [<xref rid="B76-pharmaceutics-11-00432" ref-type="bibr">76</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tissue engineering [<xref rid="B76-pharmaceutics-11-00432" ref-type="bibr">76</xref>,<xref rid="B77-pharmaceutics-11-00432" ref-type="bibr">77</xref>,<xref rid="B78-pharmaceutics-11-00432" ref-type="bibr">78</xref>,<xref rid="B82-pharmaceutics-11-00432" ref-type="bibr">82</xref>], Drug delivery [<xref rid="B80-pharmaceutics-11-00432" ref-type="bibr">80</xref>,<xref rid="B82-pharmaceutics-11-00432" ref-type="bibr">82</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Electric field responsive</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Polypyrrole polymeric nanoparticles loaded in poly lactic-<italic>co</italic>-glycolic acid and poly(ethyleneglycol) hydrogel [<xref rid="B83-pharmaceutics-11-00432" ref-type="bibr">83</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Controlled release of the cargo [<xref rid="B84-pharmaceutics-11-00432" ref-type="bibr">84</xref>] depending on the strength or the duration of applied electric field [<xref rid="B83-pharmaceutics-11-00432" ref-type="bibr">83</xref>]<break/>Biocompatibility, Minimal invasiveness [<xref rid="B83-pharmaceutics-11-00432" ref-type="bibr">83</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Drug delivery [<xref rid="B84-pharmaceutics-11-00432" ref-type="bibr">84</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Magnetic field responsive</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hemicellulose crosslinked with O-acetyl-galactoglucomannan [<xref rid="B85-pharmaceutics-11-00432" ref-type="bibr">85</xref>]<break/>Gelatin hydrogels loaded with magnetic nanoparticles [<xref rid="B86-pharmaceutics-11-00432" ref-type="bibr">86</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Successful absorption and controlled release of drugs [<xref rid="B85-pharmaceutics-11-00432" ref-type="bibr">85</xref>]<break/>Some of them dispose of anisotropic properties [<xref rid="B87-pharmaceutics-11-00432" ref-type="bibr">87</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tissue engineering [<xref rid="B86-pharmaceutics-11-00432" ref-type="bibr">86</xref>]<break/>Microfluidics, drug delivery, contrast agents [<xref rid="B88-pharmaceutics-11-00432" ref-type="bibr">88</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Light responsive</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hydroxypropyl methylcellulose and Carbopol hydrogels containing diclofenac-sodium chitosan microspheres [<xref rid="B89-pharmaceutics-11-00432" ref-type="bibr">89</xref>]<break/>Poly[2-((4,5-dimethoxy-2-nitrobenzyl)oxy)-<italic>N</italic>-(2-(methacryloyloxy)ethyl)-<italic>N</italic>, <italic>N</italic>-dimethyl-2-oxoethan-1-aminium] [<xref rid="B90-pharmaceutics-11-00432" ref-type="bibr">90</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reasonable strengthens according to application [<xref rid="B89-pharmaceutics-11-00432" ref-type="bibr">89</xref>]<break/>Reversible and irreversible, Spatiotemporal control over functional groups, Controlled release [<xref rid="B91-pharmaceutics-11-00432" ref-type="bibr">91</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Drug delivery [<xref rid="B89-pharmaceutics-11-00432" ref-type="bibr">89</xref>]<break/>Self-sterilization and self-cleaning [<xref rid="B90-pharmaceutics-11-00432" ref-type="bibr">90</xref>]<break/>Microfluidics [<xref rid="B92-pharmaceutics-11-00432" ref-type="bibr">92</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pressure responsive</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Polyacrylamide and poly(acrylamide-hydroxyethyl methacrylate) [<xref rid="B93-pharmaceutics-11-00432" ref-type="bibr">93</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Thermo- and pH sensitive [<xref rid="B94-pharmaceutics-11-00432" ref-type="bibr">94</xref>]<break/>Adhesion capacity, elasticity [<xref rid="B93-pharmaceutics-11-00432" ref-type="bibr">93</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sensing [<xref rid="B95-pharmaceutics-11-00432" ref-type="bibr">95</xref>]<break/>Drug delivery [<xref rid="B96-pharmaceutics-11-00432" ref-type="bibr">96</xref>]</td></tr><tr><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Polymer origin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Natural </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nanofibrillar cellulose [<xref rid="B97-pharmaceutics-11-00432" ref-type="bibr">97</xref>]<break/>Thiolated gelatin-poly(ethylene glycol) diacrylate [<xref rid="B98-pharmaceutics-11-00432" ref-type="bibr">98</xref>]<break/>Methacrylated gelatin [<xref rid="B99-pharmaceutics-11-00432" ref-type="bibr">99</xref>]<break/>Polycaprolactone sandwiched in a gelatin-chitosan hydrogel [<xref rid="B100-pharmaceutics-11-00432" ref-type="bibr">100</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Biomimetic and adhesion capacity [<xref rid="B101-pharmaceutics-11-00432" ref-type="bibr">101</xref>]<break/>Mechanical support for cell development [<xref rid="B102-pharmaceutics-11-00432" ref-type="bibr">102</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tissue engineering [<xref rid="B101-pharmaceutics-11-00432" ref-type="bibr">101</xref>,<xref rid="B103-pharmaceutics-11-00432" ref-type="bibr">103</xref>,<xref rid="B104-pharmaceutics-11-00432" ref-type="bibr">104</xref>], Drug delivery, Sensing [<xref rid="B102-pharmaceutics-11-00432" ref-type="bibr">102</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Synthetic </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Low acyl gellan gum bilayered hydrogel scaffolds [<xref rid="B105-pharmaceutics-11-00432" ref-type="bibr">105</xref>]<break/><italic>N</italic>-isopropylacrylamide and itaconic acid [<xref rid="B106-pharmaceutics-11-00432" ref-type="bibr">106</xref>]<break/>Poly(ethylene glycol)&#x02014;poly(propylene glycol) copolymers [<xref rid="B107-pharmaceutics-11-00432" ref-type="bibr">107</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Controllable structure and other physico-chemical properties [<xref rid="B102-pharmaceutics-11-00432" ref-type="bibr">102</xref>]<break/>Stimuli responsive [<xref rid="B106-pharmaceutics-11-00432" ref-type="bibr">106</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Drug delivery [<xref rid="B106-pharmaceutics-11-00432" ref-type="bibr">106</xref>]<break/>Tissue engineering [<xref rid="B108-pharmaceutics-11-00432" ref-type="bibr">108</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hybrid </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Alginate-polymethacrylate [<xref rid="B109-pharmaceutics-11-00432" ref-type="bibr">109</xref>]<break/>Chondroitin sulfate and poly(ethylene glycol) [<xref rid="B110-pharmaceutics-11-00432" ref-type="bibr">110</xref>]<break/>Chitosan/hyaluronic acid hydrogels loaded with poly (lactic-<italic>co</italic>-glycolic acid) microspheres [<xref rid="B111-pharmaceutics-11-00432" ref-type="bibr">111</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Biomimetic capacity [<xref rid="B109-pharmaceutics-11-00432" ref-type="bibr">109</xref>]<break/>Multicomponent [<xref rid="B112-pharmaceutics-11-00432" ref-type="bibr">112</xref>]<break/>Heterogeneous composition [<xref rid="B113-pharmaceutics-11-00432" ref-type="bibr">113</xref>]<break/>Responsive to environment changes [<xref rid="B114-pharmaceutics-11-00432" ref-type="bibr">114</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tissue engineering, drug delivery [<xref rid="B112-pharmaceutics-11-00432" ref-type="bibr">112</xref>]<break/>Wound-healing [<xref rid="B111-pharmaceutics-11-00432" ref-type="bibr">111</xref>]</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Biodegradability </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Biodegradable </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Chitosan-gelatin [<xref rid="B115-pharmaceutics-11-00432" ref-type="bibr">115</xref>]<break/>Pectin-<italic>co</italic>-poly(methacrylic acid) [<xref rid="B116-pharmaceutics-11-00432" ref-type="bibr">116</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Stable and biocompatible [<xref rid="B116-pharmaceutics-11-00432" ref-type="bibr">116</xref>]<break/>Biomimetic capacity [<xref rid="B117-pharmaceutics-11-00432" ref-type="bibr">117</xref>]<break/>Natural and synthetic polymeric structure [<xref rid="B117-pharmaceutics-11-00432" ref-type="bibr">117</xref>]<break/>Stimuli responsive [<xref rid="B118-pharmaceutics-11-00432" ref-type="bibr">118</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Drug delivery [<xref rid="B116-pharmaceutics-11-00432" ref-type="bibr">116</xref>]<break/>Tissue engineering [<xref rid="B117-pharmaceutics-11-00432" ref-type="bibr">117</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Non-biodegradable</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Poly(2-hydroxyethyl methacrylate) [<xref rid="B58-pharmaceutics-11-00432" ref-type="bibr">58</xref>]<break/>Poly(2-hydroxyethyl methacrylate)/trimethylolpropane trimethacrylate [<xref rid="B119-pharmaceutics-11-00432" ref-type="bibr">119</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Biocompatibility [<xref rid="B58-pharmaceutics-11-00432" ref-type="bibr">58</xref>]<break/>Sustained release and recharge [<xref rid="B119-pharmaceutics-11-00432" ref-type="bibr">119</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tissue engineering [<xref rid="B58-pharmaceutics-11-00432" ref-type="bibr">58</xref>]<break/>Drug delivery [<xref rid="B119-pharmaceutics-11-00432" ref-type="bibr">119</xref>]<break/>Plastic and reconstruction surgery [<xref rid="B120-pharmaceutics-11-00432" ref-type="bibr">120</xref>]</td></tr></tbody></table></table-wrap><table-wrap id="pharmaceutics-11-00432-t002" orientation="portrait" position="float"><object-id pub-id-type="pii">pharmaceutics-11-00432-t002_Table 2</object-id><label>Table 2</label><caption><p>Different completed clinical trials using hydrogel based products (<uri>ClinicalTrials.gov</uri>).</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Condition </th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Product</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Benefits</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Reference</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Prostate cancer radiotherapy</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hydrogel spacer</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Minimal side effects and toxicity<break/>Improves rectal dosimetry <break/>Reduces the rates of rectal toxicity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B221-pharmaceutics-11-00432" ref-type="bibr">221</xref>,<xref rid="B222-pharmaceutics-11-00432" ref-type="bibr">222</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gynecologic laparoscopic surgery</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Crosslinked hyaluronan gel</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Safety use<break/>Minimizes postoperative adhesion formation throughout the abdominopelvic cavity </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B223-pharmaceutics-11-00432" ref-type="bibr">223</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Corneal epithelial permeability</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Silicone hydrogel contact lenses</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Improves epithelial permeability when used with ophthalmic solutions</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B224-pharmaceutics-11-00432" ref-type="bibr">224</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Corneal infiltrates</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Identification of bacterial species during continuous wear of contact lenses<break/>Improved cornea response to contact lenses</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B225-pharmaceutics-11-00432" ref-type="bibr">225</xref>,<xref rid="B226-pharmaceutics-11-00432" ref-type="bibr">226</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Myopia</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Good ocular comfort<break/>High oxygen transmissibility</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B227-pharmaceutics-11-00432" ref-type="bibr">227</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dry eye syndrome</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Crosslinked hyaluronic acid with liposomes and crocin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Safety profile<break/>Promotes re-epithelialization</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B228-pharmaceutics-11-00432" ref-type="bibr">228</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Urinary incontinence</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Polyacrylamide hydrogel</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Facilitates urinary incontinence symptoms for patients that are ineligible for midurethral sling surgery<break/>Low rate of adverse effects</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B229-pharmaceutics-11-00432" ref-type="bibr">229</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cerebrospinal fluid leak</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fibrin sealant </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Efficient adjunct to dural sutures repair<break/>Safe profile</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B230-pharmaceutics-11-00432" ref-type="bibr">230</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Diabetes, foot ulcer</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hydrogel/hydrocolloid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Promotes wound healing<break/>Confers protection<break/>Stimulates epithelial migration</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B231-pharmaceutics-11-00432" ref-type="bibr">231</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Intracranial aneurysm</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Hydrogel coils</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Efficient endovascular coil embolization<break/>Safe profile</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B232-pharmaceutics-11-00432" ref-type="bibr">232</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cerebral aneurysm</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Improves aneurysm packing<break/>Decreases major recurrence</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B233-pharmaceutics-11-00432" ref-type="bibr">233</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Submucosal tumor of gastrointestinal tract</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Calcium-alginate gel</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No adverse events and no tissue injuries<break/>Increases mucosa-elevating capacity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B234-pharmaceutics-11-00432" ref-type="bibr">234</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Oral mucositis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mucoadhesive hydrogel</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Safety profile and tolerability<break/>Reduces oral mucositis symptoms</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B235-pharmaceutics-11-00432" ref-type="bibr">235</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Myoma </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Resorbable hydrogel</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Safety and efficacy<break/>Reduces post-operative adhesions formation following myomectomy</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B236-pharmaceutics-11-00432" ref-type="bibr">236</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pulmonary emphysema</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fibrin hydrogel</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Safe profile and no major adverse effects<break/>Promotes the formation of scar tissue<break/>Improves lung function</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B237-pharmaceutics-11-00432" ref-type="bibr">237</xref>,<xref rid="B238-pharmaceutics-11-00432" ref-type="bibr">238</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lung cancer biopsy</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hydrogel plug</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reduces postbiopsy pneumothorax and other complications associated with CT guided coaxial needle biopsy</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B239-pharmaceutics-11-00432" ref-type="bibr">239</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ischemic cardiomyopathy</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gelatin hydrogel </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Controlled release of fibroblast growth factor<break/>Increases the formation of cardiovascular networks<break/>Improves ventricular function</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B240-pharmaceutics-11-00432" ref-type="bibr">240</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Heart failure</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Alginate hydrogel</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Efficiency and safety profile<break/>No serious adverse effects<break/>Increases exercise capacity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B241-pharmaceutics-11-00432" ref-type="bibr">241</xref>,<xref rid="B242-pharmaceutics-11-00432" ref-type="bibr">242</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Elective cranial procedures with dural incision</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PEG hydrogel</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Safe profile<break/>Dural closure augmentation<break/>Rapid preparation and application</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B243-pharmaceutics-11-00432" ref-type="bibr">243</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Neuropathic pain</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lidocaine plaster</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Safety and tolerability profile<break/>Relevant pain reduction</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B244-pharmaceutics-11-00432" ref-type="bibr">244</xref>]</td></tr></tbody></table></table-wrap></floats-group></article>